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ABSTRACT OF DISSERTATION
Two types of placentitis were studied: ascending and nocardioform placentitis.
Although the first diagnosis of nocardioform placentitis was made three decades ago, little
is known about the disease, due to the lack of an experimental model. In attempt to develop
a research model, Crossiella equi was inoculated through intrauterine, intravenous,
intrapharyngeal, and oral routes, but none of the routes resulted in nocardioform placentitis.
This may indicate that unidentified factors may play a role in disease pathogenesis and that
simple presence of bacteria is not sufficient to induce nocardioform placentitis. The second
and major component of this dissertation involved the identification of diagnostic markers
for placentitis. Because ascending bacterial placentitis is readily and predictably induced
using existing experimental models, this model was used to identify diagnostic markers for
placentitis in maternal plasma and fetal fluids. Three potential biomarkers were examined:
acute phase inflammatory proteins, steroid hormones produced by the fetoplacental unit,
and protein composition of the fetal fluids. Of the three acute phase proteins investigated,
serum amyloid A and haptoglobin but not fibrinogen increased in association with
experimentally induced ascending placentitis. Androgens and progestins appear to be poor
markers for placentitis. Serum estradiol 17β concentrations were reduced in mares with
experimentally induced placentitis and appear to be a good marker for placentitis in mares.
Different methods were used to study the protein composition of the fetal fluids. Alphafetoprotein was characterized as a major protein present in the equine fetal fluids, and this
protein was elevated in plasma of mares with placentitis. In another study, using a highthroughput proteomic technique several new proteins were characterized in the amniotic
and allantoic fluids of mares carrying normal pregnancies, and several previously
uncharacterized proteins were detected in the allantoic fluid of mares with placentitis.
Three secreting proteins were elevated in allantoic fluid of mares with experimentally
induced ascending placentitis.
Key-words: ascending placentitis, nocardioform placentitis, pregnancy loss, premature
delivery, abortion
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Chapter 1
Review of the Literature

1.1. Introduction
Late-term pregnancy wastage generates several million dollars of losses to horse
owners each year due to the costs of producing a pregnancy (i.e. breeding fees, semen
transport, feed, vaccinations, veterinary services, etc.). Additionally, late term pregnancy
loss may also cause significant emotional stress to the owner that might have high
expectations for the foal from a particular mating. Placentitis, an important cause of lateterm pregnancy wastage, is estimated to affect 3 to 5% of pregnancies in Thoroughbred
mares (Troedsson & Zent 2004). Therefore, means to prevent pregnancy loss are
warranted.
Placental pathology/insufficiency was identified in a large retrospective study as
being responsible for greater than 60% of pregnancy losses (i.e. abortions, stillbirths and
neonatal deaths up to 24 hours post-delivery) in central Kentucky (Giles et al. 1993). Two
additional retrospective studies carried several years apart by the same referral diagnostic
laboratory supported the finding that placentitis was the most common cause of late
pregnancy loss in mares (Hong et al. 1993, Williams et al. 2004). Outside North America,
placentitis has also been indicated as an important cause of pregnancy loss in mares in
Brazil (Moreira et al. 1998, Marcolongo-Pereira et al. 2012), France (Laugier et al. 2011),
and Australia (Carrick et al. 2014). However, in the United Kingdom umbilical cord
pathology (e.g. torsion and entrapments) was the leading cause of pregnancy loss in
submissions received by a referral diagnostic laboratory (Smith et al. 2003). These
differences between the United Kingdom and the rest of the world can probably be
1

accounted for the methodology applied to diagnose placentitis, type of placentas presenting
lesions which are submitted for pathologic examination, presence of certain
microorganisms (e.g. nocardioform organisms) as well as potential differences in the true
incidence of diseases.

1.2. Overview of Etiopathogenesis and Epidemiology of Placentitis

Several infectious agents have been commonly recovered from placentitis cases;
bacteria are responsible for the large majority of cases and fungi for the minority (Table
1.1). Bacterial agents commonly associated with the occurrence of placentitis include
Streptococcus equi subspecies zooepidemicus, Escherichia coli, Klebsiella pneumoniae,
Pseudomonas aeruginosa, Leptospira sp, Crossiella equi (C. equi) and Amycolatopsis
species (Amycolatopsis kentuckyensis, Amycolatopsis lexingtonensis and Amycolatopsis
pretoriensis) (Hong et al. 1993, Giles et al. 1993, Moreira et al. 1998, Williams et al. 2004)
(Table 1.1). Fungi associated with equine placentitis primarily include Aspergillus ssp and
Candida albicans (Hong et al. 1993).
Leptospiral infection causing abortions are highly variable across the years in
central Kentucky (Williams et al. 2004, Erol et al. 2014). In North America, the serovar
Pomona type Kennewicki is the most important type associated with Leptospiral abortions
in mares (Sheorian et al. 2000, Timoney et al. 2011, Erol et al. 2014); however, in other
parts of the world, the serovars Bratislava, Grippotyphosa, Copenhageni, Autumnalis,
Hebdomadis, Arborea and Icterohaemorrhagiae are more commonly associated with
abortions in mares (for review, Erol et al. 2014).

Environmental conditions (e.g.

precipitation and flooding) are alleged to be important in the dissemination of the bacteria
2

from wildlife to horses (which are considered incidental hosts). Wild animals (e.g.
raccoons, white tailed deer, striped skunks, opossums, and red grey foxes) have been shown
to harbor the serovar Pomona and are thought to play a role as source of infection for
pregnant mares (Timoney et al. 2011).

Table 1.1: Ten most commonly isolated microorganisms in 236 equine placentitis cases in
central Kentucky. Adapted from Hong et al. (1993).
Frequency
Microorganisms
Number of cases
%
Streptococcus equi subspecies zooepidemicus
39
16.5
Leptospira ssp.
37
15.7
Escherichia coli
33
14.0
Fungi
16
6.7
Pseudomonas aeruginosa
11
4.7
Streptococcus equisimilis
11
4.7
Enterobacter agglomerans
5
2.1
Klebsiella pneumonia
5
2.1
α-hemolytic Streptococcus
5
2.1
Staphylococcus aureus
2
0.9
Based upon morphologic lesions and suggested pathogenesis, there are four
different types of equine placentitis: ascending, focal mucoid (nocardioform), diffuse
(hematogenous), and multifocal (Williams et al. 2004) (Figure 1.1). Ascending placentitis,
the most frequent type of placentitis, is commonly associated with beta hemolytic
streptococci and coliforms (Hong et al. 1993) (Table 1.1). Nocardioform placentitis is
commonly associated with Gram-positive branching bacilli, C. equi and Amycolatopsis
species (Figure 1.2) (Donahue & Williams 2000). In certain years, nocardioform placentitis
is the predominant type of equine placentitis in central Kentucky (Williams et al. 2004,
Carter et al. 2012) (Figure 1.3). A multifocal distribution is a rare type of placentitis and
has been sporadically seen in isolated cases in association with fungi or bacteria (Hong et
3

al. 1993, Williams et al. 2004). Diffuse placentitis can be diagnosed as isolated cases in
association with bacteria or fungi or during outbreaks mainly in association with
Leptospirosis (Figure 1.3).
Figure 1.1: Representative photographs of the four morphologic types of equine placentitis.
(A) ascending placentitis (focal extensive lesion in the chorionic surface of the
chorioallantois); arrows indicate extensive funisitis, while the asterisk indicates the
chorionic surface affected by placentititis, #: indicates aminiotinitis (B) Nocardioform
(focal mucoid lesion in the chorionic surface) ** extensive chorionic surfrace covered by
mucus; (C) hematogenous (Diffuse erosive lesions present in the allantoic surface of the
chorioallantois); (D) multifocal, in the allantoic surface view, multifoci areas of infection
can be observed in this placenta. Courtesy Dr. Neil Williams (photo B) and Dr. Rafaela
De Negri (photo C).

4

Figure 1.2: Morphologic aspects of nocardioform microorganisms in culture and
photomicrographs of Gram-stained microorganisms. (A) Amycolatopsis ssp. Three species
of Amycolatopsis have been identified in association with nocardioform placentitis: A.
kentuckyensis, A. lexingtonensis, and A. pretoriensis. (B) Gram staining of Amycolatopsis
ssp, note the Gram + and branching aspect of the organisms. (C) Crossiella equi culture
morphology, note the “donut-shape” of each colony. (D) Gram staining of Crossiella equi,
note the Gram + and branching aspect of the organisms. Courtesy Dr. Erdal Erol.

5

Figure 1.3: Confirmed placentitis cases in cases submitted to the University of Kentucky
Veterinary Diagnostic Laboratory during the 2010, 2011 and 2012 foaling seasons.
Courtesy Dr. Craig Carter. The graphic below is divided in three groups, other types of
placentitis including multifocal, ascending; nocardioform placentitis and leptospiral
abortions.

Other types of placentitis
Nocardioform placentitis
Leptospiral abortions

In ascending placentitis, it has been suggested that infectious agents (i.e. bacteria
and fungi) enter the uterus via the vagina/cervix and then colonize the caudal pole of the
chorioallantois (LeBlanc 2010, Troedsson & Macpherson 2011) (Figure 1.4). Once the
infection has been established, clinical signs such premature udder development (±
streaming of pre-foaling mammary gland secretions), and vulvar discharge may become
noticeable. Normal mammary gland development starts about 4 weeks (2 to 6 weeks) from
the foaling, with more pronounced development in the week of parturition. Premature
6

mammary gland development is not a pathognomonic sign of placentitis, but rather a nonspecific sign of pending late-term pregnancy loss which can be associated with different
conditions, such as twin pregnancy, umbilical cord torsion, and idiopathic imminent
abortion (Macpherson 2006, Troedsson & Macpherson 2011). Enlargement of the
mammary gland may be observed in mares suffering with hydrops, pre-pubic tendon
rupture (mammary gland may be filled with serosanguineous/bloody material and cranially
displaced), and normal pre-foaling ventral edema (Lofstedt 2011). In mares with
placentitis, premature mammary development might not be present until the placental
lesions are well advanced. Vulvar discharge is highly variable, as the discharge can be
smeared by and under the mare’s tail and easily missed, unless frequent monitoring is
applied. If early treatment is not applied, the lesions will progress, and then the infectious
agent(s) may gain access to the fetus through the placental vessels and umbilical cord
(Figure 1.4).
Figure 1.4: Representative diagram of the suggested pathogenesis of ascending placentitis
in mares. Adapted from LeBlanc et al. (2012)
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Infection of the chorioallantois is associated with inflammation which results in
elevation of prostaglandins (i.e. PGE2 and PGF2α) in the fetal fluids and increased
expression of pro-inflammatory cytokines (e.g. IL-6 and IL-8) (LeBlanc et al. 2002, 2012).
Lesions in mares with ascending placentitis are not restricted to the chorioallantois but in
certain cases of ascending placentitis, funisitis and amnionitis are also present (Hong et al.
1993, Williams et al. 2004). Ultimately, prostaglandin release has been suggested to lead
to abortion or delivery of a premature foal (LeBlanc et al. 2002, 2012) (Figure 1.4).
Chronic placentitis leads to placental insufficiency, which may result in growth retardation
and delivery of nonviable or weak foals. Foals born alive from mares with placentitis may
be born septic and may demand intensive veterinary critical care. In addition, despite
treatment pre-partum or and post-delivery there is no guarantee that the foal will be
athletically sound. Thus, early diagnosis and subsequent treatment are likely to improve
the possibility of delivering a live foal.
Placentitis accelerates the hypothalamic-pituitary adrenal axis (HPA) maturation
(Lyle et al. 2006, Troedsson & Macpherson, 2011). Mares with placentitis may deliver
live and viable foals by 310 days of gestation (Christensen et al. 2006, Troedsson &
Macpherson 2011), while dead foals often will be delivered, if pregnancies of comparable
gestational age of mares without placentitis are interrupted. The mechanisms associated
with survival of preterm foals from mares with placentitis are unclear, but it has been
suggested that it is related to a premature rise in fetal ACTH and cortisol. Different than
other species, final maturation of the equine fetal HPA occurs in the few days preceding
normal parturition and continues during the first several weeks after birth (for review, Hart
& Barton 2012). Foals born prematurely presented lower cortisol concentrations (<3µg/dL)
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within 2 hours post-delivery compared to normal full-term foals (12-14 µg/dl) (Rossdale
et al. 1991). In addition, premature foals showed remarkably higher ACTH concentrations
in comparison to normal full-term foals (650 pg/mL vs 300 pg/mL within the first 30
minutes post-delivery). In mares with placentitis, treatment strategies to prevent premature
delivery should be applied, thus prolonging fetal time in utero which may allow more fetal
maturation and as consequence improve the outcome for neonatal survival.
Nocardioform placentitis was first recognized ~20 years ago in central Kentucky
(Giles et al. 1986); however, little is known about the pathogenesis of this disease. Lesions
in this type of placentitis are located in the uterine body and base of the uterine horns with
no association with the cervical star (Hong et al. 1993). As a consequence, vulvar discharge
is not commonly observed in the mare with nocardioform placentitis unless the mare is
about to abort. Based upon submissions to a referral laboratory in central Kentucky, C.
equi appear to be more pathogenic than Amycolatopsis species, as more mares infected
with C. equi tend to abort, while more mares infected with Amycolatopsis ssp tend to
delivery live, premature foals.

Because nocardioform infection is restricted to the

chorioallantois (i.e. amnion, umbilical cord and fetus are not affected) (Hong et al. 1993),
chorionitis is believed to accelerate fetal maturation and to induce placental insufficiency
(i.e. In-utero growth retardation).
Little is known about the pathogenesis of diffuse or multifocal placentitis, it is
suggested that the microorganisms reach the uterus hematogenously; however, there has
been speculation that multifocal placentitis is the result of a dormant chronic infection of
the uterus that became active later in pregnancy. In multifocal placentitis, lesions can be
confined to the chorion and may also be present on the allantoic surface (Hong et al. 1993,
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Williams et al. 2004). Leptospira, the most important cause of hematogenous (or diffuse)
placentitis, is believed to gain access to the uterus through the systemic circulation.
Leptospiral lesions include amnionitis, funisitis and acute inflammatory changes in the
chorioallantois (Hong et al. 1993, Donahue & Williams 2000). Interestingly, leptospiral
abortions are associated with high immunoglobulin titers in maternal plasma, different than
other types of placentitis (Donahue & Williams 2000, Erdal et al. 2014). Leptospira is
believed to cause abortion directly by infection of the fetoplacental unit, but it appears that
systemic inflammation in association with hyperthermia and prostaglandin production may
contribute to the pregnancy loss.

1.3. Diagnosis of Placentitis

Currently the diagnosis of placentitis is based on ultrasonography and clinical signs
(i.e. premature lactation and/or vulvar discharge) (LeBlanc 2010, Troedsson &
Macpherson 2011). Transrectal ultrasonography of the caudal placental pole is commonly
used to diagnose ascending placentitis (Renaudin et al. 1997, Troedsson & Zent 2004,
Bucca et al. 2005, Troedsson & Macpherson 2011) (Figure 1.5). While performing this
technique, the operator should make a perfect midline alignment of the transducer with the
cervix and ventral aspect of the caudal pole, to assure that a branch of uterine artery/cranial
vaginal artery is imaged. Three measurements are usually taken of the combined thickness
of uterus and placenta (CTUP) and the values can be compared to reported normal ranges
(Renaudin et al. 1997, Troedsson & Zent 2004, Coutinho da Silva et al. 2013). Increased
CTUP associated with clinical signs and areas of placental separation are suggestive of
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ascending placentitis (Troedsson & Macpherson 2011). Interestingly, there appears to be
small variations in normal CTUP between horse breeds (Renaudin et al. 1997, Troedsson
& Zent 2004, Bucca et al. 2005, Hendricks et al. 2009, Coutinho da Silva et al. 2013). In
a Dutch study, parity was reported to have effects on values of CTUP, i.e. nulliparous mares
presented higher values compared to multiparous mares (Hendricks et al. 2009). Despite
the widespread use of transrectal ultrasonography to diagnose ascending placentitis, data
on sensitivity and specificity are scant.
Transabdominal ultrasonographic examination of the fetus and placenta has been
commonly used as a tool to assess fetal and placental health (Bucca et al. 2005, Bucca
2011). This approach is a particularly useful clinical tool in suspected nocardioform
placentitis (Wolfsdorf et al. 2000, Troedsson & Macpherson 2011). However, since a very
limited area of the uterus is accurately visualized by transabdominal ultrasonographic
examination, the lack of apparent lesions in the chorioallantois does not exclude the
possibility of disease. Areas of placental separation with hyperechoic exudate between the
chorioallantois and the uterus are suggestive of nocardioform placentitis (Wolfsdorf et al.
2000, Troedsson & Macpherson 2011). Presumptive diagnosis of nocardioform placentitis
can be challenging, especially if only a small area is affected. Therefore, the development
of an experimental model for this disease would help investigators to better understand its
pathogenesis, diagnosis and treatment.
Fetal heart rate monitoring and ultrasonographic character of the fetal fluids can
also be evaluated by transrectal and transabdominal ultrasonography (Reef et al. 1996,
Bucca 2011, Coutinho da Silva et al. 2013). Reduced or increased fetal heart rates (i.e.
normal heart rates ~80 beats per minute during late pregnancy) are associated with poor
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pregnancy outcome (Reef et al. 1996, Troedsson & Macpherson 2011). Increased
echogenicity of the fetal fluids are associated with imminent abortion (Troedsson &
Macpherson 2011). It is worth noting that the echogenicity of the amniotic fluid increases
with gestational age (Coutinho da Silva et al. 2013), probably related to the vernix being
released by the fetus. However, fetal stress (e.g. colic surgery, fetal hypoxia by different
reasons) may result in fetal diarrhea, and echogenicity of the amniotic fluid may increase
remarkably as consequence of solid particles floating in the amniotic fluid. The normal
amnion appears as a thin membrane surrounding the fetus; amnionitis can be observed by
ultrasonography as a thickened and irregular amniotic membrane (Troedsson &
Macpherson 2011).
Figure 1.5: Transrectal ultrasonography of the caudal pole of the chorioallantois. (A)
Normal ultrasonographic appearance of the chorioallantois and combined thickness of
uterus and placenta (i.e. <8mm) in a mare at 270 days of gestation (--); (B) Note fluid
accumulation and separation of the chorioallantois from the uterus (*), this finding is
consistent with early signs of placentitis.

Cytology and culture swabs obtained from the external cervical os in pregnant
mares can be beneficial in cases of ascending placentitis, when the cervix is open and
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discharge is present (Figure 1.6) (LeBlanc 2010). Samples for culture and cytology can be
collected with the use of a double-guarded cytobrush/swab via vaginoscopy or manually
with a sterile sleeve. The presence of neutrophils, bacteria, and/or fungal hyphae will aid
the presumptive diagnosis and give some clues about the type infection (i.e. Gram
positive/negative and shape, or presence of hyphae) while waiting for further laboratorial
diagnostic tests.
The definitive diagnosis of placentitis is attained by pathologic and microbiologic
examination of the placenta (Hong et al. 1993, Giles et al. 1993, Donahue & Williams
2000). Ordinarily, the placenta should be laid out in an “F” or “Y” shape, thereafter the
chorionic surface of the chorioallantois is examined and sampled (Hong et al. 1993,
Schlafer 2004). Macroscopic examination of the placenta allows determination of the
affected areas, classification of the lesions and sampling for further examinations (i.e.
histopathology and microbiologic evaluations). The placenta should be inverted to expose
the allantoic surface of the chorioallantois, similarly the placenta should be laid out in an
“F” shape, the amnion and umbilical cord should be spread out, examined and sampled for
pathologic examination (Schlafer 2004). Affected areas, normal tissues, and areas of
transition between the normal and affected tissues should be sampled from the
chorioallantois, amnion and umbilical cord (Hong et al. 1993, Schlafer 2004).
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Figure 1.6: Cervical cytology collected from a mare with ascending placentitis. Note the
presence of several segmented neutrophils (example indicated by an asterisk) and several
bacterial colonies (Streptocccus species indicated by the arrow). Courtesy Dr. Barry Ball.

*

Swabs collected from affected placental tissues can be used for bacterial culture
and PCR testing for abortigenic infectious agents (e.g. Leptospira, equine herpesvirus type
1, equine arteritis virus) (Schlafer 2004, Williams et al. 2004, Erdal et al. 2014). Fetal
tissues (e.g. brain, liver, spleen, kidney, heart and lungs) and fetal body fluids (e.g. heart
blood, thoracic and abdominal fluids) can be used for diagnostic testing. Fragments of
placenta and fetal tissues can be collected, macerated, and be used for culture and PCR
testing (Hong et al. 1993, Schlafer 2004, Williams et al. 2004, Erol et al. 2014). A
combination of different diagnostic methods will improve the diagnostic accuracy (Hong
et al. 1993, Schlafer 2004, Erol et al. 2012, Erol et al. 2014). However, despite extensive
testing, in about 20% of abortions submitted to a referral laboratory in central Kentucky,
the cause of abortion could not be determined (Williams et al. 2004).
Lesions detected upon histopathologic examination of the placenta vary with the
infectious agent involved and chronicity of the infection (Hong et al. 1993). Acute bacterial
placentitis is characterized by neutrophilic infiltration of the inter-villous space and/or
necrosis of the chorionic villae (Hong et al. 1993, Williams et al. 2004). Chronic placentitis
is associated with necrosis of the chorionic villi, presence of eosinophilic amorphous
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material in the chorion, and/or infiltration of mononuclear cells in the intervillous spaces
(Hong et al. 1993). Other lesions reported in association with chronic placentitis include
chorioangiosis, hyperplasia with or without squamous metaplasia of the chorionic
epithelium, and adenomatous hyperplasia of the allantois (Hong et al. 1993). Leptospiral
placentitis is characterized by edema, placental hemorrhage, brown mucoid material, green
discoloration, cystic adenomatous hyperplasia of the allantois, vasculitis, amnionitis and
funisitis as well as by the presence of spirochetes (Hong et al. 1993, Donahue & Williams,
2000) (Figure 1.7). Severe fetal lesions are also a remarkable feature of leptospiral
abortion; the aborted fetus may be emaciated and icteric, present generalized edema and
fluid accumulation and severe degenerative inflammatory lesions of lungs, liver, kidneys
(Hong et al. 1993, Donahue & Williams, 2000, Williams et al. 2004).
In nocardioform placentitis, the macroscopic lesions are focal-extensive at the base
of the uterine horn(s) and cranial uterine body on the chorionic surface of the
chorioallantois, without involvement of the cervical star (Hong et al. 1993; Donahue &
Williams 2000). A brown tenacious, mucoid material is found overlying white granular
punctuate lesions (Hong et al. 1993). Histopathologic lesions are described as chronicactive; severely affected villi are often necrotic and coated with an extensive layer of
eosinophilic amorphous material mixed with neutrophils and colonies of long filamentous
branching bacteria (Hong et al. 1993, Donahue & Williams 2000). In less severely affected
areas the same type of exudate is present in the crypts and mononuclear cells are present
in the villous stroma and chorionic stroma. Endometritis is a common finding in mares
presenting with placentitis. Adenomatous hyperplasia of the allantoic epithelium and
hyperplasia with or without squamous metaplasia of the chorionic epithelium is frequently
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observed (Hong et al. 1993, Donahue & Williams 2000). Bacterial cultures of the affected
areas are routinely used as part of the necropsy diagnostic testing in pregnancy loss cases
(i.e. abortion cases, premature delivery and suspicious placentitis cases). Methods and
procedures for bacterial culture for nocardioform actinomycetes have been recently
improved (Labeda et al. 2003, Donahue & Williams 2000, Erol et al. 2012a). Analyses by
PCR analysis for actinomycetes (i.e. C. equi and Amycolatopsis ssp) has been incorporated
as a routine test for the diagnosis of nocardioform placentitis in central Kentucky (Erol et
al. 2012). The perceived advantage of PCR in comparison to other diagnostic tools includes
a rapid turnaround time; however, the specificity and sensitivity for PCR detection have
not been reported. At present, as for other abortigenic diseases, the combination of the
different diagnostic methods is highly recommended to maximize diagnostic accuracy.
Fungal placentitis is commonly associated with chronic extensive placentitis at the
cervical star. Similar to chronic bacterial placentitis, some fungi induce multifocal
granulomatous placentitis (Hong et al. 1993). Adenomatous hyperplasia of the allantoic
epithelium, with or without squamous metaplasia can be commonly observed in chronic
placentitis (e.g. fungal placentitis, E. coli and nocardioform placentitis) (Hong et al. 1993,
Shivaprasad et al. 1994). Fungal placentitis can be found in association with bacterial
placentitis. Anecdotally, treatment for bacterial placentitis may be associated with a
secondary fungal infection; however, such associations have not been studied.
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Figure 1.7: Leptospiral abortion. (A) Chorionitis, note large area of mottling and extensive
placental edema. (B) Severely emaciated fetus aborted in a mare affected with Leptospira.
(C) Severe amnionitis in a mare aborting due to Leptospira infection. Grossly, the amnion
was hemorrhagic and necrotic (indicated by asterisks). (D) Icteric fetal carcass (serosa),
note the rib impression on the liver as a consequence of the hepatic edema. Courtesy Dr.
Rafaela De Negri.

*

*

1.3.1 Diagnostic Markers for Equine Placentitis
Several molecules have been measured in blood from pregnant mares to evaluate
fetoplacental well-being. Over the last three decades, steroids produced by the fetoplacental
unit have received the most attention (Rossdale et al. 1991, Ousey et al. 2004, Douglas
2004, Morris et al. 2007, LeBlanc 2010). Other molecules including relaxin and “equine

17

feto-protein” have also been investigated in mares with pregnancy loss (Sorensen et al.
1990, Ryan et al. 2001, Ryan et al. 2009). Recently, serum amyloid A (SAA) has been
investigated as a prognostic marker for mares with experimentally induced ascending
placentitis (Coutinho da Silva et al. 2013). Therefore, different diagnostic markers for
placental health in mares will be discussed herein.

Fetoplacental steroids
During pregnancy several steroids (i.e. estrogens, progestins and androgens) are
produced and metabolized by the fetoplacental unit (Cox et al. 1975, Raeside et al. 1979,
Pashen and Allen 1979, Raeside 2004, Ousey 2011). These steroids achieve extremely
high concentrations in the maternal and fetoplacental circulation (Ousey et al. 2003, Ousey
2011). At the present, we have very limited understanding of the function of the different
steroids during pregnancy, particularly within the fetoplacental unit.

Progestins are

responsible for maintaining pregnancy (Ginther, 1992, Scholtz et al. 2014); however, it is
unclear what functions estrogens and androgens have during pregnancy in mares. Removal
of fetal gonads did not affect pregnancy maintenance; however, concentrations of PGFM,
a metabolite of PGF2α, was remarkably reduced, and as a consequence, the second stage
of labor was delayed (Pashen & Allen 1979, 1982).
Progestins can be subclassified as pregnenes and 5α pregnanes. Pregnenes include
pregnenolone, progesterone and 5-pregnene-3β,20β–diol (P5ββ); 5α-pregnanes include 5α
hydroxyprogesterone (5α-DHP), 3β5P, 20α-5P, ββdiol, 5-pregnene-3β,20α–diol (βαdiol),
however, 5αDHP, 20α5P, and βα-diol predominate (Chavatte-Palmer et al. 1997, Ousey et
al. 2003). During the first 100 days of pregnancy, progesterone is the main progestin, with
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5αDHP also being also present in high proportion starting from ovulation (Scholtz et al.
2014). It is produced by the primary corpus luteum, and secondary and accessory corpora
lutea (Ginther 1992). Starting by 70-100 days of gestation the main source of progestins is
the equine placenta (Holtan et al. 1978, Hinrichs et al. 1987), in fact removal of the
maternal ovaries by 100 days of gestation did not affect the pregnancy maintenance
(Hinrichs et al. 1987), however, removal of maternal ovaries by 70 days of pregnancy was
associated with pregnancy loss in 50% of the mares (Holtan et al. 1978). It is worth noting
that in addition to progesterone, 5α-DHP is also present in the maternal circulation during
early pregnancy and has been recently confirmed as a potent, bioactive progestin (Scholtz
et al. 2014). Interestingly, from approximately 150 days of pregnancy, progesterone is
present in very low concentrations in the maternal plasma (Short 1950), and it appears that
other progestins (e.g. 5α-DHP) are responsible for pregnancy maintenance. During the last
30 days of gestation, maternal concentrations of progesterone rise until immediately prior
to parturition (Holtan et al. 1975).
Measurement of progestins has been used to monitor placental health in
spontaneous and experimental cases of placentitis (Rossdale et al. 1991, Douglas 2004,
Ousey et al. 2007, Morris et al. 2007). Chronic placentitis (>7 days post-inoculation) in
experimentally induced mares was associated with increased plasma progestin
concentrations (Morris et al. 2007); however, in the same study, mares that developed acute
placentitis (abortion <4 days post inoculation) experienced a rapid decline in plasma
progestin concentrations. Spontaneous cases of placentitis have been reported to cause
elevation in total progestin concentrations (Douglas 2004, Ousey et al. 2007). This increase
in concentration of progestins is thought to be linked to the accelerated adrenal gland
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maturation in the fetus of pregnant mares experiencing chronic placentitis (Rossdale et al.
1991, Lyle et al. 2006). The adrenal gland is thought to produce pregnenolone, and this
molecule is used as a precursor for progesterone in the equine placenta. It is assumed that
placentitis increases the substrate (i.e. pregnenolone) which leads to an increased peripheral
progestin concentration in mares with chronic placentitis. It has also been suggested that
placentitis affects the ability of the placenta to metabolize progesterone into other
progestins, thus progesterone will appear in higher concentration in plasma. Repeated
measurements of plasma progestins in mares with placentitis have been proposed as a
useful method to identify mares that may abort or deliver prematurely (Douglas 2004,
Morris et al. 2007, Ousey et al. 2007).
During pregnancy, the equine fetal gonads of both male and female fetuses undergo
marked

hypertrophy

and

secrete

large

quantities

of

androgens,

particularly

dehydroepiandrosterone (DHEA) and 7-dehydro DHEA (Raeside et al. 1973, Pashen et
al. 1979, Raeside et al. 1997). Dehydroepiandrosterone serves as a precursor for classic
phenolic estrogens (i.e. estrone, estradiol-17β, estradiol-17α, and their sulfoconjugates),
and 7-dehydro-DHEA serves as a precursor for ring B unsaturated estrogens (i.e. equilin,
equilenin and their hydroxyderivatives 17α-dihydroequilin, 17α-dihydroequilenin, 17βdihydroequilin, and 17β-dihydroequilenin) by the equine placenta (Raeside et al. 1979,
Pashen & Allen 1979, Bhavnani 1988, Raeside et al. 1997, Ousey 2011). In addition to
DHEA, circulating testosterone is elevated in plasma of pregnant mares (Silberzahn et al.
1984, Daels et al. 1996). To date, determination of fetoplacental androgens have not been
critically assessed in mares experiencing pregnancy losses. Because androgens serve as
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precursors of estrogens, it seems logical that placentitis affects androgen concentrations in
the maternal circulation.
The equine blastocyst begins to secrete estrogens about 10 days post ovulation
(Zavy et al. 1984, Ginther 1993); thereafter, estrogens are produced by the corpora lutea
starting by 40 days of pregnancy (Daels et al. 1991). This ovarian secretion of estrogen is
believed to be mediated by eCG and will last until the demise of the corpora lutea around
150 days of gestation (Ginther 1992, Ousey 2011). Concomitant with ovarian secretion of
estrogens (i.e. by day 40 of gestation), the fetoplacental unit also starts to secrete estrogens.
Concentrations of estrogens in maternal circulation will increase remarkably through the
second trimester of pregnancy, and maximal concentrations are achieved by 210-240 days
of gestation. From the peak of estrogen concentrations in maternal circulation, there is a
progressive reduction in estrogen concentrations through the end of pregnancy with
minimal estrogen concentrations at parturition, which is contrary to reports in domestic
ruminants (Cox 1975, Ginther, 1992, Raeside 2004, Ousey 2011). The estrogen production
parallels the enlargement of the fetal gonads (Schlafer 2011, Ousey 2011). Since estrogens
are a final product of the fetoplacental unit, determination of peripheral estrogen
concentrations in pregnant mares may provide utility in the diagnosis of equine placentitis.
Determination of estrone sulfate concentrations in maternal circulation has been
suggested as a useful marker for fetal wellbeing during early pregnancy (Kashman et al.
1988, Jeffcott et al. 1987 Stabenfeldt et al. 1991); however, studies involving estrone
sulfate in advanced pregnancy are scant (Ousey et al. 1987, Santschi et al. 1991). There
are no controlled studies assessing estrone sulfate in mares experiencing placentitis, despite
its high popularity among practitioners which frequently use estrone sulfate as a test to
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assess fetal-wellbeing and placental health. Field observations carried by a commercial
laboratory, reported that aborting mares present significantly lower “total estrogen”
(unreported crossreactivity) concentrations than do mares maintaining pregnancy (Douglas
2004). Controlled studies are warranted to confirm field observations concerning the utility
of conjugated and unconjugated estrogen concentrations in pregnant mares as markers for
placentitis.
Acute phase proteins
Acute phase proteins (APP) are elevated when inflammation is present (Pepsy et
al. 1989, Peterson et al. 2004). This group of proteins is mainly produced by the liver in
response to an inflammatory stimulus (i.e. cytokines) (Husebeck et al. 1986, Nunokawa et
al. 1993, Jacobsen & Andersen 2007, Cray 2012). Acute phase proteins are classified as
minor, moderate and major; minor and moderate (i.e. constantly present in the plasma and
concentration increases 1 to 5 and 5 to 10 fold upon inflammation, respectively) and major
(i.e. low or undetectable concentrations in the blood circulation and upon inflammatory
stimulus increases >10 and often 100 to 1000 times) (Chrisman et al. 2006, Jacobsen &
Andersen 2007). The main acute phase protein in the horse is serum amyloid A, whereas
the moderate acute phase proteins include haptoglobin (Hp) and fibrinogen (Fb), and minor
C-reactive protein (CRP) and α1-acid glycoprotein (Jacobsen & Andersen 2007, Belgrave
et al. 2013, Cray & Belgrave 2014). As a moderate APP, Hp is constantly present in plasma
of health horses and concentrations are elevated upon inflammation (Jacobsen & Andersen,
2007, Cray, 2012).
In horses, Hp has recently been shown to be a useful marker for a variety of acutechronic clinical conditions (i.e. >4 days duration) (Cray & Belgrave 2014). Recently,

22

increases in peripheral blood concentrations of SAA have been reported in mares with
experimentally induced bacterial endometritis (Christoffersen et al. 2010) and ascending
placentitis (Coutinho da Silva et al. 2013). In healthy pregnant mares, SAA concentrations
remained low throughout the last half of gestation while showing a significant increase
beginning approximately 12 hours post-partum. Maternal SAA concentrations then return
to baseline within approximately 60 hours postpartum (Coutinho da Silva et al. 2013).
Interestingly, levels of SAA in peripheral blood have been reported to increase in mares
affected by placentitis and decrease again in response to treatment (Coutinho da Silva et
al. 2013). Fibrinogen, the most widely used APP in the horse, is commonly used in
association with white blood cell counts (WBC) as means to assess inflammation in the
horse (Chrisman et al. 2006, Belgrave et al. 2013); however, anecdotally it has been
suggested that neither WBC nor Fb change in mares with placentitis. To date SAA or Hp
have not been critically evaluated as diagnostic tool for mares with spontaneous and or
with experimentally induced ascending placentitis.

Relaxin
Relaxin, a hydrophilic polypeptide hormone, is a member of the insulin-like peptide
superfamily. Equine relaxin, which is the smallest relaxin among mammals, is composed
of two subunits (i.e. A: alpha 20-residue; and B: beta 28-residue) which are connected by
disulfide bonds similar to insulin (Ginther 1992, Hossain et al. 2006). It has been suggested
that relaxin plays an important role during pregnancy, and the proposed functions include
uterine growth, distensibility of uterus, cervix and pelvic ligaments (Ginther 1992). To date
the role of relaxin during equine pregnancy is not fully understood.
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Relaxin is produced by the equine placenta and can be detected in high
concentrations in the peripheral blood from day 80 of gestation until term (Stewart et al.
1982, Stewart et al. 1992). It has been reported that relaxin is a useful biomarker assess
placental health (Ryan et al. 1999, 2001). Ryan et al. (2009) reported that there was a
positive relationship between circulating levels of relaxin and poor outcomes in high risk
pregnancies. These investigators suggested that because the placenta is the sole source of
relaxin, blood concentrations could be used as a biomarker of placental function (Ryan et
al. 1999). It is worth noting that relaxin concentrations vary greatly among different breeds
(e.g. Thoroughbred vs Standardbreds) and horse types (pony vs standard size horse mares)
(Stewart et al. 1992, Ryan et al. 2001). In addition, the lack of a commercially available
test at present precludes the use of relaxin clinically in mares.

1.3.2 Biomarkers for Chorioamnionitis in Humans
In recent years, microRNAs (miRNA), small non-coding ribonucleic acids (~22
nucleotides) have been the focus of human studies as potential biomarkers for diseases (e.g.
cancer, inflammatory and cardiovascular pathologies). MicroRNAs are associated with a
wide range of biological functions through regulation of gene expression either by
degrading or transcriptionally repressing messenger RNA (Ladomery et al. 2011).
MicroRNAs are relatively stable in the systemic circulation and represent a source of cellfree nucleic acid (Chim et al. 2008). In plasma, miRNAs are stable because they are
transported within exosomes (non-cellular vesicles), and recent findings have shown that
miRNAs present in these vesicles control immune response mediated by T-cells
(Mittelbrun et al. 2011). A number of studies have characterized pregnancy-associated
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miRNAs in women (Ladomery et al. 2011 Chim et al. 2008, Kotlabova et al. 2011) and
some have indicated changes in expression of miRNAs associated with abnormal or
preterm labor, therefore indicating their potential diagnostic application (Kotlabova et al.
2011, Mayor-Lynn et al. 2011). To date miRNAs have been received limited attention
during equine pregnancy, a recent study demonstrated changes in miRNAs in the dam’s
circulation during maternal recognition of pregnancy (Cameron 2012). Since miRNA (i.e.
miR223 and miR 338) change in the placenta of pregnant women suffering with
chorioamnionitis (Montenegro et al. 2007), it is reasonable to hypothesize that these or
other miRNA may change in mares with placentitis.
Proteomics of the amniotic fluid and fetal circulation has been used in women to
identify biomarkers for chorioamnionitis (intra-amniotic infection/inflammation)
(Ruetschi et al. 2005, Romero et al. 2008, Buhimschi et al. 2007, Buhimschi et al. 2008,
Buhimschi & Buhimschi 2010, Buhimschi et al. 2011). Ruetschi and collaborators (2005)
identified seventeen proteins that were overexpressed in amniotic fluid samples of women
with chorioamnionitis. Among these proteins, three proteins were further identified as
human neutrophil protein 1-3 as well as calgranulin A and B. Another study identified 39
proteins that are differentially expressed in amniotic fluid samples obtained from patients
with intra-amniotic infections (Romero et al. 2008). To date proteomics of the equine fetal
fluids have not been described; thus characterization of the protein composition of fetal
fluids would be a useful to identify potential new markers for equine placentitis. Recently
a study involving proteomics of human neonates demonstrated that Hp and haptoglobinrelated protein immunoreactivity (Hp-RP) are useful markers for neonatal sepsis
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(Buhimschi et al. 2011). Proteomics of the fetal fluids and the newborn foal may aid in
identifying new diagnostic markers for placentitis and neonatal sepsis.
Macrophage migration inhibitory factor (MIF), an inflammatory marker, is
elevated in amniotic fluid in chorioamnionitis (Chaiworapongsa et al. 2005). Interestingly,
during early pregnancy, non-infectious early pregnancy losses in women were associated
with reduced serum levels of MIF (Yamada et al. 2003). Macrophage migration inhibitory
factor is expressed in high levels by the embryo and endometrium during early pregnancy
in horses (Klein & Troedsson 2013). Unfortunately, our preliminary results measuring MIF
in plasma of mares with placentitis showed that MIF is highly variable across days and
mares, and there were no associations between placentitis and concentrations of MIF
(Canisso et al. 2012), therefore, measuring MIF does not appear useful as a diagnostic
marker for placentitis.
In human medicine, CRP has been the most widely studied APP, as a non-specific
biomarker for placental and fetal health (Wu et al. 2009, Popowski et al. 2011, Lee et al.
2012). Changes in concentrations of CRP in the systemic circulation of women suffering
with chorioamnionitis have been demonstrated by several authors (Popowski et al. 2011,
Smith et al. 2012, Lee et al. 2012). In horses, CRP is a minor APP and has received limited
attention (Nunokawa et al. 1993, Lavoie-Lamoureux et al. 2012), likely due to the lack of
remarkable changes in different diseases evaluated to date.
In mammals, infection of the placenta triggers the local innate immune response
through activation of Toll-like receptors (TRL), a group of receptors responsible for
recognition of pathogen patterns and tissue damage (Kim et al. 2004, Romero et al. 2007).
Activation of TLR (e.g. TRL-2 and TRL-4) initiates a cascade of events of the innate
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immune response that results in migration of phagocytic cells to infected/damaged tissues
and production of inflammatory mediators (e.g. cytokines, prostaglandins, and many others
mediators) (Kim et al. 2004; Romero et al. 2007). Cytokines are small molecules (peptides,
proteins, glycoproteins) that modulate the immune system/response, either by promoting
or suppressing inflammation (Oppenheim 2001, Dinarello 2007). Dozens of cytokines are
known, and there are several cell-types that produce (e.g. macrophages, monocytes,
fibroblasts, dendritic cells, B lymphocytes, NK cells and epithelial cells) and secrete these
molecules (Oppenheim 2001, Dinarello 2007). Normal placental tissues of mammals
including the mare and women constitutively express pro-inflammatory cytokines (Jana et
al. 2008; LeBlanc et al. 2012, Palm et al. 2013, Pitman et al. 2013). However, placental
infection in women is associated with an increased production of several pro-inflammatory
cytokines (e.g. IL-6, IL-8 and TNF- α) not only in placental tissues, but also in the fetal
and maternal blood (Vogel et al. 2005, Romero et al. 2007). Pro-inflammatory cytokines
have been shown to be useful markers for placental infection, and valuable prognosticators
to determine whether a pregnancy will be carried to term in humans (El-Bastawissi et al.
2000, Gervasi et al. 2012, Cobo et al. 2012, La-Sala et al. 2012, Cobo et al. 2013).
However, there have been few studies evaluating pro and anti-inflammatory cytokines in
mares with experimentally induced ascending placentitis (LeBlanc et al. 2002, 2012). It is
unlikely that measuring cytokines in plasma will be widely used tool in veterinary medicine
due to the limited clinical availability of assays for equine cytokines.
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1.4.Treatment of Placentitis

Bacterial infection of the equine pregnant uterus in the middle of gestation can
result in acute abortions with no lesions in the fetal membranes and minimal to no outward
clinical signs (e.g. vulvar discharge, premature mammary gland development) (Hong et al.
1993, Giles et al. 1993). Therefore, treatment is often not an option to prevent this type of
abortion. On the other hand, bacterial infections of the uterus late in pregnancy tend to be
associated with chronic placentitis (Hong et al. 1993); these mares will usually show the
clinical signs as described above, thus if a diagnosis is made early enough, treatment can
be applied and pregnancies can be potentially rescued (Troedsson & Zent 2004).
Primarily, treatment for placentitis should be aimed to prolong maintenance of a
viable fetus in utero to allow time for fetal development and maturation. To achieve this
goal, therapy should: 1) control bacterial infection of placenta and fetus, 2) maintain the
myometrial quiescence and 3) block the production of pro-inflammatory cytokines
(LeBlanc 2010, Troedsson & Macpherson 2011). To date, there are few evidence-based
therapies for mares with placentitis. The limited evidence-based treatment strategies come
from mares with experimentally induced placentitis. Unfortunately, as noted above,
experimentally induced placentitis does not necessarily mirror spontaneous infections;
thus, data generated from experimentally induced placentitis should be interpreted with
caution.
Treatment for placentitis is commonly based on a combination of antibiotics, antiinflammatories, and progestins (LeBlanc 2010, Bailey et al. 2010 Troedsson &
Macpherson 2011) (Table 1.2). The rationale to use anti-inflammatories is based on the
finding that mares with experimentally induced placentitis have increased uterine
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contractility (McGlothlin et al. 2004) as a consequence of the prostaglandin production
(LeBlanc et al. 2002) and increased expression of pro-inflammatory cytokines (LeBlanc et
al. 2012). Similarly, progestin therapy for mares with placentitis is used to block
myometrial contractions (Bailey et al. 2010). The evidence-based for the use of antiinflammatories and progestins is based on studies with cloprostenol-induced abortion
during early pregnancy. In these studies, all mares receiving cloprostenol but also treated
with altrenogest (a progestin) maintained the pregnancy (8/8); however, mares given
cloprostenol and also treated with progesterone resulted in 5 of 8 pregnancies maintained,
as expected all mares receiving cloprostenol (n=5) but no other treatment aborted (Daels
et al. 1996). From this study, it has been assumed that mares with placentitis during late
pregnancy will behave in a similar manner although this has not been critically evaluated.
Antibiotics are included as part of the therapy for the bacterial infection of the fetal
membranes and to treat and/or prevent bacteria reaching the fetus (LeBlanc 2010,
Troedsson & Macpherson, 2011). To date, few antimicrobials have been shown to cross
the placental barrier and to achieve effective minimal inhibitory concentrations (MICs) in
the fetal fluids and fetus against common bacteria causing placentitis (LeBlanc 2010,
Troedsson & Macpherson, 2011).
Antimicrobials that have been shown to cross the placenta include sulfatrimethoprim, penicillin and gentamicin (Murchie et al. 2006, Rebello et al. 2006).
Ceftiofur crystalline free acid, a drug that has effective in vitro antimicrobial activity
against many bacteria causing placentitis was recently tested (Macpherson et al. 2013).
Unfortunately, administration of ceftiofur crystalline free acid to pony mares did not result
in concentrations of desfuroylceftiofur acetamide (i.e. the active metabolite) needed to
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effectively treat bacterial placentitis, and it did not improve survival of foals born from
mares with experimentally induced ascending placentitis (Macpherson et al. 2013). These
findings discourage the use of this antibiotic to treat placentitis in mares.
Controversy exists regarding the duration of antimicrobial therapy once a diagnosis
of placentitis is made. Anecdotally, short antimicrobial treatment (i.e. 10-15 days) has been
advocated to be an effective and a thoughtful approach to treat placentitis as well as an
approach to avoid bacterial resistance associated with prolonged antimicrobial therapy
(LeBlanc 2010). However, evidence-based findings in mares with experimentally induced
placentitis do not support the claim for effectiveness of short-term antimicrobial therapy.
In fact, mares with experimentally induced ascending placentitis did not carry foals to term
when treatment was discontinued after 2 weeks; however, an apparent increase in survival
rates was observed when mares were kept on antimicrobials for a prolonged period of time
(Rebello et al. 2006, Bailey et al. 2010). Another interesting finding about antimicrobial
therapy from the same group demonstrated that mares kept on a prolonged treatment with
antibiotics, present positive endometrial bacterial culture within 6 hours post abortion or
delivery of a viable foal (Diaw et al. 2010). These findings suggest that antimicrobials
administered to mares with experimentally induced placentitis may suppress bacterial
growth, but do not achieve complete bacterial elimination.
Empirically, estrogen supplementation has been advocated to treat mares with
placentitis (Douglas 2004). As aforementioned, this author reported that mares with
placentitis that subsequently aborted had remarkably lower “total estrogen” concentrations
than mares of the same gestational age that maintained pregnancy. As estrogens are
produced in high concentrations during the second and third trimesters of pregnancy, it is
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unlikely that estrogen supplementation will be able to restore normal estrogen
concentrations. For example, it required continuous intravenous infusion of 126-231 mg
of estrone sulfate per hour to achieve peripheral pregnancy levels of estrone sulfate
(Raeside & Rosskopf 1980). Therefore, to date, estrogen therapy has not been critically
assessed by controlled studies or prospectively assigned field studies.
Other drugs that have been added to the treatment of equine placentitis include
acetylsalicylic acid, pentoxifylline, and dexamethasone (LeBlanc 2010) (Table 1.2).
Acetylsalicylic acid has been given to mares with placentitis under the impression that this
drug would improve the blood flow to the mare’s uterus; however, there is no evidencebasis in the literature to support this practice. In human medicine, low dose of
acetylsalicylic acid has been shown to reduce the risks of preeclampsia in women
(Henderson et al. 2014). Similarly, pentoxifylline has been included as part of the treatment
for mares with placentitis with the idea that this drug possesses antinflammatory and
rheolytic properties (Macpherson 2006, Bailey et al. 2010) which might improve the
oxygenation of the pregnant uterus. Pentoxifylline was found to be present in the fetal
fluids of pregnant mares treated with the standard dose (Rebello et al. 2006) and has been
added to the treatment of mares with experimentally induced placentitis (Bailey et al.
2010). However, it is unclear whether this drug has any beneficial effect on the treatment
of placentitis. In addition, uterine artery blood flow remained unchanged when
pentoxifylline was given to early pregnant mares during a short treatment period (Bailey
et al. 2012). Dexamethasone has been suggested to be useful for the treatment of placentitis
(LeBlanc 2010); however, it is uncertain whether administering this drug improves
pregnancy outcome in mares with placentitis. At best, very limited to no evidence-basis
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exists to support the practice to include these drugs (i.e. acetylsalicylic acid, pentoxifylline,
and dexamethasone) in the treatment of placentitis.
Since the pathogenesis of nocardioform placentitis is unknown, and there are no
established experimental models to the study this type of placentitis, treatment for
nocardioform placentitis has been empirically applied and based on treatments used for
other types of equine placentitis. To date there are no evidence-based reports supporting
the treatment of nocardioform placentitis in mares. A recent retrospective study
demonstrated in vitro antimicrobial sensitivity for Amycolatopsis ssp and C. equi (Erol et
al. 2012b) (Table 1.3). However, it is unclear whether these antimicrobials are effective in
vivo. It is also unclear whether addition of antinflammatories is effective or necessary for
the treatment of nocardioform placentitis.
Tocolytic agents such as clenbuterol and isoxsuprine have also been used in
practice as part of the treatment of mares with placentitis (LeBlanc 2010); however, there
is no evidence-basis to support such practice. In fact, in a study carried out with normal
pre-foaling mares clenbuterol was not effective in delaying parturition, and treated mares
foaled earlier than control mares (Palmer et al. 2002). The lack of efficacy of clenbuterol
to delay parturition should discourage the practice to give this drug to mares with
placentitis.
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Table 1.2: Therapeutic agents commonly used to treat placentitis in mares
Therapeutic agent

Dose

Proposed effect
placentitis
IV, Antimicrobial,

Potassium Penicillin
G
Gentamicin
Trimethoprim
sulpamethoxazole
Altrenogest

22,000 IU/kg,
QID
6.6 mg/kg, IV, SID
Antimicrobial
15-30mg/kg, PO, BID Antimicrobial

in

mares

with

0.088 mg/kg, PO, SID Tocolytic, suggested to prevent
prostaglandin mediated abortion
Pentoxifylline
8.5 mg/kg, PO, BID
Anti-pro-inflammatory
cytokines,
rheolytic
Flunixin meglumine 1.1 mg/kg, PO/IV, Anti-inflammatory, not detected in the
SID, or BID
fetal fluids
Acetylsalicylic acid
50 mg/kg, PO, BID
Suggested to improve blood flow to the
uterus by inducing thrombocytopenia,
this has not been critically tested
Dexamethasone
40, 35, 25 mg, SID This treatment has not been critically
24h, IV for 6 days, tested in mares with placentitis. Clinical
decreasing dose every experiences and published studies
2 days
suggested to be useful approach for
other complications during pregnancy
(e.g. body wall ruptures)
Adapted from: Rebello et al. (2006), Murchie et al. (2006), LeBlanc (2010), Troedsson &
MacPherson (2011).
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Table 1.3: In vitro anti-microbial sensitivity for Amycolatopsis ssp (n=38) and Crossiella
equi (n=22) isolated from placentas in mares aborting in central Kentucky. The minimum
inhibitory concentrations required to inhibit the growth of 50% and 90% of organisms
(MIC50/MIC90) (Adapted from Erol et al. 2012b).

Lately a new practice of antimicrobial therapy has been introduced, without a
clinical diagnosis of placentitis; mares are administered antimicrobials for 10 days of the
month throughout pregnancy (LeBlanc 2010). The idea of such practice would be that
antimicrobial treatment would treat-subclinical/undiagnosed placental infection. This
practice not only should be discouraged to the lack of proven efficacy, but also because it
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favors bacterial resistant. Thus there is an enormous risk to create super resistant bacteria
which may become a major threat not only to the horses but to public health.

1.5 Experimental Models of Bacterial Placental Disease in Large Animals

Experimental models for abortigenic diseases in domestic animals vary according
to the animal species, infectious agent, natural route of infection, as well as the ability of
the organism to survive in the environment. Different routes of infection have been used to
induce disease experimentally; some models involve a vector that is important in the
natural infection (e.g. Foot Hill Abortion in cattle), in other models, macerated tissues
obtained from aborted materials are directly administered to susceptible animals. In the
present review, only ruminant, porcine, and equine models will be briefly reviewed.
Induction of abortigenic diseases with different bacterial species (e.g. Brucella ovis,
Brucella abortus, Brucella melitensis, Brucella suis, Chlamydophila abortus) in several
species of ruminants (i.e. goats, sheep, bison and cattle) and pigs have been achieved by
intravenous or subconjuntival inoculation (Meador & Deyoe 1986, Anderson et al. 1986,
Palmer et al. 1996, El Idrissi et al. 2001, Jungersen et al. 2006, Marques et al. 2010, Olsen
& Johnson 2011, McCollum et al. 2013). Other routes, such as to the nasal and rectal mucus
membranes through the inoculation of infected semen with Brucella ovis have also been
described in sheep (Ridler et al. 2014). Oral administration of Chlamydophila abortus
(Tsakos et al. 2001) have been recently described in sheep. These routes probably mimic
the natural infection, while others such as intravenous and subconjunctival by pass the
means of natural infection. Once inoculated through either route noted above, bacteria gain
access to the pregnant uterus and then cause severe necrotizing placentitis (Meador &
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Deyoe 1986, Anderson et al. 1986, Palmer et al. 1996, El Idrissi et al. 2001, Tsakos et al.
2001, Jungersen et al. 2006, Marques et al. 2010, Olsen & Johnson 2011, McCollum et al.
2013, Poester et al. 2013).
It is likely that Brucella species migrate through the systemic circulation in immune
cells (i.e. monocytes). Similar mechanisms are thought to occur for other bacterial species.
Classically, Brucella ssp present tropism for trophoblastic cells, testes and mammary gland
(Poester et al. 2013). Even though experimental inoculation of Brucella ssp through
intravenous and subconjunctival routes induces abortion, oral transmission appears to be
the most important route, except for Brucella ovis and Brucella suis where venereal
transmission appears to be most relevant. Most species of Brucella can infect any mammal,
including horses. In horses, “fistulous withers” is the most common clinical presentation
in animals exposed to Brucella abortus; however, sporadic abortions have also been
described (Denny 1973, Robertson et al. 1973, Hinton et al. 1977). Brucellosis in horses
occurs where horses are kept with a herd of cattle where Brucella abortus is endemic.
Epizootic bovine abortion (i.e. Foothill abortion) can be induced by administration
of macerated products of the aborted fetus (e.g. thymus) subcutaneously or through tick
vector (i.e. Ornithodoros coriaceus) (Stott et al. 2002, Coker et al. 2012). From the
subcutaneous tissue, the microorganism (an unidentified Deltaproteobacterium member of
the order Myxococcales) (King et al. 2005), reaches the maternal circulation and the
pregnant uterus and fetus. Placental lesions are not commonly present, but severe chronic
inflammatory lesions are present in the fetus thymic atrophy, hepatomegaly, ascites, and
generalized lymphomegaly (Hall et al. 2002).
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Models to study Leptospirosis in cattle include inoculation through subconjunctival
route, inoculation of bacteria into the central area of a placentome (through laparotomy),
and intravenous inoculation (Aycardi et al. 1982, Ellis et al. 1986, Smith et al. 1994). The
bacteria enter the systemic circulation and pregnant uterus and then cause placentitis, fetal
lesions, abortion, stillbirths and weak neonates (Aycardi et al. 1982, Ellis et al. 1986, Smith
et al. 1994, Donahue & Williams 2000). Different serovars of Leptospira affect cattle and
horses, the subtype Pomona concentrates most of the serovars that affect both species
(Schlafer & Palmer 2007).
Experimental induction and challenges with Campylobacter fetus subspecies fetus
in sheep involves oral administration of the bacteria, which is the natural route of infection
(Grogono-Thomas & Woodland 1996). Interestingly, a different subspecies of this genera,
causes a different disease (i.e. early embryonic death and abortion is less commonly
observed) in cattle, thus experimental infection of Campylobacter fetus subspecies
venereallis infection in cows is achieved through intracervical inoculation of the bacteria
in non-pregnant cows or intra-preputial inoculation in bulls (Ardila et al. 2012).
To date there is only one effective model to induce experimentally bacterial
placentitis in mares. The model was initially described by Dr. Michelle LeBlanc’s group
at the University of Florida (Mays et al. 2002, LeBlanc et al. 2002). The model involves
the inoculation of a pathogenic strain of Streptococcus equi subspecies zooepidemicus (107
to 109 cfu), into the cervix of mares during the 3rd trimester of pregnancy. Since the original
description of the model, it has been used by other researchers with very predictable
outcomes (Christensen et al. 2009, Bailey et al. 2010, Macpherson et al. 2013, Finger et
al. 2014). One of the limitations of this research model is that a large inoculum is
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administered to mares intracervically, with a resulting acute ascending placentitis and rapid
abortion. This clinical presentation appears much more rapid that seen in spontaneous
placentitis which tends to be insidious and chronic. Therefore, studies to address diagnostic
makers and treatments strategies should be interpreted with caution regarding the clinical
presentation of spontaneous and experimental placentitis.

1.6. Conclusions
Placental disease is an important cause of pregnancy wastage in broodmares.
Bacterial infections are responsible for a large portion of abortion cases. There are four
different morphologic types of placentitis: ascending, focal mucoid (nocardioform), diffuse
(hematogenous), and multifocal, whereas, ascending is the most frequent type of
placentitis, whereby beta-hemolytic streptococci predominate. The diagnosis of equine
placentitis is based on clinical signs (i.e. vulvar discharge, premature udder developing and
lactation) and ultrasonography. While transrectal ultrasonography has been shown to be a
valuable clinical tool to diagnose and manage cases of placentitis; the technique is prone
to false positive diagnosis and early cases of the disease can be missed. Treatment of
placentitis should be aimed on prolonging the permanence of the foal in uterus, to achieve
this goal; control of placental and fetal infection, maintaining of the uterus quiescent and
by blocking the production of pro-inflammatory cytokines. Few antibiotics (i.e. Penicillin,
gentamycin, and sulfa-trimethoprim) have been shown to cross the placenta and achieve
satisfactory inhibitory concentrations.

Copyright © Igor Frederico Canisso 2014
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Chapter 2:
Attempts to Induce Nocardioform Placentitis (C. equi) Experimentally in Mares
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Williams, N.M. b, Dorton, A.R. c, Wolfsdorf, K.E. d, Squires, E.L. a, Troedsson, M.H. T. a
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Reproduction Laboratory, The Maxwell H. Gluck Equine Research Center; bVeterinary
Diagnostic Laboratory, Department of Veterinary Science, University of Kentucky,
Lexington, KY 40546, USA.
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Woodford Equine Hospital, Versailles KY 40383, USA.
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Haygard Equine Medical Institute, Lexington, KY 40511, USA.
*Early view Equine Veterinary Journal, April 2014

2.1. Summary:

Reasons for performing study: Nocardioform placentitis in horses is poorly understood,
and the development of an experimental horse model would be of help in understanding
the pathogenesis of the disease.
Objectives: To investigate whether (1) intrauterine inoculation of C. equi during the
periovulatory period or (2) i.v., oral or intranasopharyngeal inoculation of C. equi during
mid-gestation would result in nocardioform placentitis, and (3) before and after mating
endometrial swabs present evidence of nocardioform-associated organisms (C. equi or
Amycolatopsis ssp).
Methods: Study I, mares (n=20) received an intrauterine inoculation of C. equi 24h after
artificial insemination. Endometrial swabs were obtained 24h post-inoculation for PCR
analysis for C. equi. In Study II, pregnant mares (at 180 and 240 days of gestation) were
inoculated with C. equi by intranasopharyngeal (n=5), oral (n=4) or i.v. (n=4) routes. Sixty
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contemporaneous pregnant mares maintained on the same farm served as controls animals.
In Study III, privately-owned Thoroughbred mares (n=200) had endometrial swabs
collected before and within 24-48h post-mating for detection of nocardioform
microorganisms.
Results: In Study I, C.equi was identified by PCR in 3/20 mares following intrauterine
inoculation. Pregnancy was established in 19 of 20 treated mares. There were 2 embryonic
losses and one abortion at 177d of gestation (undetermined cause). Sixteen mares delivered
a normal foal and placenta. In Study II, one mare (oral inoculation) aborted at 200 days of
gestation (unidentified cause). The remaining mares delivered a normal foal and placenta.
In Study III, none of the mares yielded positive endometrial PCR for nocardioform
microorganisms.
Conclusions: We were unable to induce nocardioform placentitis, and there was no
evidence of nocardioform microorganisms in endometrial swabs of broodmares before or
after mating. These findings suggest that nocardioform placentitis is not induced simply
via the presence of nocardioform actinomycetes, and that route, insufficient duration of
exposure and dose may play a role in the development of disease. Additional
predispositions may be involved in the development of nocardioform placentitis.
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2.2. Introduction
Placentitis is an important cause of pregnancy wastage in mares. In the USA,
placental pathology accounts for the majority of late-term pregnancy losses and neonatal
deaths in the first 24h of life (Giles et al. 1993, Hong et al. 1993, Williams et al. 2004).
Four different types of equine placentitis have been described according to the
morphological lesions and suggested pathogenesis, namely ascending, focal mucoid
(nocardioform), diffuse (hematogenous), and multifocal (Williams et al. 2004). Overall,
ascending placentitis is the most prevalent type of placentitis (Giles et al. 1993, Hong et
al. 1993).
Nocardioform placentitis was first diagnosed in 1985 in central Kentucky by the
University of Kentucky Veterinary Diagnostic Laboratory (UKVDL) (Giles et al. 1988).
Since its initial description, the number of mares suffering from this disease has fluctuated
across years in the region (Giles et al. 1993, Hong et al. 1993, Giles et al. 1988, Williams
et al. 2004, Donahue & Williams 2000, Carter et al. 2012, Erol et al. 2012a), and
nocardioform placentitis has also been diagnosed in other areas of the United States
(Christensen et al. 2006). Additionally, isolated cases of nocardioform placentitis have
been reported in other parts of the world, including South Africa (Volkmann et al. 2001)
and Italy (Cartoli et al. 2004). During the 2002 and 2003 foaling seasons, a total of 128
cases of nocardioform placentitis were diagnosed by the UKVDL (Williams et al. 2004).
Most recently, during the 2011 foaling season, the UKVDL registered 390 confirmed cases
of nocardioform placentitis (N.M. Williams, unpublished data).
Microorganisms associated with nocardioform placentitis include Amycolatopsis
species (Amycolatopsis kentuckyensis, Amycolatopsis lexingtonensis and Amycolatopsis
pretoriensis) and Crossiella equi (C. equi) (Donahue et al. 2002, Labeda et al. 2003,
42

Christensen et al. 2006, Labeda et al. 2009, Erol et al. 2012ab). In 2009, two new species
of Streptomyces (Streptomyces atriruber and Streptomyces silaceus) were isolated from
nocardioform placentitis cases (Labeda et al. 2009). Historically, these bacterial agents
have been denominated as nocardioform actinomycetes or more recently as gram-positive
branching bacilli based on PCR and 16S ribosomal RNA analyses (Erol et al. 2012a). In
the 2010-2011 foaling season in central Kentucky, C. equi and Amycolatopsis ssp were
responsible for 85% of the cases submitted to the UKVDL. In the remaining cases lesions
were present but the bacterial species were not identified (Erol et al. 2012a). Based upon
observations of cases submitted to the UKVDL, it appears that mares affected with C. equi
are more prone to abortion, whereas mares infected with other actinomycetes tend to
deliver live premature foals (unpublished observations, UKVDL). In addition, it is worth
noting that to date the causative organisms have only been cultured from clinical placentitis
cases and not from the environment.
A specific distinction between bacteria causing nocardioform placentitis (i.e. C.
equi and Amycolatopsis ssp) and other actinomycetes that affect horses is related to the
propensity to infect not only the fetal membranes but also the offspring in utero. For
example, mares affected by Cellulosimicrobium cellulans in Kentucky presented mucoid
placentitis associated with fetal lesions (Bolin et al. 2004). Similarly, a group of
actinomycetes (e.g. Cellulosimicrobium sp, Cellulomonas sp) and other nonspecific
bacterial species have been associated with mucoid placentitis and fetal lesions in a
condition known as equine amnionitis and fetal loss (EAFL) that is associated with
ingestion of processionary caterpillars in Australia (Todhunter et al. 2013). On the other
hand, the actinomycetes causing nocardioform placentitis do not infect the fetus in utero as
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is commonly seen in other types of placentitis. In other words, the bacterial infection in
NPL is limited to the chorionic surface of the placenta (Hong et al. 1993, Williams et al.
2004, Donahue & Williams 2000).
The definitive diagnosis of nocardioform placentitis is based on the presence of
macroscopic and microscopic lesions, bacterial culture and identification of bacterial DNA
by polymerase chain reaction (PCR) of samples from the chorioallantois (Hong et al. 1993,
Donahue & Williams 2000, Erol et al. 2012ab). A presumptive clinical diagnosis can be
attained through clinical examination and ventral transabdominal ultrasonography
(Christensen et al. 2006, Wolfsdorf et al. 2000). Mares suffering from nocardioform
placentitis present areas of placental separation with accumulation of hyperechoic exudate
in the ventral uterine body and/or base of the horns (Christensen et al. 2006, Wolfsdorf et
al. 2000, Troedsson & Macpherson 2011). Because the cervical star region is not involved,
no vulvar discharge or cervical softening is observed unless the mare is very close to
abortion or parturition. Premature mammary gland development, which is the first common
sign observed in mares with ascending placentitis, is not always observed in mares during
initial stages of nocardioform placentitis. The absence of outward clinical signs (i.e. vulvar
discharge and premature mammary development) makes the presumptive diagnosis of
nocardioform placentitis challenging for the clinician.
The pathogenesis of nocardioform placentitis is unknown, and a reliable model to
reproduce the disease would therefore be useful. The objective of these studies was to
develop an experimental model for induction of clinical nocardioform placentitis in mares.
Specifically, we investigated (1) whether intrauterine inoculation of C. equi during the
periovulatory period or (2) intravenous, oral or intranasopharyngeal inoculation of C. equi
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between 180 and 240d of gestation would result in nocardioform placentitis, and (3)
whether endometrial swabs obtained from Thoroughbred mares before and after mating
would provide evidence for the presence of C. equi or Amycolatopsis ssp.
2.3. Material and methods
All the experimental animal work in this research project was carried out at the
University of Kentucky, Lexington, KY, USA, from September of 2011 to November of
2012 (Studies I&II) with approval from the Institutional Animal Care and Use Committee
(Protocol # 2011-0840). The endometrial swabs (Study III) were collected during the 2012
breeding season at commercial Thoroughbred farms in central Kentucky. In Studies I&II,
all the animals were kept in paddocks and supplemented with hay, grain, water, and trace
minerals ad libitum. In Study II, during more intensive handling procedures and
immediately pre-foaling, the mares were kept in individual stalls during the night and
turned out on pasture during the day. The C. equi strain used in this study was a reference
strain, originally isolated from an equine abortion case submitted to the UKVDL
(Reference number: LDDC 22291-98T, NRRLB-24105). This isolate was stored at -80oC
and had a very low passage number (passage 3).

Study I: Intrauterine inoculation of C. equi in estrous mares 24h after artificial insemination
Twenty mares of different light horse breeds and with a mean age of 10.5 years
(range: 5-20 years) were used in this study. Detailed breeding management is described in
the appendices. Estrous mares were bred with ≥ 500 million progressively motile sperm in
fresh semen pooled from three fertile stallions and diluted using a commercial extender
(without antibiotics).
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At 24h post breeding, each mare received an intrauterine inoculation of C. equi
(1x104 colony-forming-unit in 1mL of skimmed milk). Bacteria were kept at 37oC in
enriched TGY (tryptone-glucose-yeast) broth medium, and then plated onto minimal agar
(Czapek’s agar) plates for 2-3 days. Bacterial cultures were prepared and preserved in 2
mL cryovials at -80oC until inoculation. Serial dilution and plating were used to determine
cfu. Immediately before inoculation, the samples were thawed at room temperature. After
inoculation, bacterial culture was performed from each cryovial to confirm viability of the
inoculum. At 24h post-inoculation, each mare had an endometrial swab collected for PCR
testing for C. equi (Sells 1996, Tan et al. 2006, Erol et al. 2012a).
Pregnancy diagnosis was performed by transrectal ultrasound at 15, 25, 35, 60, 90
and 120 days post-ovulation. From 150 days to term, the mares were examined monthly by
transabdominal ultrasonography (transducer 2–6 MHz) to confirm normal pregnancy and
to evaluate the fetal membranes (Troedsson & Macpherson 2011).
All the placentas from inoculated mares in Study I were submitted to the UKVDL
for pathological evaluation, culture (i.e. for C.equi and Amycolatopsis ssp) and PCR for
both organisms. A swab from each chorioallantois was collected and cultured according
to Erol et al. (2012ab). PCRs for C.equi and Amycolatopsis ssp were performed according
to established protocols (Sells 1996, Tan et al. 2006, Erol et al. 2012a) at the UKVDL, an
accredited veterinary diagnostic laboratory by American Association of Veterinary
Laboratory Diagnosticians. As part of the quality control and assurance cycle, a negative
amplification control, a negative extraction control and a positive extraction control (C.
equi or Amycolatopsis reference strains) were performed in each PCR run.
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Sixty contemporaneous pregnant mares of various light breeds and ages (mean
10.5yrs; range 4-20yrs) kept at the same farm were used as controls. All placentas were
examined by two veterinarians and, if signs of placentitis were observed, the placenta was
submitted to the UKVDL for full pathological examination (Hong et al. 1993, Williams et
al. 2004, Donahue & Williams 2000). Unlike mares in the inoculated groups, control mares
were not regularly monitored by ultrasonography. Therefore, the experimental end point
for the control mares was the presence of nocardioform placentitis lesions after foaling.
None of the mares received antibiotics during pregnancy or any type of treatment for
placentitis or other clinical problems. Additionally, 10 placentas from control mares were
submitted for full pathological examination.

Study II: Intravenous, Intranasopharyngeal and Oral Inoculation of C. equi to Pregnant
Mares
Thirteen mares of various light breeds and ages (mean 13.2 years; range 8-19 years)
were used in this experiment. Mares were bred with fresh extended semen and ovulation
was confirmed by ultrasound performed every other day. Before the beginning of the
experiment, each mare was examined by transabdominal ultrasonography to confirm
normal pregnancy. Mares were randomly allocated into three treatment groups, and
inoculated with C. equi as follows: nasopharyngeal (n=5), oral (n=4), and intravenous
(n=4). The inoculations were performed from 180 to 240d of pregnancy; mares in the
intravenous route group received the inoculum once at 180d of gestation, whereas mares
in the oral and nasopharyngeal route groups received the bacteria four times at two week
intervals (i.e. 180 to 240d of gestation). In this experiment, each inoculum contained 1x109
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cfu of C. equi. Detailed explanation of the bacterial culture is described elsewhere (Erol et
al. 2012ab) and in the supplemental information.
For all the different routes of inoculation, mares were restrained in stocks and when
necessary sedated with xylazine hydrochloride (0.2-0.4 mg/kg intravenously) immediately
pre-inoculation. Inoculating doses were prepared at a final concentration of 1x109 cfu/mL
of C. equi, and were transported refrigerated to the farm (<5 min). Immediately before
inoculation, the inoculum was thoroughly mixed and diluted 1:4 with sterile Dulbecco’s
phosphate buffer solution. For respiratory route administration, the inoculum was loaded
into a 20 mL sterile syringe and administered deep into the nasopharayngeal cavity using
an AI pipette. For oral administrations, the mare’s oral cavity was thoroughly flushed with
water to remove any residual feedstuff. Thereafter the inoculum (i.e. 5 mL solution) was
deposited deep into the mare’s mouth. After inoculation through the nasopharyngeal and
oral routes the mare’s head was held up for 5 min.
Intravenous inoculation was performed through a jugular catheter (14G; 3 inches
long). The inoculum was administered slowly (>2 min), and the catheter was then flushed
thoroughly with sterile Dulbecco’s phosphate buffer solution (100 mL) to avoid bacterial
retention on the catheter or in the subcutaneous tissues.
Immediately before inoculation and thereafter for the first 72h, all mares were
examined clinically at 12h intervals for evidence of sepsis. At 24h post inoculation, CBC,
fibrinogen and serum amyloid A analyses were determined for the mares receiving the
bacteria via the i.v. route. Concentrations of serum amyloid A were determined (at 12, 24,
48 and 72h after inoculation for mares receiving the bacteria intravenously) by
immunoturbimetric assay (Jacobsen et al. 2006) at the University of Miami.
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All mares were thoroughly examined every 2 weeks by transabdominal
ultrasonography with a curvilinear transducer 2–6 MHz, from 24h before inoculation until
parturition. The control mares described in Study I also served as controls for Study II. All
placentas from inoculated mares were submitted for full pathological examination as
described for Study I.

Study III: Endometrial PCR for C. equi and Amycolatopsis ssp in Mares

A total of 200 commercial Thoroughbred mares had an endometrial swab collected
immediately before and within 24-48h after natural mating. Mares had the perineal area
thoroughly prepared in a standard manner. Swabs were submitted to the UKVDL for PCR
analysis for C. equi and Amycolatopsis ssp as described above.

2.4. Results
Study I
The overall pregnancy rate was 95% (19 of 20 mares). One mare was bred during only
one cycle and did not become pregnant. This mare went into seasonal reproductive
transition after the first estrous cycle and was not rebred. Fifteen mares became pregnant
on the first cycle. Three mares became pregnant on the second estrous cycle; one mare
became pregnant after 3 cycles. There were 2 embryonic losses (between 25-35d and 3560d); it is worth noting that both mares had unremarkable ultrasonographic examinations
and negative PCR for C.equi and bacterial culture upon diagnosis of pregnancy loss. One
mare aborted at 177d of gestation. Unfortunately, the placenta and part of the fetus were
taken by wild scavengers. Therefore, the cause of abortion could not be determined. Nine
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days pre-abortion, transabdominal ultrasonography was unremarkable and the fetus was
alive. Fetal material and a nasal swab from the dam were PCR negative for EHV-1. Paired
serology taken at three week intervals presented low titers for Lepstopira species (data not
shown).
Out of 25 inoculations, only three mares had a positive endometrial PCR result for
C. equi at 24h post inoculation. Two of the mares with positive PCR delivered a normal
foal and placenta, and the remaining mare aborted (as noted above). All ultrasonographic
examinations were unremarkable during the entire experiment (data not shown). None of
the mares presented clinical or pathological (i.e. macroscopic or histopathological lesions)
or microbiological (culture and PCR) evidence of nocardioform placentitis.
All mares in the control group delivered normal foals and fetal membranes,
although one of these mares had a small (~12cm2) lesion on the chorion that was grossly
consistent with nocardioform placentitis. Macroscopically there was loss of villi and
increased pallor centrally with raised tan thickenings peripherally. Histopathology
confirmed signs consistent with placentitis including necrotic villi with accumulation of
eosinophilic debris on the chorionic surface that contained long filamentous bacteria. The
villi were infiltrated by moderate numbers of macrophages, neutrophils and lymphocytes
and the stroma contained large infiltrates of lymphocytes. The remainder of the placenta
was unremarkable. Macroscopic and microscopic findings were consistent with
nocardioform placentitis (Donahue & Williams 2000, Williams et al. 2004). However,
PCR was negative for C. equi and Amycolatopsis ssp, aerobic culture yielded saprophytic
bacteria but no nocardioform organisms were isolated.
Study II
50

All mares remained healthy after inoculation and physical exam parameters
remained within normal ranges (data not shown). Blood PCR at 12 and 24h post IV
inoculation were negative for C. equi and Amycolatopsis ssp. Concentrations of SAA
remained baseline (i.e. <20mg/L) from immediately before to 72h after intravenous
inoculation (i.e. 12, 24, 48 and 72h, data not shown). Fibrinogen and CBC analyses for the
group receiving the bacteria intravenously were within normal ranges by 24h after
inoculation.
Twelve mares delivered a normal foal and placenta with no clinical,
microbiological or pathological evidence of nocardioform placentitis. One mare aborted
at 200d of gestation after two inoculations through the oral route. The cause of abortion
was not established but there was no pathological evidence of nocardioform placentitis.
Study III
All the PCR analyses on samples collected shortly before and post-mating were
negative for C. equi and Amycolatopsis ssp.

2.5. Discussion
This is the first report to attempt experimental induction of nocardioform
placentitis. None of the experimental approaches in the present study resulted in clinical,
pathological or microbiological evidence of nocardioform placentitis. Additionally, none
of the uterine swabs recovered from 200 commercial broodmares before or post-mating
yielded a positive PCR for actinomycetes nocardioform species.
As there are no established experimental models for nocardioform placentitis, there
are no data regarding infective dose, culture conditions or route of inoculation for these
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organisms required to induce the disease in horses; therefore the infective dose in this study
was determined empirically and general route of inoculations (i.v., intranasopharyngeal
and oral routes) were tried in order to address whether the transmission occurs
hematogenously. Possible explanations for the inability to induce nocardioform placentitis
in the current experimental model include: inadequate infective dose, low pathogenicity of
the bacteria, improper route of exposure, insufficient duration of exposure, and absence of
host immunosuppression of unknown origin that may make some pregnant mares prone to
developing nocardioform placentitis. In Studies I & II the inoculating doses were
empirically chosen because there is no basis in the literature for determining the dose of C.
equi required to establish infection.
Although the source of actinomycetes responsible for nocardioform placentitis
remains undetermined, there are some associations which suggest an environmental source
for these pathogens. In a retrospective analysis of the weather conditions in central
Kentucky, we found a strong negative correlation (r=-0.7) between rainfall in August and
September and the number of nocardioform placentitis cases during the subsequent winter
and spring (unpublished data). In central Kentucky, most Thoroughbred mares will be at
6-8 months of gestation by August-September; therefore in Study II, pregnant mares were
inoculated at this stage of gestation in an attempt to mimic supposed natural exposure.
Indeed, if the nocardioform actinomycetes are found in the environment (i.e. soil), the oral
and nasopharyngeal routes would likely allow prolonged exposure to the environmental
source of pathogen, thus, these two routes were evaluated here using multiple inoculations.
However, multiple attempts to isolate C. equi from the environment (stalls, soil, water,
hay, grass) were unsuccessful (Erol E, unpublished observation), either due to low number
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of microorganisms in the environment or the presence of these organisms in other areas of
the environment. In addition, UKVDL performs thousands of fecal culture from mares
yearly; however, these organisms have not been isolated from fecal samples (Erol E,
unpublished observation), suggesting that C. equi is not shed in feces.
The lesions observed in spontaneously occurring nocardioform placentitis suggest
that the bacteria either enter the uterus either hematogenously or during gynecological
intrauterine interventions (e.g. uterine lavage, endometrial swabbing, etc) or at mating.
Mares in Study I, received the bacteria 24h post-breeding as we considered that this would
increase the persistence of the inoculum in the uterus, since mixing the inoculum with the
semen would potentially result in rapid drainage of the fluid through the cervix after
breeding. It is worth noting that previous attempts, carried out at our facilities in 19982000, using intrauterine inoculation (n=5 mares C. equi; 106 cfu) post-ovulation failed to
induce nocardioform placentitis. All mares became pregnant and four mares delivered live
normal foals. A normally developed foal from the 5th mare was found suffocated in the
placenta. No abnormalities were found in any of the placentas (unpublished data,
K.J.McDowell). Additionally, every-other-day intrauterine inoculation (inoculum 106 cfu
C. equi) of five non-bred mares (supplemented with progesterone 150mg/IM) for 10 days
post ovulation failed to yield a C. equi positive endometrial culture (swabs collected 24h
after each of the 5 inoculations) (K.J.McDowell, unpublished data).These results and our
findings (Study I) support the concept that C. equi grows poorly in the uterine lumen of the
non-pregnant mare.
The bacteria appear not to be transmitted during mating, since the 200 mares
sampled here had negative PCR for C. equi and Amycolatopsis ssp (Study III), and mares
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receiving the bacteria by the intrauterine route after insemination (Study I) did not develop
clinical or pathological evidence of nocardioform placentitis. These experiments do not
completely exclude the possibility that nocardioform organisms are acquired during
breeding, as the sample size was too small to detect a low rate of infection at mating. If, in
fact, nocardioform transmission occurs during mating, using 200 mares with an alpha error
of 0.05 and power of 0.8 and based on a one-tailed test, we would have been able to detect
an incidence of 2.1% of positive PCR; however, with the estimated incidence of 0.1%
nocardioform placentitis in Central Kentucky, >4000 mares would need to be sampled to
be sure of detecting infection.
Data presented here support the hypothesis that C. equi has low pathogenicity,
because bacteria administered intravenously neither induced changes in peripheral
leukocyte counts nor resulted in positive blood culture 24h post inoculation or positive
PCR at 12, 24, 48 or 72h post inoculation, and intravenous inoculation did not cause
elevations in the concentrations of SAA (i.e. 12, 24, 48 and 72h post inoculation), a
sensitive marker of inflammation (Jacobsen et al. 2006). Absence of clinical signs after
intravenous inoculation further corroborates the hypothesis of the lack of pathogenicity of
this organism and that the bacteria appear to replicate poorly in the systemic circulation
under normal conditions.
In the present Studies (I & II), we hypothesized that different routes of transmission
(i.e. intrauterine, oral and intranasopharyngeal) were important in the pathogenesis of
nocardioform placentitis, but we were unable to reproduce the disease through any tested
route of inoculation. It is possible that the bacteria can be acquired by other routes of
transmission not tested here (e.g. ocular, mucosal or dermal); however, this remains
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speculative until the route of transmission is established. Another possible explanation for
the lack of success in reproducing the disease includes insufficient time or duration of
exposure to the actinomycetes. Some of the routes (intrauterine and intravenous) involved
a single administration. Perhaps, to become infected a mare needs prolonged exposure to
the bacteria (e.g. continual environmental exposure). Anecdotally, it has been suggested
that the mechanism leading to uterine nocardioform infections is likely to be related to a
deficient immune response of the prospective host (perhaps mediated by progesterone); to
date, this hypothesis has not been tested. In a preliminary study, two pregnant mares (240d
of gestation) were intracervically inoculated with 1x109 cfu of C. equi, both mares
developed ascending placentitis due to secondary beta hemolytic streptococci (Canisso et
al. 2013). These findings support the concept that C. equi grows poorly in the uterine
lumen of normal pregnant mares.
Interestingly, field and experimental cases of EAFL in Australia also present
mucoid placentitis (Todhunter et al. 2013, Cawell-Smith et al. 2013) similar to
nocardioform placentitis; however, EAFL is associated with additional placental and fetal
lesions. To our knowledge, neither C.equi nor Amycolatopsis ssp have been associated with
EAFL. Researchers believe that intestinal lesions caused by processionary (Todhunter et
al. 2013, Cawell-Smith et al. 2013) and eastern tent (McDowell et al. 2010) caterpillars
are involved in the pathogenesis of EAFL and mare reproductive loss syndrome (MRLS).
However, field and experimental cases of MRLS are not associated with nocardioform
placentitis (McDowell et al. 2010), instead during the 2001 MRLS outbreak in Kentucky
(>3000 pregnancy losses) the UKVDL registered one of lowest incidences of nocardioform
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placentitis cases in almost 30 years. Thus at this time there is no evidence linking MRLS
and nocardioform placentitis in central Kentucky.
In conclusion, intrauterine inoculation of C. equi after ovulation did not result in
clinical or pathological evidence of nocardioform placentitis in mares. Intravenous, oral
or pharyngeal inoculation of C. equi between 180 and 240d of gestation also failed to
induce clinical or pathological evidence of nocardioform placentitis in mares. None of the
endometrial swabs recovered shortly before or after mating of 200 commercial
Thoroughbred broodmares tested positive for C. equi or Amycolatopsis ssp by PCR. The
route of transmission and pathogenesis of equine nocardioform placentitis therefore
remains undetermined. Alternative routes of inoculation, using different bacterial isolates
and species, doses and intervals should be tested.
2.6. Acknowledgments
Funds provided by the Kentucky Thoroughbred Association/Kentucky Thoroughbred
Breeders and Owners and by the University of Kentucky (Department of Veterinary
Science, Albert Clay Endowment, and Geoffrey Hughes fellowship). We are grateful to
Dr. Claudia Klein, Dr. Thomas Swerczek and Mss. Pauline Bignon, Sydney Hughes and
Jessalyn Walters for their assistance. We would like thank the Drs. Walter Zent,
KristinaLu, and Jeffery L. Pumphrey for their help collecting the endometrial swabs in
experiment III. We would like to thank Dr. Carolyn Cray (University of Miami) for the
serum amyloid A analyses. Parts of these results were presented as an abstract during the
annual meeting of the Society for Theriogenology, 2013.

Copyright © Igor Frederico Canisso 2014

56

Chapter 3:
Serum amyloid A and Haptoglobin Concentrations are Increased in Plasma of
Mares with Ascending Placentitis in the Absence of Changes in Peripheral
Leukocyte Counts or Fibrinogen Concentration
Canisso, I.F.a*; Ball, B.A.a; Cray,Cc; Williams, NMb; Scoggin, K.E.a, Davolli, G.M.a,
Squires, E.L.a, Troedsson, MHTa
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3.1. Summary
Currently placentitis, an important cause of late pregnancy loss, is diagnosed by

clinical signs and ultrasonography. Acute phase proteins (APP) are mainly produced and
secreted by the liver in response to acute inflammatory stimuli, and we hypothesized that
APP are elevated in mares with placentitis. Concentrations of serum amyloid A (SAA),
haptoglobin (Hp), fibrinogen (Fb) and white blood cell counts (WBC) were determined in
plasma of mares with experimentally induced placentitis and gestationally aged-matched
control mares. Placentitis was induced via intracervical inoculation of Streptococcus equi
subspecies zooepidemicus, a common isolate from clinical cases of bacterial placentitis.
Concentrations of SAA and Hp were also determined in 10 days pre-partum in normal
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mares. Mares with placentitis aborted within 5-25 days after inoculation. Concentrations
of SAA and Hp rapidly increase subsequent to experimental induction of placentitis and
remain elevated until abortion. Neither Fb nor WBC appeared to be useful markers for
placentitis. Parturition did not trigger an increase in either SAA or Hp in normal foaling
mares.
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3.2. Introduction
Ascending placentitis is a common cause of late-term abortion and premature
delivery in mares (Giles et al. 1993, Troedsson & Zent 2004, Williams et al. 2004, LeBlanc
2010, Laugier et al. 2011); it can be caused by fungal or bacterial agents with bacteria
being responsible for about 90% of clinical cases (Hong et al. 1993). Bacterial agents
commonly associated with the occurrence of ascending placentitis include Streptococcus
equi subspecies zooepidemicus, Escherichia coli, Klebsiella pneumoniae, Pseudomonas
aeruginosa, of which beta-hemolytic streptococci predominate (Hong et al. 1993, Williams
et al. 2004, LeBlanc 2010). Generally, only one or eventually two species of bacteria are
isolated from most clinical cases (Hong et al. 1993). The incidence of placentitis in wellmanaged Thoroughbred farms has been estimated as 3-5% (Troedsson & Zent 2004). The
pathogenesis of ascending placentitis in mares is not well established; however, it is
believed that bacterial agents enter the uterus via the cervix (LeBlanc 2010). Placental
infection/inflammation leads to abortion or delivery of a pre-mature foal (LeBlanc et al.
2012). Chronic placentitis may also lead to placental insufficiency, which may result in the
delivery of a nonviable foal. Foals born alive from mares suffering placentitis are often
septic and demand intensive care and are not necessarily viable athletes (Barr 2005).
Mares with ascending placentitis present premature mammary development and
purulent vulvar discharge, and if not treated, mares will delivery prematurely (i.e. abortion,
stillbirth, or have septic foals) (LeBlanc 2010, Troedsson & Macpherson 2011).
Manifestation of such clinical signs warrant immediate veterinary attention; thus the
clinical diagnosis can be confirmed based upon clinical signs and transrectal
ultrasonography of the placenta near the cervix (Troedsson & Macpherson 2011). While
later stages of placentitis are easily diagnosed via ultrasonography, earlier stages and
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subclinical cases of placentitis can be missed. Therefore, improved and earlier diagnostic
methods may improve treatment outcomes in some of these cases.
Ascending placentitis is widely associated with focal extensive inflammatory and
necrotic changes of the chorioallantois near the cervical star (Hong et al. 1993). Mares with
experimentally induced ascending placentitis present increased concentration of PGE 2 and
PGF 2α in the fetal fluids and increased transcripts for IL-6 and IL-8 in the chorioallantois
(LeBlanc et al. 2002). Unlike placentitis in women (i.e. chorioamnionitis), where the
disease can be life-threating (Fahey 2008, Tita 2010), equine ascending placentitis is
thought to be a local inflammatory disease of the pregnant uterus with little or no systemic
inflammatory response. Mares with spontaneous or experimentally induced ascending
placentitis do not present systemic clinical signs (e.g. sepsis, life threating complications).
A growing body of literature has been dedicated to use acute phase inflammatory proteins
(APP) to diagnose placental disease (i.e. chorioamnionitis, funisitis and early-onset of
neonatal sepsis) in humans (Wu et al. 2009, Popowski et al. 2011, Lee et al. 2012). A
recent study conducted to address the usefulness of serum amyloid A (SAA) determination
as prognostic marker for mares with placentitis indicated that mares with experimentally
induced ascending placentitis present an increase in SAA concentrations when they did not
receive a common treatment (i.e. antibiotics, anti-inflammatories and progestins) for
ascending placentitis (Coutinho da Silva et al. 2013). In addition to changes associated
with placentitis, Coutinho da Silva et al. (2013) suggested that parturition was associated
with an increase in SAA concentration in normal periparturient mares. Because sample
frequency prior to parturition was limited, results from this report were equivocal
concerning a pre-partum rise in SAA in the normal mare at parturition.

60

Haptoglobin (Hp), a moderate APP, is constantly present in plasma of healthy
horses, and concentrations are increased upon inflammation (Jacobsen et al. 2007, Cray &
Belgrave 2014). Recent studies, involving human neonates, suggested that Hp is a useful
marker for neonatal sepsis (Buhimschi et al. 2011, Ferrazzi et al. 2012). In horses, Hp
appeared to be a useful marker to evaluate acute-chronic conditions (i.e. >4-day duration)
(Cray & Belgrave 2014). To date, there have been no studies assessing Hp in mares with
placentitis.
Fibrinogen (Fb) is the APP used most frequently in the horse to evaluate
inflammation; however, to the best of our knowledge, there are no published reports in the
literature evaluating this APP in equine placentitis. Total white blood cell counts (WBC)
are widely used in human and veterinary medicine as a routine screening test for disease
and as a method to monitor treatment response. In women, WBC in peripheral blood has
been used as an indicator of chorioamnionitis (Sereepapong et al. 2001), although other
reports do not support such an assertion (Cray & Belgrave 2014). Other authors found that
WBC in fetal fluids along with bacterial culture appears to be superior for the diagnosis of
chorioamnionitis compared to peripheral leukocyte counts (Buhimschi et al. 2011). To the
best of our knowledge there are no controlled studies or randomized trials addressing
changes in peripheral WBC counts in equine placentitis.
The objectives of the current study were to: (i) compare plasma concentrations of
APP and the WBC in mares with experimentally induced ascending placentitis and
gestationally aged-matched control mares carrying normal pregnancies, and (ii) describe
SAA (serum amyloid A) and Hp (haptoglobin) concentrations in normal pre-foaling mares.
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3.3. Material and Methods
Animal Husbandry
Clinically healthy adult horse mares of different ages were enrolled in these
experiments. Mares were maintained at the Maine Chance Farm, Department of Veterinary
Science, University of Kentucky, Lexington, KY. All the experimental protocols were
approved by the Institutional Animal Use and Care committee at the University of
Kentucky (Project #2010-0769). All the animals were kept in paddocks and supplemented
with hay, grain and water ad libitum along with trace minerals. Immediately pre-abortion
or prior to normal parturition; the mares were kept in individual stalls (16 x 16 feet) during
the night and turned out in pasture during the day.
Study I: Serum Amyloid A, Haptoglobin, Fibrinogen and WBC in Mares with Ascending
Placentitis
Experimental design
Mares carrying normal pregnancies (260-280 days of gestation) were assigned to
(i) a control group with (n= 7) or without trans-abdominal ultrasound-guided fetal fluid
sampling (FFS; n=10) and (ii) a treatment group with experimentally induced ascending
placentitis with (n =7) or without FFS (n=10). Fetal fluid sampling was performed at 0, 5
and 12 days post inoculation (DPI) or until abortion. Similar methodology has been
described elsewhere (Canisso et al. 2014). Here briefly, the mare was sedated, placed in
stocks and fetal fluids were collected with transabdominal ultrasound and an echotip spinal
needle (18Gx6”; 30o short bevel, Chiba-Type spinal needle, with stylet, Echo Block PTC
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Havel’s Cincinnati, OH, USA) (Canisso et al. 2014). Fetal fluid sampling was performed
in a subset of mares as part of another study.
Experimental Induction of Ascending Placentitis
Ascending placentitis was induced via intracervical inoculation of Streptococcus
equi ssp. zooepidemicus. The experimental model for induction of bacterial placentitis in
the mare was modified from that previously described (LeBlanc et al. 2002) and has been
successfully used by different laboratories as a reliable and predictable model to induce
ascending bacterial placentitis in the mare (Coutinho da Silva et al. 2013, Morris et al.
2007). Sham inoculation of control mares was not performed in the present study as this
procedure may induce placentitis in an unpredictable manner; as noted by previous
publications. The bacterial inoculum was deposited midway intracervically with the usage
of a semi-flexible artificial insemination pipette. The inoculum was contained in a 0.5-mL
straw and was deposited with the use of a stylet. The bacterial strain used was isolated from
a placenta from a mare diagnosed with spontaneously ascending placentitis by the
Veterinary Diagnostic Laboratory at the University of Kentucky. The bacterial isolate was
preserved in cryovials containing skim milk at -80oC until use. Prior to inoculation,
bacterial cultures were prepared and bacterial counts performed in standard fashion using
blood Agar plates (incubated at 37oC), serial dilution and plating were used to determine
the number of colony-forming units. The bacterial inoculum, containing 5 million colony
forming units (cfu), was suspended in 0.5 mL of phosphate buffered saline. Once
inoculation was carried out, a swab was obtained from the leftover in the cryovial and
cultured in similar conditions to assure that the bacteria inoculum was still viable.
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Transrectal Ultrasonography
Before the beginning of the experiment, mares underwent transrectal
ultrasonography to assess the caudal placental pole to assure that all mares were carrying
normal pregnancies. Three measurements of the combined thickness of uterus and placenta
(CTUP) were taken and compared with previously established normal ranges (Renaudin et
al. 1997, Coutinho da Silva et al. 2013). All mares had CTUP values within previously
reported normal ranges and presented normal ultrasonographic appearance of the caudal
pole of the placenta (data not shown); therefore all mares were enrolled in this study.
Thereafter, all mares had transrectal ultrasonography performed every other day for 12
days or until abortion. Transrectal ultrasonography examinations were performed to follow
ultrasonographic changes in inoculated mares and to confirm the lack of changes in mares
in the control group. Particularly, we assessed for changes that are highly indicative of
placentitis such as areas of placental separation and fluid accumulation between the uterus
and chorioallantois.
Blood Sampling and Determination of Serum Amyloid A and Haptoglobin
Blood samples were obtained immediately before inoculation/initial fetal fluid
sampling (d=0), and then daily for 12 days or until abortion. Blood was attained by jugular
venipuncture into heparinized 10-mL tubes. Immediately after collection, the blood was
centrifuged at 600 xg for 10 min at 5o C. Plasma was harvested and preserved at -20o C
until further analysis. Concentration of SAA was analyzed by a turbidometric
immunoassay. The assay was developed for humans (LZ test SAA, Eiken Chemical©
Tokyo, Japan) and has been validated for horses (Jacobsen et al. 2006, Belgrave et al.
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2013). Concentrations of Hp were determined by the use of a commercial colorimetric
assay (Phase™, Tri-Delta Diagnostics Inc., Boonton Township, NJ) (Cray & Belgrave
2014). Both SAA and Hp were analyzed at the Acute Phase Proteins Laboratory (Miller
School of Medicine, University of Miami, Miami, FL, USA).
Determination of WBC and Fibrinogen
A subset of mares carrying normal pregnancies [(n=9), without (n=3) and with
(n=6) FFS] and with experimentally induced placentitis [(n=8), without (n=5) and with
(n=3) FFS] were examined to determine leukocyte counts and circulating fibrinogen.
Blood was collected daily from inoculation until abortion or for 12 days for control mares.
Fibrinogen was determined by comparing total plasma and serum protein. For WBC, an
EDTA-anticoagulated blood sample was collected, and analyzed on an automated platform
(Genesis, Oxford Science, Oxford CT, USA).
Placental and Fetal Pathology
Placentas from control and inoculated mares, and all aborted fetuses underwent
complete pathological (macroscopic and histopathologic examination) and microbiological
evaluation (Hong et al. 1993).

Here briefly, the placenta was laid out and the

chorioallantois, amnion, and umbilical cord were examined. Areas with no apparent lesions
and areas presenting macroscopic lesions were sampled and preserved in buffered formalin
for further histopathologic evaluation. Swabs were collected from the chorioallantois and
used to perform aerobic bacterial culture (Hong et al. 1993). Fetuses were necropsied in
routine fashion and internal organs (liver, spleen, stomach content, lung, heart, and trachea)
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were macroscopically examined and sampled for histopathologic evaluations and aerobic
bacterial culture (Hong et al. 1993).
Study II: Pre-Partum Plasma Concentrations of Serum Amyloid A and Haptoglobin in
Mares Carrying Normal Pregnancies
To address the question of whether normal parturition is associated with an increase
in plasma concentrations of SAA and Hp, healthy pregnant mares (n=7) were sampled daily
beginning between 310 and 320 days of gestations through parturition. Jugular
venipunctures were performed daily. Immediately after collection, blood was centrifuged
at 600xg for 10 min, and the plasma was harvested and stored at -20o C until further
analyses. Concentrations of SAA and Hp in plasma samples were analyzed as
aforementioned for days -10, -8, -6, -4, -2, -1, and 0 (the day of parturition). All placentas
underwent complete pathologic and microbiologic evaluations as in Study I.
Statistical Analyses
All the data analyses were carried out with JMP 10 (SAS Institute Cary NC).
Changes in SAA, Hp and Fb concentrations as well as WBC were analyzed relative to days
post-inoculation (DPI, 0 to 7 days) as well as relative to days from abortion (DFA,-7 days
to 0) in separate mixed models. Mare was accounted as random effect and treatment; DPI
(or DFA) were fixed effects. Fetal fluid sampling was nested within group. As we were
interested to evaluate the acute changes in APP and WBC following inoculation, the data
were analyzed for changes up to 7 DPI. On the other hand, as the interval from inoculation
to abortion was variable, we were interested to examine the changes in the seven days prior
to abortion. Two and three way interactions were also included in the different models for
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DPI and DFA. Prior to analyses, the data were log transformed. Post-hoc comparisons
across days were analyzed by Fisher’s Least Significant Difference Test. In study II,
changes in SAA and Hp for normal pre-foaling mares were analyzed by mixed model with
mare as random effect and days pre-foaling as a fixed effect. Significance was set at p<0.05,
statistical tendency was defined as 0.05 ≤ p <0.10. Data are presented as mean ± S.E.M.
3.4. Results
Overall, mares with experimentally induced ascending placentitis aborted within 525 DPI with a mean of 9.4 ± 1.3 DPI. Only one mare in the control group (subgroup FFS)
aborted 8 days after the last sampling; pathological and microbiological examination of the
placenta and fetus revealed no lesions and culture yielded saprophytic non-pathogenic
bacteria and negative virus isolation (data not shown); thus the cause of abortion was not
determined. Three mares (17.6% of the mares that were inoculated) failed to develop
placentitis after a single inoculation. One mare with experimentally induced placentitis
(subgroup without FFS) did not develop placentitis; she delivered a normal foal and
placenta with no pathological or microbiological evidence of placentitis. Two mares in the
group with experimentally induced placentitis (one with and another without FFS) did not
develop placentitis and were re-inoculated 14 days after the first inoculation. The mare
without FFS aborted 20 days after re-inoculation and the other mare with FFS aborted 9
days after re-inoculation. All four of these mares were excluded from the analyses for DPI
or DFA for APP or WBC; however, their SAA and Hp concentrations are presented in the
supplement (appendices Fig. 3.1 to 3.4). One mare in the control group developed
extensive cellulitis at the Viborg’s triangle secondary to venipuncture, thus she was
excluded from the analysis and her WBC, and APP concentrations are presented separately
in the appendices (Fig. 3.5).
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Streptococcus equi ssp. zooepidemicus was the single bacteria cultured from 12
fetuses and placentas from inoculated mares; however, in other 3 fetuses and placentas
from inoculated mares, Escherichia coli was also cultured in association with the
Streptococcus equi ssp. zooepidemicus. Actinobacillus equuli was isolated in association
with Streptococcus equi ssp. zooepidemicus of one fetus and its placenta. All inoculated
mares, but one mare, developed ultrasonographic changes consistent with ascending
placentitis (i.e. placental separation, fluid accumulation between uterus and the
chorioallantois) (data not shown). All mares in the control group presented normal
ultrasonographic findings (data not shown). With the exception of one mare that failed to
develop placentitis after experimental induction (noted above) and the control mare with
FFS that aborted, all the remaining mares that aborted with experimentally induced
ascending placentitis developed gross and histopathologic lesions consistent with
ascending placentitis (i.e. neutrophilic infiltration in the intervillous spaces, necrosis of
chorionic villi, infiltration of mononuclear inflammatory cells in the intervillous spaces,
villous stroma, chorionic stroma, endothelium and allantois) (Hong et al. 1993) (data not
shown). All mares in the control group delivered macroscopically and microscopically
normal placentas. Bacterial culture yielded non-pathogenic saprophytic bacteria (data not
shown).
All but two foals from mares with experimentally induced ascending placentitis
were dead at delivery. One foal was spontaneously delivered alive and one foal was
delivered upon induction of parturition because of sepsis in the mare. Both of these foals
had clinical evidence of sepsis and were euthanized immediately post-delivery.
Streptococcus equi ssp. zooepidemicus was isolated in all of their internal organs.
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Unexpectedly, one mare with experimentally induced ascending placentitis developed
systemic clinical signs of sepsis (hyperthermia (40oC, reference 37-38.8oC);
hyperfibrinogenemia (900 mg/dL, reference 200-400 mg/dL); leukocytosis (15.1x103
WBCs/µL, reference 7-12 x103 WBCs/µL); dehydration (normal PCV, 42.4%, reference
30-44%, and slightly elevated total proteins 8 g/dL, reference 5.4-7.6 g/dL); neutrophilia
(88%, reference 50-70%); lymphopenia (6%, reference 22-40%); and left shift (4%,
reference 0-2%)) 14 days post inoculation. The mare received treatment for sepsis
including intravenous fluids for approximately 3h and then parturition was induced with
oxytocin continuous rate infusion (approximately 1 unit/minute). A live foal was delivered
≤20min of the treatment commence. Intravenous oxytocin treatment was continued and the
placenta was delivered in ~30min (Canisso et al. 2013). The foal was euthanized
immediately and submitted accompanied by its placenta for full pathologic and
microbiologic evaluation as aforementioned.
SAA, Hp, Fb and WBC in Mares with Ascending Placentitis
Overall, there were significant effects of time and time x group interaction on
concentrations of SAA based upon either DPI (p<0.0001) or DFA (p=0.01) (Fig. 3.1).
Concentrations of SAA were significantly elevated from 2 DPI and from -6 DFA until
abortion in inoculated mares compared to control mares (Fig. 3.1) (p<0.05). For Hp
concentrations, there were significant effects of time and a time x group interaction, based
upon DPI (p<0.0001) or DFA (p=0.001) (Fig. 3.2). Concentrations of Hp were elevated
from 3 DPI and -3 DFA in inoculated mares compared to control mares (Fig. 3.2) (p<0.05).
There was a significant interaction between FFS and group on the concentration of Hp
(p<0.0001).
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There were effects of DPI (p=0.03) and a group by DPI interaction (P=0.02) on
WBC. However, there were no effects on WBC in the previous 7 DFA (p=0.26) and no
interaction between group and WBC (DFA, p=0.98) (Fig. 3.3). On Fb analyses, there was
an effect of time for DPI (p=0.002); however, there was no effect on DFA (p=0.27). There
were no time interactions between group and DPI (p=0.83) or DFA (p=0.61) (Fig. 3.4) and
between group and FFS (p=0.65). However, there were significant three way interactions
among FFS, group and time (p=0.02).
Figure. 3.1 Serum amyloid A concentrations in mares with experimentally induced
ascending placentitis and gestationally age-matched control mares carrying normal
pregnancies. (a) 0 to 7 DPI; 0 = the day of inoculation or commence of sampling for mares
in the control group. (b) -7 to 0 (i.e. day of abortion) DFA. There were no significant
differences between mares in the control group and mares with placentitis (DPI p=0.25;
DFA p=0.06). Concentrations of SAA were elevated from 2 DPI and -6 DFA (p<0.05).
There were significant time and group interactions (DPI p<0.0001; and DFA p=0.01).
*Within day denotes significant statistical difference p<0.05.
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Figure. 3.2 Haptoglobin concentrations in mares with experimentally induced ascending
placentitis and gestationally age-matched control mares carrying normal pregnancies. (a)
0 to 7 DPI; 0= the day of inoculation or commence of sampling for mares in the control
group). (b) -7 to 0 (i.e. day of abortion) DFA. There were no significant differences
between mares in the control group and mares with placentitis (DPI p=0.61; DFA p=0.9).
Concentrations of Hp were elevated by 3 DPI and -3 DFA (p<0.05), and there were
significant time x group interactions (DPI p<0.0001; and DFA p=0.001). *Within day
denotes significant statistical difference p<0.05.
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Figure 3.3 White blood cell counts (WBC) in mares with experimentally induced ascending
placentitis and gestationally age-matched control mares carrying normal pregnancies. (a)
0 to 7 DPI; 0= the day of inoculation or commence of sampling for mares in the control
group. (b) -7 to 0 (i.e. day of abortion) DFA. There were no significant differences between
mares in the control group and mares with placentitis (DPI p=0.76; DFA 0.70). There were
effects of DPI (p=0.03) and interaction between group and time (DPI, p=0.02). There were
no effects on WBC in the previous 7 DFA (p=0.26) and no interaction between group and
WBC (DFA, p=0.98). *Within day denotes significant statistical difference p<0.05.
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Figure 3.4: Fibrinogen concentrations in mares with experimentally induced ascending
placentitis and gestationally age-matched control mares carrying normal pregnancies. (a)
0 to 7 DPI; 0= the day of inoculation or commence of sampling for mares in the control
group. (b) -7 to 0 (i.e. day of abortion) DFA. There were no significant differences between
mares in the control group and mares with placentitis (DPI, p=0.87; DFA=0.81). There was
effect of time for DPI (p=0.002); however, there was no effect on DFA (p=0.27). There
were no time group interactions (DPI p=0.83; DFA p=0.61) or group and FFS (p=0.65).
There were significant three way interactions among FFS, group and time (p=0.02).
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Normal Parturition Does not Cause Elevation in Serum Amyloid A and Hp in Mares
There were no differences in SAA (p=0.94) and Hp (p=0.98) concentrations in the
10 days prior to parturition (Fig. 3.5).
Figure 3.5: Serum amyloid A (SAA, left axis) and haptoglobin (Hp, right axis)
concentrations 10 days prepartum in seven mares carrying normal pregnancies undergoing
to uneventful parturition. There were no significant differences across days for SAA
(p=0.94) or Hp concentrations (p=0.98).

3.5. Discussion
After experimental induction of ascending placentitis, concentrations of SAA and
Hp changed rapidly and markedly post inoculation. As a major and positive APP, it is
expected that SAA will be rapidly elevated after the onset of inflammation (Jacobsen &
Andersen 2007). Similar to other research models for diseases in mammals (Hulten et al.
2002, 2003, Dabrowski et al. 2007) concentrations of SAA were significantly elevated
before detectable changes in Hp and several folds of magnitude in comparison to mares in
the control group and before experimental induction of placentitis. A new aspect of our
study supported by another recent report (Coutinho da Silva et al. 2013), is the fact that
placentitis induces changes in APP (i.e. SAA and Hp) concentrations at the systemic
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circulation. Until very recently, equine placentitis was considered a localized disease of the
pregnant uterus with no systemic involvement. However, the finding that placentitis
induces changes in APP (i.e. SAA and Hp) concentrations opens a new field of
investigation on the inflammatory response in mares with placentitis. In humans, APP (e.g.
C-reactive protein; CRP) have been focus of numerous publications involving infection of
the placental and fetal tissues (Wu et al. 2009, Popowski et al. 2011, Lee et al. 2012,
Ferrazzi et al. 2012). Changes in concentrations of CRP in the systemic circulation of
women suffering with chorioamnionitis have been demonstrated by several studies (Wu et
al. 2009, Popowski et al. 2011, Lee et al. 2012, Ferrazzi et al. 2012). In human medicine,
CRP is the APP more commonly used to assess risk for premature labor (Smith et al. 2012).
Inflammatory APP are produced by the liver in all mammals studied to date (UrieliShoval et al. 1998, Jacobsen & Andersen 2007, Chrisman et al. 2008, Berg et al. 2011,
Leschi et al. 2012). However, transcripts for SAA and Hp were also described in several
other normal tissues in cattle and horses (Berg et al. 2011) as well as humans (Urieli-Shoval
et al. 1998). In the horse, the endometrium presented moderate expression (i.e. defined by
the authors as >1% of the liver expression) in normal non-pregnant mares (Berg et al. 2011)
Interestingly, in experimentally induced endometritis using a large inoculum of E. coli (1
billion cfu) in non-pregnant mares (Christoffersen et al. 2010), the animals presented a
systemic inflammatory response (i.e. fever, elevated systemic SAA) and increased
endometrial expression of SAA by 3-12h post inoculation. This study suggested
upregulation of SAA in the endometrium could result in measurable elevation of systemic
SAA in mares. In a more recent study by the same authors (Christoffersen et al. 2012), a
smaller inoculating dose of E. coli (105 cfu) was not associated with systemic signs of
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endotoxemia or increases in plasma SAA concentrations; however endometrial expression
of SAA was 10-100 fold higher compared to pre-inoculation expression of SAA.
Therefore, our findings along with those of Coutinho da Silva et al. (2013) raise a question
on the origin of SAA and perhaps Hp in mares with placental inflammation. It appears
likely that the liver may not be the sole source of APP in these mares, but that other tissues
such as endometrium may contribute to the systemic elevation of SAA and Hp in mares
with experimentally induced placentitis.
On a comparative basis, it is worth noting that the epitheliochorial placenta of
equids allows limited exchange of large molecules between maternal and fetal circulation
in comparison to the hemochorial placenta of humans. Thus the structural and
morphofunctional differences between fetal membranes of mares and women may explain
why infection of the maternal-fetal unit can be life threating in women (Fahey 2008, Tita
2010) but is rarely so in mares where the disease is restricted to the gravid uterus.
As observed here and supported in other studies using this experimental model,
only a single bacterial specie or less commonly two species of bacteria are isolated in
clinical cases or experimental cases of ascending placentitis (Hong et al. 1993). In the
present report, Streptococcus equi ssp. zooepidemicus was the single isolate in 80% of the
experimental mares; however, in the remaining mares, a second bacterial specie was also
isolated (i.e. Escherichia coli and Actinobacillus equuli). However, in the human clinical
condition known as chorioamnionitis/funisitis, mixed infection with enteric bacteria
appears to be a more common clinical presentation (Hillier et al. 1991, Sherman et
al.1997).

76

In the study by Coutinho da Silva and collaborators (2013), concentration of SAA
was elevated by four days post experimental induction in all five mares that were
experimentally induced with ascending placentitis and did not receive treatment after onset
of clinical signs. This is two days later than the present report in which SAA was already
significantly elevated from 2 DPI and remained elevated until abortion. Coutinho da Silva
et al. (2013) used a different immunoassay method to determine the concentrations of SAA,
used a different bacterial isolate of Streptococcus equi ssp zooepidemicus and their
inoculating dose was remarkably higher than the one used in our study (10 million cfu
versus 5 million). Perhaps a higher inoculating dose may explain why mares in the group
with experimentally induced ascending placentitis that did not receive treatment for
placentitis aborted ~2 days (Coutinho da Silva et al. 2013) earlier than the average in the
present report (~9DPI).
Both Hp and Fb are classified as moderate APP in the horse (i.e. constantly present
in the blood, and upon inflammation present only a moderate elevation of 1 to 10 times
baseline), thus it is expected that upon inflammatory insult both molecules will be elevated
from two to five days post insult in the horse (Jacobsen & Andersen 2006, Cray & Belgrave
2014). However in the present study Fb was not elevated in mares with experimentally
induced ascending placentitis but there was an effect of time. Interesting, total WBC was
higher in control mares at 7 DPI. While we cannot explain the origin of this higher
concentration of WBC, upon normal foaling no placentae from mares in the control group
presented evidence of inflammation or other changes that suggest placental lesion. In
addition, the total WBC in control mares remained within normal ranges (reference 7-12
x103 WBCs/µL). However, from the sampling period (~280 days of gestation) to normal
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parturition (~340 days of gestation) in the present report corresponded approximately to a
2-months period, so changes induced by the sampling could have disappeared.
Additionally, the origin of the inflammation could have been the body wall or uterine wall.
Interesting that SAA, a very sensitive marker for inflammation, was not elevated in the
control group. This is interesting because FFS had no effect on SAA concentrations, and
this APP is known to be more sensitive marker for inflammation than Fb and WBC in the
horse (Belgrave et al. 2013). We did not expect Fb or WBC to be elevated in mares with
experimentally induced ascending placentitis, based on our experiences with
spontaneously occurring cases. However, we believe that a controlled study was warranted
to confirm clinical observations.
Parturition did not trigger an elevation in SAA or Hp in mares carrying normal
pregnancies and delivering normal foals. A prior report (Coutinho et al. 2013) suggested
that parturition induced changes in serum concentrations of SAA in mares carrying normal
pregnancies and delivering normal foals. These authors (Coutinho et al. 2013) used a
different assay to measure SAA and the mares were sampled in weekly intervals than the
more frequent protocol used here. Our findings support the hypothesis that increases in
SAA and Hp are not associated with parturition, but with placentitis as evidenced by the
lack of effect of normal parturition.
In conclusion, SAA and Hp rapidly increase in mares subsequent to experimental
induction of ascending placentitis and remain elevated until abortion with SAA increasing
earlier than Hp. Neither Fb nor WBC change in mares with placentitis, therefore are not
markers for placentitis. There were no detectable changes in the concentrations of SAA
and Hp in normal mares in the immediate prepartum period. The findings of the present
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study open a new field of investigation. Elevations of SAA and Hp in mares with
experimentally induced ascending placentitis suggest that these two APP might be useful,
but nonspecific, biomarkers for mares with spontaneously occurring placentitis, thus this
should be tested in prospective controlled designed studies with field cases. It appears
likely that SAA and Hp will be useful markers to diagnose field cases of placentitis in
mares; however, these two APP should be tested prospectively to confirm whether these
APP are useful biomarkers in spontaneous clinical cases.
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Chapter 4
Experimentally-Induced Ascending Placentitis Does not Change Peripheral
Androgen Concentrations in Mares
I. F. Canisso1*, B. A. Ball1, A. Esteller-Vico1, N M. Williams2, E L. Squires1, M.H.
Troedsson1,
1

Reproduction Laboratory, Maxwell H. Gluck Equine Research Center; 2Veterinary

Diagnostic Laboratory, Department of Veterinary Science, University of Kentucky
Lexington KY 40546-0099, USA.
*Submitted to the Equine Veterinary Journal.
4.1. Summary
Reasons for performing study: Currently, the diagnosis of ascending placentitis is based
on clinical signs and transrectal ultrasonography; while advanced stages of placentitis can
be easily diagnosed, early stages can be missed. Thus additional tools to diagnose
placentitis are necessary.
Objectives: To characterize peripheral dehydroepiandrosterone sulphate (DHEA-S) and
testosterone concentrations in mares carrying normal pregnancies (Study I) and to compare
plasma concentrations of DHEA-S and testosterone in mares with placentitis and
gestationally age-matched control mares (Study II).
Methods: In study I, mares (n=18) had serum samples collected every two weeks from
100d of gestation to term. In study II, pregnant mares (260-280d of gestation) were
assigned to a control group (n=17) and to a group with experimentally induced placentitis
(n=17). Within each group, a subset (n=7) of mares had fetal fluid sampling (FFS)
performed at 0, 5, 12 days post inoculation (DPI) or until abortion. Placentitis was induced
via intracervical inoculation of Streptococcus equi ssp zooepidemicus. Blood was collected
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at inoculation/commence for control mares (day=0) and daily for 12 DPI or until abortion.
Concentrations of DHEA-S and testosterone were determined by ELISA.
Results: In study I, androgen concentrations increased during pregnancy with
concentrations of DHEA-S peaking by 180 days of gestation. Testosterone concentrations
were progressively elevated from days 100 to 180 with a plateau until ~240d and a
progressive decline until 290d of gestation. In study II, mares with experimentally induced
placentitis aborted within 5-25 DPI (mean 9.4±1.3 days). Concentrations of DHEA-S and
testosterone were not significantly different between groups, except DHEA-S was
significantly reduced on the day of abortion for mares in the placentitis group (subset
having FFS).
Conclusions: Concentrations of DHEA-S and testosterone were elevated and varied
through pregnancy; however, neither testosterone nor DHEA-S concentrations in the
pregnant mares were predictive of impending abortion in mares with experimentally
induced ascending placentitis.
Keywords: pregnancy, testosterone, dehydroepiandrosterone, placentitis, abortion, equine
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4.2. Introduction
Placentitis has been identified as the major cause of late-term pregnancy loss (i.e.
abortions, stillbirths and neonatal deaths) in broodmares in central Kentucky (Giles et al.
1993, Hong et al. 1993, Williams et al. 2004, Troedsson & Zent 2004). Outside North
America, placentitis has also been reported to be an important cause of pregnancy wastage
in France (Laugier et al. 2011) and Australia (Carrick et al. 2012). However, in the United
Kingdom umbilical cord pathology (e.g. torsion and entrapments) was recognized as the
leading cause of pregnancy loss in submissions received by a referral laboratory (Smith et
al. 2003). Differences in incidences across countries can be explained by surveillance
systems, methodology to perform the pathologic examination, and true incidence of
infectious agents.
Ascending placentitis is commonly associated with bacteria and less commonly
with fungi; infrequently, mixed bacterial fungal infections have also been observed (Hong
et al. 1993). Common bacterial isolates associated with the occurrence of ascending
placentitis are similar to ordinary isolates in endometritis and include Streptococcus equi
subspecies zooepidemicus, Escherichia coli, Streptococcus equisimilis, Klebsiella
pneumoniae, Pseudomonas aeruginosa, whereby beta-hemolytic streptococci predominate
(Giles et al. 1993, Hong et al. 1993, Williams et al. 2004).
Currently, ascending placentitis is diagnosed based on clinical signs (i.e. vulvar
discharge, premature udder development and lactation) and transrectal ultrasonography
(Renaudin et al. 1997, LeBlanc 2010, Troedsson & Macpherson 2011). While transrectal
ultrasound of the caudal placental pole has been shown to be a useful tool to diagnose and
manage clinical cases of ascending placentitis (Troedsson & Zent 2004) the technique is
prone to false positive diagnoses and early stages of the disease can be missed. Additional
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diagnostic tools for placentitis have the potential to improve the identification of early
stages of the diseases and may therefore improve the likelihood to deliver a viable foal as
well as help to avoid unnecessary treatment of normal pregnant mares.
During pregnancy several estrogens, progestins and androgens are produced in high
concentrations by the equine fetoplacental unit and are released into the maternal
circulation (Cox 1975, Raeside et al. 1979, Pashen & Allen 1979, Raeside 2004, Ousey
2011) In particular, the hypertrophied fetal gonads of both male and female fetuses secrete
large quantities of androgens, particularly dehydroepiandrosterone (DHEA, 3βhydroxyandrost-5-en-17-one also known as 5-androsten-3β-ol-17-one) and 7-dehydro
DHEA (3β-hydroxy-5,7-androstadien-17-one) (Raeside et al. 1997).
Dehydroepiandrosterone serves as a precursor for classic phenolic estrogens (i.e.
estrone, estradiol-17β estradiol-17α, and their sulfoconjugates) and 7-dehydro-DHEA
serves as a precursor for ring B unsaturated estrogens (i.e. equilin, equilenin and their
hydroxyderivatives 17α-dihydroequilin, 17α-dihydroequilenin, 17β-dihydroequilin, and
17β-dihydroequilenin) by the equine placenta (Raeside et al. 1979, Pashen & Allen, 1979,
Bhavnani 1988, Raeside 2004, Ousey 2011). Normally, both precursors are rapidly
aromatized by the placenta into estrogens; however, some DHEA, particularly the
sulfoconjugate (DHEA-S) is present in high concentrations in maternal circulation during
pregnancy in mares (Meinecke & Gips 1990). In addition to DHEA-S, circulating
testosterone is elevated in plasma of pregnant mares (Silberzahn et al. 1984, Daels et al.
1996). During early pregnancy, the corpora lutea have been shown to be an important
source of testosterone (Ginther 1992); however, late in pregnancy this androgen is probable
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synthesized from DHEA (through androstenedione as an intermediate) and released into
the maternal circulation (Bhavnani 1988, Raeside et al. 1997, Ousey 2011).
The fetal gonads produce DHEA and 7-dehydro DHEA from cholesterol and from
farnesyl pyrophosphate, respectively (Bhavnani 1988, Tait et al. 1985, Raeside 2004). The
sulfoconjugated form of DHEA predominates in the blood of pregnant mares blood (6:1),
(Meinecke & Gips 1990) however, in the newborn foal the non-conjugated form
predominates (i.e. DHEA) (Raeside et al. 1997) Based on immunolabeling and labelled
precursors studies, DHEA is converted into androstenedione by 3β-hydroxysteroid
dehydrogenase, and then androstenedione can be converted into estrone by aromatase or
into testosterone by 17-β hydroxysteroid dehydrogenase (17-β-HSD) (Bhavnani 1988,
Henderson et al. 1984, Chavatte et al. 1995, Han et al. 1995, Ousey 2011). Estrone can be
converted into estradiol 17-β by 17-βHSD in the chorioallantois (Ousey 2011). In the mare,
it is thought that estrone sulfate can be converted into estradiol 17 β sulfate by 17-βHSD
in the endometrium (Ousey 2011).
Controlled studies and field investigations have reported that estrogens change in
mares experiencing pregnancy loss (Kashamn et al. 1988, Douglas 2004). However, there
are no reports on changes in DHEA-S or testosterone in mares suffering placental disease.
Since mares experiencing placentitis, both spontaneous (Douglas 2004) and experimentally
induced (unpublished observations), present remarkable reduction in estrogens
concentrations, and androgens are products of the fetoplacental unit used as substrate to
produce estrogens, we hypothesize that placentitis would result in increased concentrations
of androgens in the maternal plasma. Therefore, the objectives of this study were: (i) to
describe DHEA-S and testosterone concentrations in mares carrying normal pregnancies;
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(ii) to compare plasma concentrations of DHEA-S and testosterone in mares with
experimentally induced placentitis to those in control mares.

4.3. Material and Methods
Mares were maintained at the Maine Chance Farm University of Kentucky. All the
experimental protocols were approved by the Institutional Animal Care and Use committee
at the University of Kentucky (Project #2010-0769). All the animals were kept in paddocks
and supplemented with hay, grain and water ad libitum along with trace minerals. In study
I, mares were kept in pastures during the entire experiment and foaling was not attended.
In study II, immediately pre-abortion or prior to normal parturition; the mares were kept in
individual stalls (16 x 16 feet) during the night and turned out in pasture during the day.

Study I: Concentrations of DHEA-S and testosterone in mares carrying normal pregnancies
Animals
Eighteen light-breed mares were enrolled in this study. The mares were bred with
fresh extended semen during the breeding season of the northern hemisphere. Ovulation
was determined by transrectal ultrasonography. Postpartum placentas and foals were
examined to assure normality.

Blood Sampling and Immunoassays
Blood samples were collected every two weeks from 100 days of gestation to term.
This gestational age was chosen because that is the suggested time that the fetal-placental
unit starts to be the predominant steroidogenic organ (Ousey 2011). Testosterone is
elevated starting at 40 to 50 days of pregnancy, and this elevation is mainly associated with
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the ovarian production of testosterone (Ginther 1992, Daels et al. 1996). Blood was
collected by jugular venipuncture, allowed to clot, centrifuged at 600 xg for 10 min and
then serum was harvested and preserved at -20 oC. Determination of DHEA-S and
testosterone were achieved with specific equine immunoassays.
Analysis of testosterone was performed in triplicate using a testosterone antibody
(R156/7 UC-Davis) and testosterone conjugated with horseradish peroxidase and
testosterone. The standard curve ranged from 0.02 ng/mL to 10 ng/mL, with a limit of
detection of 0.021 ng/mL (CV’s; intrassay 9.7% and interassay 17%). The testosterone
antisera has a high cross-reactivity with only one testosterone metabolite 5 α
dihydrotestosterone (57%) and low cross reactivity with androstenedione (0.3%)
(Thompson et al. 2008). The testosterone immunoassay has been previously validated
against a radio immunoassay (Coat-a-count total testosterone radioimmunoassay;
PITKTT-8), and chemiluminescence immunoassay (Immulite total testosterone; PILKTW12) (unpublished observations).
Determinations of DHEA-S concentrations were performed in duplicate using a
DHEA-S antibody (Schwarzenberger et al. 1993) and DHEA-S conjugated with 3horseradish peroxidase. The standard curve ranged from 0.05 ng/mL to 20 ng/ml, with a
limit of detection of 0.0315 ng/ml (CV’s; intra-assay 6.5% and inter-assay 10.3%). Crossreactivity for the DHEA-S antisera has been previous reported (Schwarzenberger et al.
1993). Here briefly, DHEA 100%, 5-androsten-3β-ol-17-one 38.2%, 5-androstene -3 β, 17
β –diol 0.14%, 5-androstene -3,17-dione 6.6%, 4-androstene-3, 17-dione 0.3%,
testosterone <0.1%β, epiandrosterone 8.8%, androsterone 3.2%, 5 α-diol 1.6%, estrone
<0.1%. The DHEA-S antiserum was raised in sheep against 3- β-hydroxy-5-androsten-17-
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one-3 hemisuccinate/BSA. The antiserum was kindly provided by Dr James Raeside and
has been previously reported for immunoassay of DHEA-S (Raeside et al. 1997,
Schwarzenberger et al. 1993). The dilution of antiserum was prepared at 1:9000 in sodium
bicarbonate solution (0.05 M, pH 9.6). Standard solutions were prepared with DHEA-S at
the concentrations 0.05, 0.1, 0.2, 0.5, 1, 2, 5, 10, 20 ng/ml. Plates were incubated for two
hours at room temperature, before being washed with an automated plate washer. Substrate
solution

containing

citric

acid

(0.05

M),

ABTS

(40mM;

2,2’-azino-bis3-

ethylbenzothiazoline-6-sulphonic acid), and H 2 O 2 (0.5 mM) was added to the plates;
thereafter, plates were incubated at room temperature for two hours. Stop solution (i.e.
0.15 M hydrofluoric acid, 0.006 M NaOH, 1.0 M EDTA) was added at the end of the
incubation, and reading was carried out by the use of an ELISA microplate reader.

Study II: Concentrations of DHEA-S and testosterone in mares with experimentally
induced placentitis
Experimental Design
Mares of light-breed types carrying normal pregnancies (260-280 days of gestation)
were assigned to (1) a control group with (n= 17) and (2) a group with experimentally
induced ascending placentitis (n =17). As part of another study, within each group, 7 mares
had transabdominal ultrasound guided fetal fluid sampling at 0, 5 and 12 days post
inoculation (DPI) or until abortion. Similar methodology has been published elsewhere
(Canisso et al. 2014). Here briefly, the mare was sedated, placed in stocks and fetal fluids
samples were collected with transabdominal ultrasound and an echotip spinal needle
(18Gx6”; 30o short bevel, Chiba-Type spinal needle, couple with a stylet).
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Experimental Induction of Ascending Placentitis
Ascending placentitis was induced via intracervical inoculation of Streptococcus
equi ssp. zooepidemicus. The experimental model for induction of bacterial placentitis in
the mare was modified from that previously described (LeBlanc et al. 2002). This protocol
has been successfully used by different laboratories as a reliable and predictable model to
induce ascending bacterial placentitis in the mare (Morris et al. 2007, Christensen et al.
2010, Coutinho da Silva et al. 2013). Sham inoculation of control mares was not performed
in the present study as this procedure may induce placentitis in an unpredictable manner;
as noted by previous publications (Christensen et al. 2010, Macpherson et al. 2013,
Coutinho da Silva et al. 2013) The bacterial inoculum was deposited midway in the cervical
lumen with a semi-flexible artificial insemination pipette. The inoculum was contained in
a 0.5-mL straw and was deposited with the use of a stylet. The bacterial strain used was
isolated from the placenta from a mare diagnosed with spontaneously ascending placentitis
by the University of Kentucky Veterinary Diagnostic Laboratory. The bacterial isolate was
preserved in cryovials containing skim milk at -80oC until use. Prior to inoculation,
bacterial cultures were prepared and bacterial counts performed in standard fashion using
blood Agar plates (incubated at 37oC), serial dilution and plating were used to determine
the number of colony-forming units. The bacterial inoculum (5 million cfu) was suspended
in 0.5 ml of phosphate-buffered saline. Once inoculation was carried out, a swab was
obtained from the leftover in the cryovial and cultured in similar conditions to assure that
the bacteria inoculum was still viable.
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Blood Sampling and Immunoassays
Blood samples were obtained immediately before inoculation/initial fetal fluid
sampling (d=0), and then daily for 12 days DPI or until abortion. Blood was attained by
jugular venipuncture into heparinized 10-mL tubes. Immediately after collection, the blood
was centrifuged at 600 xg for 10 min at 5o C. Plasma was harvested and preserved at -20o C
until further analysis for DHEA-S and testosterone as described in study I.
Placental and Fetal Pathology
All aborted fetuses and placentas from inoculated mares and control underwent
pathologic and microbiological examination as previously described (Hong et al. 1993) at
the University of Kentucky Veterinary Diagnostic Laboratory. Here briefly, the placenta
was laid out and the chorioallantois, amnion, and umbilical cord were examined. Areas
with no apparent lesions and areas presenting macroscopic lesions were sampled and
preserved in buffered formalin for further histopathological evaluation. Swabs were
collected from the chorioallantois and used to perform aerobic bacterial culture (Hong et
al. 1993). Fetuses were necropsied in routine fashion and internal organs (liver, spleen,
stomach content, lung, heart, and trachea) were macroscopically examined and sampled
for histopathologic evaluations and aerobic bacterial culture (Hong et al. 1993).

Statistical Analyses
All analyses were performed using JMP software. In study I, data were logtransformed and analysed with a mixed model (mare as random effect and time as a fixed
effect). Post hoc comparisons were made by Fisher’s protected least significant difference
(day effect) test. In study II, data were log-transformed and analysed with a mixed model.
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Because time of abortion varied from 5 to 25 days, changes in DHEA-S and testosterone
concentrations were analysed relative to days from abortion (DFA,-8 days to 0). Mare was
accounted as random effect and group and time (i.e. DFA) were fixed effects. Fetal fluid
sampling was nested within group. Two way interactions were also included in the different
models. Significance was set at p<0.05. Data are presented as mean ± S.E.M.

4.4. Results
Study I
All mares had normal gestation lengths (mean 348 ± 2.8 days; range: 328-362 days)
and delivered normal placentas. Sixteen mares delivered live healthy foals; two mares had
dystocias and delivered upon obstetrical interventions; one at 328 and another at 339 days
of gestation. Pathological examination of the fetal membranes and foals concluded that
dystocia was the cause of the intra-partum death. There was significant day-effect for both
androgens (p<0.0001) (Fig. 4.1 & 4.2). Concentrations of DHEA-S peaked by six months
of gestation (p<0.05) (Fig. 4.1). However, testosterone was progressively elevated from
days 100 to 180, and then remained elevated until ~240 days of gestation; thereafter a
progressive decline was observed towards 290 days of gestation. Concentrations of
testosterone remained constant between ~290 days and term (p>0.05) (Fig. 4.2).
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Figure. 4.1: Dehydroepiandrosterone sulfate (DHEA-S) concentrations in eighteen lightbreed mares carrying normal pregnancies from ~100 days of gestation to term. There were
significant differences across sampling days (p<0.0001), with a peak between 175 and 189
days of gestation (p<0.05).

Figure 4.2: Testosterone concentrations in eighteen light-breed mares carrying normal
pregnancies from 100 days of gestation to term. There were significant differences across
sampling days (p<0.0001). Under the conditions of the present study, testosterone did not
present a distinct peak. However, testosterone was progressively elevated from days 100
to 180, and then remained plateaued until ~240 days of gestation; thereafter a progressive
decline was observed towards 290 days of gestation.
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Study II
The mean time from inoculation to abortion was 9.4 ± 1.3 days (range: 5-25 DPI)
for mares with experimentally induced ascending placentitis. One control mare in subgroup
FFS aborted 8 days after the last sampling; pathological and microbiological examination
of the placenta and fetus revealed no lesions and culture yielded saprophytic nonpathogenic bacteria (Table 4.1) and negative virus isolation (data not shown); thus the
cause of abortion was not determined. One mare in the placentitis group (subgroup without
FFS) failed to develop placentitis after experimental inoculation; she delivered a normal
foal and placenta with no microbiological (Table 4.1) or pathological evidence of
placentitis. These two mares were excluded from the analyses. Two mares in the group
with experimentally induced placentitis (one with and another without FFS) did not
develop placentitis and were re-inoculated 14 days after the first inoculation. Results from
14 days following the first inoculation were excluded from the analyses for DHEA-S or
testosterone. The re-inoculated mare without FFS aborted at 20 DPI and the other reinoculated mare with FFS aborted 9 DPI.
As expected, Streptococcus equi ssp. zooepidemicus was the most prevalent isolate
from placentas and fetuses from inoculated mares, however, in other fetuses and placentas
from inoculated mares, Escherichia coli (n=3) and Actinobacillus equuli (n=1) were also
cultured in association with the Streptococcus equi ssp. Zooepidemicus (Table 4.1). Except
for one mare that failed to develop placentitis after experimental inoculation (noted above)
and the control mare with FFS that aborted, all the remaining mares that aborted with
experimentally induced ascending placentitis developed gross and histopathologic lesions
consistent with ascending placentitis (i.e. neutrophilic infiltration in the intervillous spaces,
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necrosis of chorionic villi, infiltration of mononuclear inflammatory cells in the intervillous
spaces, villous stroma, chorionic stroma, endothelium and allantois) (Hong et al. 1993)
(data not shown). All mares in the control group delivered macroscopically and
microscopically normal placentas. Bacterial culture yielded non-pathogenic saprophytic
bacteria (Table 4.1). All but two fetuses from the experimentally induced ascending
placentitis group were dead at delivery. These two foals delivered alive (one spontaneously
and one upon inducted parturition), had clinical evidence of sepsis and were euthanized
immediately post-delivery. Streptococcus equi ssp. zooepidemicus was isolated in all of
their internal organs.
Analyses with the full mixed model for the concentrations of DHEA-S showed no
differences between groups (p=0.88), or effects of time (DFA p<0.0001), but there were
interactions between groups and DFA (p<0.0001) and between FFS and DFA (p=0.0001).
Therefore, the data were re-analyzed in separated mixed models (with mare as random
effect, group and DFA as fixed effects), for mares having FFS and mares without FFS.
Comparisons between groups were performed as aforementioned. Concentrations of
DHEA-S in mares without FFS, revealed no differences between groups (p=0.52), or
effects of time (DFA p=0.1) or interactions between group and time (Group*DFA p=0.17)
(Figure 4.3). However, for the subset of mares having FFS, there were no differences
between groups (p=0.57), but there were effects of time (DFA p<0.0001), and time by
group interaction (DFA*group p<0.001). Post hoc comparisons showed that the day of
abortion was significantly different in mares with experimentally induced ascending
placentitis (p<0.05) (Figure 4.3).
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For the testosterone concentrations, there were no significant differences between
mares in the control group and mares with placentitis (DFA p=0.15) (Fig. 4). There were
no effects on time (DFA p=0.07) or interactions between group and time (DFA p=0.43)
(Fig. 4.4).
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Figure 4.3 Dehydroepiandrosterone sulfate (DHEA-S) concentrations in mares with
experimentally induced ascending placentitis (n=17) and gestationally age-matched control
mares carrying normal pregnancies (n=17). Days from abortion (DFA), -8 to 0 (i.e. day of
abortion) DFA. Within groups, a subset of 7 mares had fetal fluid sampling (FFS)
performed at 0, 5 and 12 days post inoculation or until abortion. (A) Represents mares from
both groups without FFS. There were no groups differences (p=0.52), effects of (DFA
p=0.10) or interactions between group and time (group*DFA p=0.17). (B) Represents the
subset of mares from both groups having FFS. There were no group differences (p=0.57).
However, there were effects of time (DFA p<0.0001), and interaction between time and
group (group*DFA p<0.001). As denoted by the letters on the figure above, the day of
abortion was significantly different than the remaining sampling days (p<0.05).
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Figure. 4.4 Testosterone concentrations in mares with experimentally induced ascending
placentitis (n=17) and gestationally age-matched control mares carrying normal
pregnancies (n=17). Days from abortion (DFA), -8 to 0 (i.e. day of abortion) DFA. There
were no significant differences between mares in the control group and mares with
placentitis (DFA p=0.15). There were no effects of fetal fluid sampling (FFS p=0.64), or
effects time (DFA p=0.07) or interactions between group and time (DFA p=0.43) and
group and time and FFS (p<0.99).
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Table 4.1: Bacterial culture results from aborted fetuses and placentas from mares in the
control group and mares with experimentally induced ascending placentitis.
Organism

Number

S. equi ssp zooepidemicus

12

S. equi ssp zooepidemicus & E.coli

3

S. equi ssp zooepidemicus & Actinobacillus equuli

1

Non-pathogenic bacteria*

18

*This represents all mares in the control group and one mare that did not develop placentitis
after inoculation and that was not re-inoculated.

4.5. Discussion

Because both DHEA-S and testosterone are products of the fetal placental unit, we
hypothesized that disruption of placental function resulting from experimentally induced
ascending placentitis would affect the ability of these tissues to metabolize the precursor
(DHEA) to estrogens and testosterone. However, contrary to our hypothesis,
concentrations of both androgens examined herein were not different between groups after
experimental induction of ascending placentitis in mares. Therefore, our findings in mares
with experimentally induced ascending placentitis suggest that neither androgen can be
used as a diagnostic marker for spontaneous placentitis; however this has not been critically
tested.
The experimental model used to induce ascending placentitis differs from
spontaneous clinical cases of ascending placentitis, as spontaneous cases tend to be more
insidious and chronic in comparison with the experimental model, which induces a more
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acute placentitis. However, we used a smaller inoculating dose (5 million vs. ~10million
cfu) compared to previous studies (Leblanc et al. 2002, Christensen et al. 2010, Bailey et
al. 2010, Macpherson et al. 2013, Coutinho da Silva et al. 2013) and mares here aborted
from 5-25 days after inoculation with an average of ~9.5 days. Furthermore, we did not
observe acute abortions (i.e. 2-3 days post inoculation) as reported elsewhere. (Coutinho
da Silva et al. 2013).

Nonetheless, concentrations of both androgens did not vary

remarkably throughout the experimental days, except DHEA-S which was significantly
reduced on the day of abortion for mares (subgroup with FFS) with experimentally induced
ascending placentitis.
Recent findings from our laboratory appeared to support our hypothesis that
placentitis affects peripheral androgen concentrations in mares with placentitis; the study
demonstrated that inhibition of estrogen synthesis using letrozole (a non-steroidal
aromatase inhibitor) resulted in elevation of DHEA-S and testosterone in plasma of lateterm pregnant mares (unpublished data). We considered that the placental insult prompted
by placentitis would cause similar effects for both androgens. Unpublished observations
from our laboratory had shown that mares with experimentally induced ascending
placentitis present a reduction in estrogens concentrations post-inoculation, therefore it was
plausible to hypothesize that concentrations of androgens could be elevated in mares with
placentitis.

Since ascending placentitis only causes partial compromise of the

chorioallantois (based on pathologic lesions), the remaining unaffected tissues may
compensate for the affected portion. This could explain why we failed to observe
differences for both androgens.
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Mares experiencing pregnancy loss present lower estrogen concentrations in
comparison to normal mares for the same gestational age (Douglas 2004). It is believed
that the placental damage would compromise the ability of the placenta to produce
estrogens, as a consequence we hypothesized that the precursor (DHEA) would accumulate
in the maternal plasma and as consequence DHEA-S would be also elevated as a
consequence of increased substrate. Perhaps the mechanism leading to the reduction of
estrogens in mares with placentitis is related to other unknown mechanisms. Here we
reported the first controlled study attempting to use androgens, particularly DHEA-S and
testosterone, as diagnostic markers for mares with placentitis. Previously, a clinical
descriptive case report had measured DHEA-S and DHEA in eight high risk pregnant
mares; however, the authors found that neither DHEA-S nor DHEA appeared to be
particularly useful markers in these mares (Meinecke & Gips 1990). Our findings appear
to support the clinical observations by Meinecke & Gips (1990).
In normal pregnant mares, concentrations of both DHEA-S and testosterone varied
greatly within mares across 100 days of gestation to term. Concentrations of DHEA-S
peaked by ~180 days of gestation which is similar to a previous report involving five
pregnant mares (Rance et al. 1978) and slightly before previously reported peak
concentrations for estrogens (Ginther 1992).The earlier rise in DHEA suggests that the
equine fetal gonads are synthesizing the precursor (i.e. DHEA) and that the placenta is not
fully converting DHEA into estrogens. Interestingly, contrary to an earlier report,[19]
testosterone did not peak, but rather plateaued from approximately 180 -290 days of
gestation. The absolute concentrations of testosterone in the current study were about
three-fold higher than those reported previously (Silberzahan et al. 1984). Potential
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reasons for the disparity in testosterone concentrations in these studies includes differences
on the assays (ELISA vs RIA) and antibody crossreactivity. The testosterone antibody used
in this study has a high cross-reactivity with dihydrotestosterone; however, at this point it
is unknown whether this metabolite of testosterone is present in significant concentrations
in plasma of mares in the second and third trimester of pregnancy.
In conclusion, DHEA-S and testosterone were present in high concentrations in
pregnant mares and varied through day 100 to term. There were no significant differences
for concentrations of DHEA-S and testosterone between mares with experimentally
induced ascending placentitis and gestationally age-matched control mares. Based on our
experimental results we suggest that neither androgen here evaluated in mares with
experimentally induced ascending placentitis appear to be a useful marker for spontaneous
placentitis.
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5.1. Summary
Reasons for performing study: Placental steroids have been suggested as useful
diagnostic markers for pregnancy loss in mares; however, there are few controlled studies
that have examined changes in steroids in mares with placentitis.
Objectives: To compare plasma concentrations of estradiol 17β, estrone sulfate and
progestins in mares with placentitis and with gestationally age-matched control mares.
Methods: Pregnant mares (260-280d of gestation) were allocated to a control group and to
a group with experimentally induced placentitis. Induction of placentitis was achieved via
intracervical inoculation of Streptococcus equi ssp zooepidemicus. Plasma was collected
at inoculation for mares in the placentitis group or commence for control mares (day=0),
and then daily until abortion or for 12 days post inoculation (DPI). Concentrations of
estrone sulfate and progestins were determined by ELISA, whereas estradiol 17β was
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determined by a chemiluminescence immunoassay. Data were analyzed by mixed models,
for DPI and for days from abortion (DFA) for the different steroids.
Results: Mares with experimentally induced placentitis aborted within 5-25 DPI. There
were significant effects of time (DPI, p<0.0001; DFA p=0.0008) and time by group
interactions (DPI or DFA p<0.001) for the concentrations of estradiol 17-β. Concentrations
of estradiol 17-β were significantly reduced at 4 DPI and at - 2 DFA (p<0.05). Analyses of
estrone sulfate revealed effects of time (DPI p<0.003; DFA p=0.01) and time by group
interactions (DPI p=0.002; DFA p<0.0001).

Estrone sulfate concentrations were

significantly reduced 6 and 7 DPI and on the day of abortion (0 DFA) for mares with
experimentally induced placentitis. There were no effects of time (DPI p=0.72; DFA
p=0.76) or time by group interactions (DPI*group p=0.99; DFA*group p=0.54) on
progestin concentrations.
Conclusions: Concentrations of estrogens but not progestins changed significantly in
mares with experimentally induced ascending placentitis. Prospectively controlled studies
are warranted to evaluate whether estrogens are useful markers for spontaneous placentitis.
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5.2. Introduction
Placentitis is an important cause of pregnancy wastage in broodmares (Giles et al.
1993, Williams et al. 2004). Currently, diagnosis of placentitis is based upon
ultrasonography and clinical signs (i.e. premature lactation and/or vulvar discharge)
(Troedsson & Macpherson 2011). Transrectal ultrasonography of the cervical pole of the
placenta (Renaudin et al. 1997) has been shown to be a useful tool to confirm and to
manage clinical ascending placentitis (Troedsson & Zent 2004). However, data on
sensitivity and specificity are scant. Clinical signs vary and may only be detected in
advanced stages of placentitis (Troedsson & Macpherson 2011); thus, development of new
diagnostic tests for placentitis will potentially enhance veterinary care for pregnant mares.
The endocrine fetoplacental unit synthesizes and metabolizes steroids (i.e.
progestins, androgens, and estrogens) (Cox 1975, Pashen & Allen 1979, Raeside 2004),
which are responsible for pregnancy maintenance and for preparation of the mare for
parturition (Cox 1975, Pashen & Allen 1979, Raeside 2004, Ousey 2011). The fetal adrenal
gland plays a role in endocrine support of pregnancy as an important source of substrate
(i.e. pregnenolone) for the placental production of progestins (Ousey 2011). The fetal
adrenal gland expresses P450 side chain cleavage (P450scc) that converts cholesterol to
pregnenolone (Chavattee et al. 1995, Han et al. 1995, Ousey 2011, Weng et al. 2007).
Pregnenolone is then metabolized to progesterone by the action of 3β-hydroxysteroid
dehydrogenase (3β-HSD) in the equine placenta (Chavattee et al. 1995, Han et al. 1995,
Ousey 2011). Under, normal conditions, progesterone is rapidly converted into 5αdihydroprogesterone (5α-DHP; 5α-pregnane,3,20-dione) by the action of a 5α reductase
present in the equine placenta and endometrium (Ousey et al. 2003, Ousey 2011), and
5αDHP may be further converted into 20α-hydroxy-5α-pregnan-3-one (20α5P) by 20 α103

reductase expressed in the placenta (Ousey et al. 2003, Ousey 2011). Progestins can be
sub-classified as pregnenes and 5α pregnanes. Pregnenes include pregnenolone,
progesterone and 5-pregnene-3β,20β–diol (P5ββ) (Ousey et al. 2003); 5α-pregnanes
include 5α-DHP, 3β5P, 20α-5P, ββdiol, 5-pregnene-3β,20α–diol (βαdiol) (Ousey et al.
2003); however, 5αDHP, 20α5P, and βα-diol predominate (Chavatte et al. 1997).
During pregnancy, the hypertrophied fetal gonads of both male and female fetuses
produce large quantities of androgens, particularly dehydroepiandrosterone (DHEA) and
7-dehydro DHEA from cholesterol and from farnesyl pyrophosphate, respectively [1214,17]. Classic phenolic estrogens (i.e. estrone, estradiol-17β estradiol-17α, and their
sulfoconjugates) are synthesized from DHEA (Raeside 2004). . Ring B unsaturated
estrogens (i.e. equilin, equilenin and their hydroxyderivatives 17α-dihydroequilin, 17αdihydroequilenin, 17β-dihydroequilin, and 17β-dihydroequilenin) are produced from 7dehydro-DHEA by the equine placenta (Cox 1975, Raeside et al. 1979, Pashen & Allen
1979, Raeside, Ousey 2011). Immunolabeling studies of the chorioallantois and labelled
precursor studies suggested that DHEA is converted into androstenedione by 3β-HSD and
that androstenedione can be converted into estrone by aromatase or into testosterone by
17-β hydroxysteroid dehydrogenase (17-β-HSD) (Tait et al. 1985, Bhavnani 1988,
Chavattee et al. 1995, Raeside 2004, Ousey 2011). In turn, estrone can be converted into
estradiol 17-β by 17-βHSD in the chorioallantois (Raeside 2004, Ousey 2011). It is thought
that estrone sulfate can be converted into estradiol 17 β sulfate by 17-βHSD in the
endometrium (Ousey 2011). The key role of the placenta in steroidogenesis during equine
pregnancy suggests that pathologic conditions of the fetoplacental unit will compromise
the ability of different steroids to be metabolized and released in the maternal circulation.
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Abnormalities of pregnancy may alter the normal profile of placental steroids and
serial determinations of peripheral steroids in the pregnant mare have been suggested as
useful diagnostic markers for placentitis (Kashman et al. 1988, Rossdale et al. 1991,
Douglas 2004, Ousey et al. 2005). Mares with placental pathology may have increased
plasma concentrations of progestins as a result of fetal stress (Douglas 2004, Ousey et al.
2005, Ousey 2011). Estrone sulfate has been suggested to be a useful marker for fetal wellbeing during early pregnancy (Kashman et al. 1988); however, studies involving estrone
sulfate in advanced pregnancy are scant (Kashman et al. 1988, Ousey et al. 1987). To our
knowledge, there are no controlled studies assessing estrone sulfate in mares experiencing
placentitis, despite its frequent use to assess fetal well-being. Field studies carried by a
commercial laboratory reported that mares at risk for abortion had significantly lower “total
estrogen” (unreported cross-reactivity) concentrations than mares that maintained
pregnancy (Douglas 2004). Controlled studies are warranted to confirm field observations
about estrogens and progestins and to assess whether estrone sulfate is a useful marker for
placentitis. Therefore, we hypothesized that experimentally induced placentitis will be
associated with the reduction of estrogens and increase in progestin concentrations. The
objective of the current study was to compare plasma concentrations of progestins,
estradiol 17β, and estrone sulfate in mares with experimentally induced ascending
placentitis and gestationally aged-matched control mares carrying normal pregnancies.
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5.3. Material and Methods
Animal Husbandry
Horse mares enrolled in these experiments were maintained at the Maine Chance
Farm. All the experimental protocols were approved by the Institutional Animal Care and
Use Committee at the University of Kentucky. All mares were kept in paddocks and
supplemented with hay, grain and water ad libitum along with trace minerals. Upon
imminent abortion or normal parturition, mares were kept in individual stalls (16 x 16 feet)
during the night and turned out in pasture throughout the day.
Experimental Design & Induction of Ascending Placentitis
Mares carrying normal pregnancies (260-280 days of gestation) were assigned to
(1) a control group and to (2) a group with experimentally induced ascending placentitis.
As part of another study, within each group, a subset of mares had fetal fluid sampling
(FFS) performed at 0, 5 and 12 days post inoculation (DPI) or until abortion. Similar
methodology has been described elsewhere (Paccamonti et al. 1995) and has been slightly
modified (Canisso et al. 2014). Briefly, the mare was sedated, placed in stocks and fetal
fluids were collected with transabdominal ultrasound and an echotip spinal needle
(18G×6”; 30o short bevel, Chiba-Type spinal needle, with stylet, Echo Block PTC Havel’s
Cincinnati, OH, USA) (Canisso et al. 2014).
Ascending placentitis was induced via intracervical inoculation of Streptococcus
equi ssp. zooepidemicus. The experimental model for induction of bacterial placentitis in
the mare was modified from that previously described (LeBlanc et al. 2002) and has been
successfully used by different laboratories as a reliable and predictable model to induce
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ascending bacterial placentitis in the mare (Coutinho da Silva et al. 2013, Morris et al.
2007). Sham inoculation of control mares was not performed in the present study as this
procedure may induce placentitis in an unpredictable manner; as noted by previous
publications. The bacterial inoculum was deposited midway intracervically with the usage
of a semi-flexible artificial insemination pipette. The inoculum was contained in a 0.5-mL
straw and was deposited with the use of a stylet. The bacterial strain used was isolated from
a placenta from a mare diagnosed with spontaneously ascending placentitis by the
Veterinary Diagnostic Laboratory at the University of Kentucky. The bacterial isolate was
preserved in cryovials containing skim milk at -80oC until use. Prior to inoculation,
bacterial cultures were prepared and bacterial counts performed in standard fashion using
blood Agar plates (incubated at 37oC), serial dilution and plating were used to determine
the number of colony-forming units. The bacterial inoculum, containing 5 million colony
forming units (cfu), was suspended in 0.5 ml of phosphate buffered saline. Once
inoculation was carried out, a swab was obtained from the leftover in the cryovial and
cultured in similar conditions to assure that the bacteria inoculum was still viable.
Transrectal Ultrasonography
Before the beginning of the experiment, mares underwent transrectal
ultrasonography to assess the caudal placental pole to assure that all mares were carrying
normal pregnancies. Three measurements of the combined thickness of uterus and placenta
(CTUP) were taken and compared with previously established normal ranges (Renaudin et
al. 1997). All mares had CTUP measures within previously reported normal ranges and
presented normal ultrasonography appearance of the caudal pole of the placenta (data not
shown); therefore all mares were enrolled in this study.
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Thereafter, all mares had

transrectal ultrasonography performed every other day for 12 days or until abortion to
follow ultrasonographic changes in inoculated mares and to confirm the lack of changes in
mares in the control group. Particularly, we assessed changes that are highly indicative of
placentitis including placental separation and fluid accumulation between the uterus and
chorioallantois. It was out of the scope of this study to compare or associate
ultrasonographic findings with steroid concentrations. A previous publication using a
different progestin assay had addressed these associations (Morris et al. 2007).
Determination of Estradiol 17β, Estrone sulfate and Progestins Concentrations
Blood samples were obtained immediately before inoculation/initial FFS (d=0), and
then daily for 12 days or until abortion. Blood was attained by jugular venipuncture into
heparinized 10-mL tubes. Immediately after collection, the blood was centrifuged at 600
xg for 10 min at 5o C. Plasma was harvested and preserved at -20o C until further analysis.
Estradiol 17β concentrations were determined in 17 mares in the control group and
14 mares in the group with experimentally induced ascending placentitis. As part of another
study, FFS was performed in a subset of 7 mares in the control group and 5 mares in the
placentitis group. Concentrations of estradiol 17β were determined by chemiluminescent
immunoassay (Estradiol, Immulite 1000, Siemens; intra-assay CVs were 1.2-1.4%;
interassay CVs were 2-3.15%). The detection range for this assay varies from 20 to 2,000
pg/mL with an analytical sensitivity of 15 pg/mL. According to the manufacturer, the cross
reactivity for this assay is non-significant for most adrenal and reproductive steroids (the
reader is referred to kit’s manual, for more information), thus the highest reported cross
reactivity was 2.09% with estrone.
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Concentrations of estrone sulfate were measured in 28 mares, with 14 in each
group. As part of another study, FFS was performed in a subset of 7 mares in the control
group and 6 mares in the placentitis group. Estrone sulfate was determined (in triplicate)
using a competitive immunoassay previously validated for horses (Stabenfeldt et al. 1991,
Carneiro et al. 1998). The standard curve ranged from 0.05 ng/mL to 20 ng/mL with a limit
of detection of 0.05 ng/well (intra-assays CV of 10.2% and inter-assay CV of 16.6%). The
reported cross-reactivity of the polyclonal antibody (R583) used for this assay are estrone3-sulphate (100%), estrone-3-glucorinide (70%), estrone (269%), and estradiol-17β (9.8%)
(Stabenfeldt et al. 1991).
Progestin concentrations were determined in 14 mares in the control group and 14
mares in the group with experimentally induced ascending placentitis. As part of another
study, FFS was performed in a subset of 6 mares in the control group and 7 mares in the
placentitis group. Progestins concentrations were determined (in duplicate) by the use of a
competitive immunoassay (Munro & Stabenfeldt 1984). Cross-reactivity for this antisera
was reported in the initial description as 11α-hydroxyprogesterone 21.4%, 17 αhydroxyprogesterone 0.25%, 20α-hydroxyprogesterone 0.32%, 20β-hydroxyprogestone
2.38%, 5 α-DHP 29.5%, estradiol 17β 0.02%, cortisol 0.02%, androstenedione 0.07%, and
testosterone 0.03% (Munro & Stabenfeldt 1984). The standard curve ranged from 0.05
ng/mL to 20 ng/mL, with a limit of detection of 0.25 ng/well (intra-assays CV of 15.4%
and inter-assay CV of 18.5%).
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Placental and Fetal Pathology
Placentas from control and inoculated mares, and all aborted fetuses underwent
complete pathological (macroscopic and histopathologic examination) and microbiological
evaluation (Hong et al. 1993).

Here briefly, the placenta was laid out and the

chorioallantois, amnion, and umbilical cord were examined. Areas with no apparent lesions
and areas presenting macroscopic lesions were sampled and preserved in buffered formalin
for further histopathologic evaluation. Swabs were collected from the chorioallantois and
used to perform aerobic bacterial culture (Hong et al. 1993). Fetuses were necropsied in
routine fashion and internal organs (liver, spleen, stomach content, lung, heart, and trachea)
were macroscopically examined and sampled for histopathologic evaluations and aerobic
bacterial culture (Hong et al. 1993).
Statistical Analyses
All the data analyses were carried out with JMP 10 (SAS Institute, Cary NC, USA).
Concentrations of estradiol 17β, estrone sulfate and progestins were analyzed relative to
days post-inoculation (DPI, 0 to 7 days) as well as relative to days from abortion (DFA,-8
days to 0) in separate mixed models. Mare was accounted as random effect, and treatment
and time (DPI or DFA) were fixed effects. Fetal fluid sampling was nested within group.
As we were interested in evaluating the acute changes in steroids concentrations following
inoculation, the data were analyzed for changes up to 7 DPI. On the other hand, as the
interval from inoculation to abortion was variable, we examined the changes in steroids in
the eight days prior to abortion. Two and three way interactions were also included in the
different models for DPI and DFA. Since there were no effects of FFS, data were combined
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within groups for further analyses. Prior to analyses, the data were log transformed as
necessary. Post-hoc comparisons across days were analyzed by Fisher’s Least Significant
Difference Test. Data are presented as mean ± S.E.M. Correlations between estradiol 17 
and estrone sulfate were determined by pairwise comparisons.

5.3. Results
Mares with experimentally induced placentitis aborted between 5 and 25 DPI.
Three mares that were inoculated failed to develop placentitis after a single inoculation.
One mare with experimentally induced placentitis (subgroup without FFS) did not develop
placentitis; she delivered a normal foal and a placenta with no pathological or
microbiological evidence of placentitis, this mare was excluded from the analyses. Two
mares in the group with experimentally induced placentitis (one with and another without
FFS) did not develop placentitis and were re-inoculated 14 days after the first inoculation.
The mare without FFS aborted 20 days after re-inoculation and the other mare with FFS
aborted 9 days after re-inoculation. The first 14 days following the first inoculation in these
two were re-inoculated mare were excluded from the analyses.
As expected and noted in a parallel publication, Streptococcus equi ssp.
zooepidemicus was the predominant bacterial isolate, however E. coli was also isolated in
association with Streptococcus equi ssp. zooepidemicus. All inoculated mares, but one
mare, developed ultrasonographic changes consistent with ascending placentitis (i.e.
placental separation, fluid accumulation between uterus and the chorioallantois). All mares
in the control group presented normal ultrasonographic findings (data not shown). With the
exception of one mare that failed to develop placentitis after experimental induction (noted
above) and the control mare with FFS that aborted, all the remaining mares that aborted
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with experimentally induced ascending placentitis developed gross and histopathologic
lesions consistent with ascending placentitis (Hong et al. 1993) (data not shown). All mares
in the control group delivered macroscopically and microscopically normal placentas.
Bacterial culture yielded non-pathogenic saprophytic bacteria (data not shown).
There were significant effects of time (DPI, p<0.0001; DFA p=0.0008) and time by
group interactions (DPI or DFA p<0.001) for the concentrations of estradiol 17-β (Figure
1). Post hoc comparisons revealed that concentrations of estradiol 17-β was significantly
reduced 4 DPI and - 2 DFA (p<0.05). Analyses of estrone sulfate revealed effects of time
(DPI p<0.003; DFA p=0.01) and time by group interactions (DPI p=0.002; DFA
p<0.0001). Estrone sulfate concentrations were significantly reduced 6 and 7 DPI and in
the day of abortion (0 DFA) for mares with experimentally induced ascending placentitis
(Figure 2). For the progestin concentrations, there were no effects of time (DPI p=0.72;
DFA p=0.76) or time by group interactions (DPI*group p=0.99; DFA*group p=0.54)
(Figure 3). Estradiol 17 and estrone sulfate concentrations were moderately correlated
(r=0.34, p=0.001).
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Figure 5.1. Estradiol 17-β concentrations in mares with experimentally induced ascending
placentitis (n=14) and gestationally age-matched control mares carrying normal
pregnancies (n=17). The average time from inoculation to abortion was 7.8 days (range 514 days). (A) Represents 0 (i.e. day of inoculation/commence of sampling for control
mares) to 7 days post inoculation (DPI). (B) Represents samples for days from abortion
(DFA) -8 to 0 (i.e. day of abortion). There were significant effects of time (DPI, p<0.0001;
DFA p=0.0008) and time by group interactions (DPI or DFA p<0.001). Post hoc
comparisons revealed that concentrations of estradiol 17-β was significantly reduced 4 DPI
and - 2 DFA (p<0.05). *Within day denotes significant difference (p<0.05) between
groups.
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Figure 5.2: Estrone sulfate concentrations in mares with experimentally induced ascending
placentitis (n=14) and gestationally age-matched control mares carrying normal
pregnancies (n=14). The average time from inoculation to abortion was 9.4 days (5-25
days). (A) Represents 0 (i.e. day of inoculation/commence of sampling for control mares)
to 7 days post inoculation (DPI). B) Represents samples for days from abortion (DFA) -8
to 0 (i.e. day of abortion). There were effects of time (DPI p<0.003; DFA p=0.01) and time
by group interactions (DPI p=0.002; DFA p<0.0001). Estrone sulfate concentrations were
significantly reduced 6 and 7 DPI and on the day of abortion (0 DFA) (p<0.05). *Within
day denotes significant statistical difference p<0.05.
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Figure 5.3: Progestin concentrations in mares with experimentally induced ascending
placentitis (n=14) and gestationally age-matched control mares carrying normal
pregnancies (n=14). The average time from inoculation to abortion was 9.4 days (range 525 days) (A) Represents 0 (i.e. day of inoculation/commence of sampling for control
mares) to 7 days post inoculation (DPI). B) Represents samples for days from abortion
(DFA) -8 to 0 (i.e. day of abortion). There were no effects of time (DPI p=0.72; DFA
p=0.76) or time by group interactions (DPI*group p=0.99; DFA*group p=0.54) for the
concentrations of progestins.

5.5 Discussion

Although peripheral estrogens in the mare have been suggested as a possible marker
for fetoplacental well-being for many years (Kashman et al. 1988), this is the first report
to demonstrate time-dependent changes in estrogen concentrations subsequent to
experimentally induced, ascending placentitis in mares. Approximately, 99% of the
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estradiol 17β in pregnant mares is present as a sulfoconjugate; however, the remaining 1%
is present in the maternal circulation as estradiol 17β (Ginther 1992). Here, we
demonstrated that free estradiol 17 β was significantly reduced following experimental
induction of placentitis, therefore, this steroid may be a useful diagnostic marker for
placentitis in mares with spontaneous disease. Interestingly, estrone sulfate, a commonly
used hormone to monitor the fetal wellbeing, was only reduced several days after
inoculation/or close to abortion. This suggest that this marker only changes in advanced
stages of placentitis, but also may reflect the long half-life of this hormone in maternal
plasma which may limit its clinical applications. Concentrations of estradiol 17 β and
estrone sulfate presented low correlations, this lack of associations can be explained by the
different half-lives, as sulfoconjugated steroids are thought to have longer half-lives.
Prior studies have reported changes in estrone sulfate concentrations relative to
early fetal loss in the mare; however, the experimental induction of pregnancy loss in these
mares involved acute induction of fetal death or luteolysis which have very different effects
on placental function than the induction of ascending placentitis in the current study
(Kashman et al. 1988, Stabenfeldt et al. 1991). Santschi et al. (1991) examined changes in
estrone sulfate concentrations in pregnant mares with a variety of medical and surgical
conditions and concluded that estrone sulfate concentrations in late gestation frequently
overlapped with those of normal pregnancy. In contrast, Douglas (2004) reported
significantly lower “total serum estrogen” concentrations in mares that aborted with
placentitis than mares that delivered live foals during the interval between 150 and 280
days of gestation. In Douglas’ study (2004), estrogens were determined using an assay for
17α estradiol, thus limited direct comparisons can be drawn.
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It is surprising that progestin concentrations did not change in mares with
experimentally induced placentitis in the current study. In a previous study, significant
differences in progestin concentrations were reported following placentitis (Morris et al.
2007). In mares with experimental placentitis, it was found that chronic placentitis (defined
by the authors as mares aborting >7 days after inoculatiuon) was associated with increased
plasma progestin concentrations (Morris et al. 2007). Conversely, mares that developed
acute placentitis and abortion soon after infection experienced a rapid drop in plasma
progestin concentrations (Morris et al. 2007). The authors suggested that measurement of
repeated samples of plasma progestin concentrations in mares with placentitis might be a
useful method to identify mares that may abort or deliver prematurely, especially if
combined with transrectal ultrasonography. In the present study, we did not analyze
changes in progestin concentrations based upon interval to abortion, but rather examined
changes in concentrations for progestins for all mares based upon days from abortion. In
the current study, there were no significant changes in plasma progestin concentrations in
mares aborting with experimentally induced placentitis. In another report with seven
spontaneous cases of placentitis, gas chromatography-mass spectrophotometry analyses
revealed changes in different progestins which appeared to be elevated (i.e. P4, P5,3β5P,
P5ββ, ββ-diol, βα-diol, 5α-DHP, 20α5P, 20β-OH) (Ousey et al. 2007). Since the mares in
that report were not sampled at regular and similar intervals, additional studies should be
carried with mares sampled at regular intervals and gestationally age-matched control
mares should be also sampled. It is also worth noting that the antibody used in our study
for determination of progestin concentrations was different than the antibody used by
Morris et al. (2007). As noted before, the antibody used in the present study (Munro &
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Stabenfeldt 1984) cross-reacts with 5α-DHP in ~30%; however, the assay used by Morris
et al. (200), the authors reported that their assay cross-reacted with 5α-DHP 10%. It is
possible that differences in cross-reactivity can explain the discrepant results between
Morris et al. (2007) and our findings.
In conclusion, estrogens but not progestins changed following experimental
induction of placentitis in mares. Estradiol 17β concentrations changed rapidly in plasma
of mares with experimentally induced ascending placentitis, contrary to estrone sulfate
which changed only close to abortion. Concentrations of estradiol 17β and estrone sulfate
are only moderately correlated. Our observations with experimental cases of ascending
placentitis should be expanded to prospectively controlled field studies to confirm the
usefulness of estradiol 17β as a diagnostic maker for placental disease in the mare.
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Alpha-fetoprotein is Present in the Equine Fetal Fluids and is Increased in Plasma
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6.1. Summary
The objectives of this study were to: (i) determine alpha-fetoprotein (AFP) concentrations
in fetal fluids (FF), (ii) compare plasma concentrations of AFP in mares with placentitis
(n=17) and gestationally age-matched control mares (n=17), and (iii) use cytology of the
FF to determine its origin. Fetal fluid sampling (FFS, n=7/group) was performed at 0, 5
and 12 days post inoculation (DPI) or until abortion. Plasma was harvested daily for 12
days or until abortion.

Placentitis was induced via intracervical inoculation of

Streptococcus equi ssp. zooepidemicus. Proteins present in the FF were resolved by 1DSDS-PAGE. Immunoblotting was used to detect the presence of AFP in fetal fluids.
Concentrations of AFP in FF and plasma were determined with a chemiluminescence
immunoassay. Mixed models for DPI, and for days from abortion (DFA) were used to
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analyze plasma concentrations of AFP. A protein band ~68 kDa consistent with the AFP
size was present in all samples. Immunoblotting for AFP revealed a single protein (~68
kDa) in all samples. Concentrations of AFP in FF appeared higher than those in maternal
plasma. There were effects of time (DPI p<0.0001; DFA p=0.0002) and time-by-group
interactions (DPI*Group p<0.06; Group*DFA p<0.001). Amniotic fluid was found to be
rich in epithelial cells; however, allantoic fluid was acellular. This study confirmed that
AFP is present in the FF of mares during the third trimester of pregnancy. Cytology can be
used to identify the origin of the FF. Experimentally induced placentitis was associated
with an elevation in plasma concentrations of AFP.
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6.2. Introduction

Ascending placentitis, an importance cause of pregnancy wastage, is the most
prevalent type of placentitis in mares (Hong et al. 1993); three other less common
morphologic forms have been recognized (i.e. focal mucoid, hematogenous, and
multifocal) (Williams et al. 2004). Ascending placentitis can be caused by fungal or
bacterial agents with bacteria being responsible for about 90% of clinical cases (Hong et
al. 1993). Bacterial agents commonly associated with the occurrence of ascending
placentitis include Streptococcus equi subspecies zooepidemicus (S. zooepidemicus),
Escherichia coli (E. coli), Klebsiella pneumoniae, and Pseudomonas aeruginosa, although
beta-hemolytic streptococci predominate (Hong et al. 1993, Giles et al. 1993, Williams et
al. 2004).
Currently the diagnosis of ascending placentitis is based on clinical signs (i.e.
premature mammary gland development ± streaming milk, and vulvar discharge) and
transrectal ultrasonography of the caudal pole of the placenta (Troedsson & Macpherson,
2011). Although ultrasonography of the placenta has been shown to be a useful tool for
the clinical diagnosis of ascending placentitis (Troedsson & Zent 2004), information on the
sensitivity and specificity of the technique is limited.

Furthermore, early stages of

placentitis may not be detected with transrectal ultrasonography. Therefore, new diagnostic
markers are needed for early diagnosis and to avoid unnecessary treatment of normal
pregnant mares.
To date several markers have been investigated in mares experiencing pregnancy
losses. Among these markers, steroids produced by the fetoplacental unit have been the
focus of the majority of the reports (Rossdale et al. 1991, Douglas 2004, Ousey et al. 2005,
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Morris et al. 2007). Relaxin, a placental specific hormone has also been investigated in
high risk pregnant mares (Ryan et al. 2009); however, the lack of a commercially available
equine assay precludes the use of relaxin. Lately, inflammatory acute phase proteins,
particularly serum amyloid A and haptoglobin have also been investigated (Canisso et al.
2014a); however, it is unclear whether these inflammatory proteins are useful markers for
spontaneous cases of placentitis.
Different diagnostic markers have been identified in amniotic fluid of women with
chorioamnionitis. Some of these markers are also present in blood and have been used as
diagnostic tools for pathologic conditions of the placenta and fetus (Gravett et al. 2004,
Ruetschi et al. 2005, Romero et al. 2008, Buhimschi & Buhimschi 2012). However, in
comparison to humans, the physiology and pathology of the fetal fluids in domestic
mammals, particularly in the horse, is poorly understood. In horses, studies have been
conducted primarily to examine the the presence of certain enzymes also present in other
body systems as well as quantification of electrolyte composition (Schmidt et al. 1991,
Williams et al. 1993, Holdstock et al. 1995, Paccamonti et al. 1995, Lyle et al. 2006,
Zanella et al. 2013, Finger et al. 2014). A more detailed study of protein composition of
equine fetal fluids would potentially allow the identification of proteins that are highly
expressed in the fetal fluids, and possibly also present in blood.
Data from other domestic mammals suggested that alpha-fetoprotein (AFP) is a
major protein present in the allantoic and amniotic fluids (Okano et al. 1977, Smith et al.
1979, Luft et al. 1984, Deutsch 1991); Alpha-fetoprotein is a member of the albuminoid
superfamily, the other protein members of this superfamily are vitamin D binding protein,
alpha-albumin, and afamin (Lichenstein et al. 1994, Mizejewski 1995). In mammalian
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fetuses, among other functions, AFP is associated with estrogen-binding (allowing
development of GnRH surge center in females), anti-oxidative activities (through binding
of heavy metals), and immunoregulation (Peck et al. 1978, Mizejewski 1995, Gabant et al.
2002, De Mees et al. 2006). In horses, AFP is highly expressed during early pregnancy by
the conceptus (Simpson et al. 2000). Although there are no reports of AFP concentrations
associated with equine fetal fluids later in gestation, it seems likely that AFP continues to
be a major protein present during the later stages of equine gestation. Cytologic
preparations of the equine fetal fluids have been suggested to be a useful method to identify
the type of fetal fluid (i.e. allantoic or amniotic) (Lyle et al. 2006), however, we were
unable to find any report describing the cytology appearance of these fluids. Therefore, we
were interested to confirm whether AFP is present in the fetal fluids of mares during the
third trimester of pregnancy and whether this protein can be measured in plasma of the
pregnant mare, and whether concentrations of this molecule change followed experimental
induction of placentitis. The objectives of this study were to: (i) describe AFP
concentration in the equine fetal fluids, (ii) compare the concentrations of alpha-fetoprotein
in plasma of mares with experimentally induced placentitis and gestationally age-matched
control mares, and (iii) use cytological preparations of the fetal fluids to determine its
origin.
6.3. Material and methods
Animal Husbandry
Mares were maintained at the Maine Chance Farm, Department of Veterinary
Science, University of Kentucky, Lexington, KY. The Institutional Animal Care and Use
Committee at the University of Kentucky approved all the experimental protocols (Project
#2010-0769). All the mares were kept in paddocks and supplemented with hay, grain and
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water ad libitum along with trace minerals. Immediately prior to normal parturition or preabortion; the mares were kept in individual stalls (16 × 16 feet) during the night and turned
out on pasture during the day.
Study Design
Mares carrying normal pregnancies (260-280 days of gestation) were assigned to
(1) a control group with (n=7) or without (n=10) trans-abdominal ultrasound-guided fetal
fluid sampling (FFS) and (2) a treatment group with experimentally induced ascending
placentitis with (n =7) or without FFS (n=10). Fetal fluid sampling was performed at 0, 5
and 12 days post inoculation (DPI) or until abortion. Similar methodology has been
previously described elsewhere (Paccamonti et al., 1995) and slightly modified by us
(Canisso et al., 2014b). Briefly, the mare was sedated, placed in stocks and fetal fluids were
collected with transabdominal ultrasound and an echotip spinal needle (18G×6”; 30o short
bevel, Chiba-Type spinal needle, with stylet, Echo Block PTC Havel’s Cincinnati, OH,
USA) (Canisso et al. 2014b).

Blood samples were obtained immediately before

inoculation/initial FFS (d=0) and then daily for 12 days or until abortion.
Immediately after collection, aliquots of fetal fluids were frozen in liquid nitrogen
and preserved at -80oC until further analyses. To confirm the origin of each sample, an
aliquot was submitted to the Veterinary Diagnostic Laboratory at the University of
Kentucky (UKVDL) for determination of creatinine, calcium, sodium and chloride as
previously described (Holdstock et al. 1995; Paccamonti et al. 1995). Amniotic fluid has
low creatinine concentrations and relatively high chloride concentrations, whereas
allantoic fluid has high creatinine concentrations and low calcium concentrations
(Paccamonti et al. 1995). Data for creatinine and electrolyte concentrations are presented
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in the supporting information. In addition, cytologic examination of all fetal fluid samples
was performed. The slides were prepared by standard cytospin technique and stained by
Diff-Quick. All fetal fluid samples were submitted for routine aerobic bacterial culture at
the UKVDL.
Blood was collected daily from inoculation until 12 DPI or abortion. Blood was
attained by jugular venipuncture into heparinized 10-mL tubes. Immediately after
collection, the blood was centrifuged at 600×g for 10 min at 5o C. Plasma was harvested
and preserved at -20o C until further analysis.
Experimental Induction of Ascending Placentitis
Placentitis was induced via intracervical inoculation of S. zooepidemicus. The
experimental model for induction of bacterial placentitis in the mare was modified (Canisso
et al. 2014a) from that previously described (Mays et al. 2002; LeBlanc et al. 2002). The
bacterial inoculum was deposited midway intracervically with a semi-flexible artificial
insemination pipette. The inoculum was contained in a 0.5-mL straw was deposited with
the use of a stylet (Canisso et al. 2014a). The bacterial strain used was isolated from the
placenta of a mare diagnosed with spontaneously ascending placentitis by the UKVDL.
The bacterial isolate was preserved in cryovials containing skim milk at -80oC until use.
Prior to inoculation, bacterial cultures were prepared and bacterial counts performed in
standard fashion using blood-agar plates (incubated at 37oC) with serial dilution and plating
to determine the number of colony-forming units. The bacterial inoculum was suspended
in 0.5 ml of phosphate-buffered saline. Once inoculation was carried out, a swab was
obtained from the remaining sample in the cryovial and cultured in similar conditions to
assure that the bacteria in the inoculum remained viable.
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Placental and Fetal Pathology
Placentas from control and inoculated mares, and all aborted fetuses underwent
complete pathological (macroscopic and histopathologic examination) and microbiological
evaluation (Hong et al. 1993). Briefly, the placenta was laid out and the chorioallantois,
amnion, and umbilical cord were examined. Areas with no apparent lesions and areas
presenting macroscopic lesions were sampled and preserved in buffered formalin for
further histopathologic evaluation. Swabs were collected from the chorioallantois and used
to perform aerobic bacterial culture (Hong et al. 1993). Fetuses were necropsied in routine
fashion and internal organs (liver, spleen, stomach content, lung, heart, and trachea) were
macroscopically examined and sampled for histopathologic evaluations and aerobic
bacterial culture (Hong et al. 1993).
Electrophoresis
Total protein concentration of fetal fluids was determined with the Coomassie
Protein Assay Kit (Thermo Scientific, Waltham, MA, USA) according to the
manufacturer’s instructions. Samples (10 µg total protein) were diluted (1:1 v/v) with
Laemmli sample buffer (Bio-Rad Laboratories, Hercules, CA) and incubated at 95°C for 4
min followed by electrophoresis on 4-20% SDS polyacrylamide gels (Mini-PROTEAN
TGXTM Precast Polyacrylamide Gel, Bio-Rad Laboratories, Hercules, CA, USA). The gels
were run with a running buffer (Tris-Glycine 0.1% SDS) at 200V for 45 min. All gels were
stained with Coomassie blue (0.05%, w/v) and subsequently de-stained with methanol
(20%) and glacial acetic acid (10%). Images were obtained using an automatic reader (Cell
& Biosciences, San Andreas, CA, USA).
Immunoblotting Alpha-fetoprotein
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To confirm the specificity of the AFP antibody, western blotting was performed
using fetal fluid samples. Samples (10 µg total protein) were diluted with Laemmli sample
buffer (BioRad, Hercules, CA, USA) and incubated at 95°C for 4 min followed by
electrophoresis on 10% SDS polyacrylamide gels. After electrophoresis, proteins were
transferred to 0.2 µm nitrocellulose membranes (Bio-Rad Laboratories, Hercules, CA,
USA) using a wet electroblotting apparatus (Bio-Rad Laboratories, Hercules, CA, USA).
Membranes were incubated for 1 h in 1×PBS with 0.05% Tween (1×PBS-T) with 5% nonfat dry milk and 3% BSA to block non-specific binding followed by incubation with goat
anti-human AFP polyclonal antibody (1:1,000, Santa Cruz Biotechnology Inc., Dallas, TX,
USA) diluted in 1×PBS-T with 0.3% BSA for 2 h at room temperature. Following several
wash steps with 1×PBS-T, binding of primary antibody was detected using horseradish
peroxidase (HRP)-conjugated rabbit anti-goat IgG (1:5,000, R&D Systems, Minneapolis,
MN, USA) and SuperSignal West Pico Chemiluminescent Substrate (Thermo Scientific,
Waltham, MA, USA). Images were visualized using an automatic analyzer (Cell &
Biosciences, San Andreas, CA, USA). Dilutional parallelism (10 µg-1 µg) was confirmed
with fetal fluid samples and equine fetal sera samples (data not shown). Plasma samples
of pregnant mares (n=3), non-pregnant mares (n=3), and geldings (n=4) were
immunoblotted, and AFP was not detected in plasma of these animals (data not shown).

Determination of Alpha-fetoprotein Concentrations
Concentrations of AFP in fetal fluids and plasma were measured with a
heterologous commercial immunoassay (AFP Siemens Healthcare Diagnostics Tarrytown,
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NY, USA) on a chemiluminescence platform (Immulite® 1000 platform; Siemens
Healthcare Diagnostics Tarrytown, NY, USA). This assay has a range of 0.2 to 300 units
of AFP, samples above the upper detection limit were diluted automatically by entering the
dilution ratio in the platform with the diluent that accompanies the commercial kit. Since
AFP is a glycoprotein of the albuminoid superfamily (i.e. closely related to albumin)
(Deutsch 1991), we examined whether the AFP immunoassay would recognize equine
albumin (i.e. the major plasma protein in horses). Plasma samples of geldings (n=4), equine
fetuses (n=3; 300 d gestational age, thought to have high concentrations of AFP), pregnant
mares in the second and third trimester (n=5) and non-pregnant mares (n=3) were assayed
for AFP. According to the manufacturer, conversion of units/mL to ng/mL of human AFP
is accomplished with a correction factor of 1.21.
Statistical Analyses
All the data analyses were carried out with JMP 10 (SAS Institute, Cary, NC, USA).
Plasma concentrations of AFP were analyzed using a mixed model for days from abortion
(DFA, -7 to 0), with time being treated as a continuous variable, mare as a random effect,
and group as a fixed effect. Plasma concentrations of AFP were also analyzed using a
mixed model for days post inoculation (DPI, days 0, 5, 6 and 7). Two way interactions
were examined between fixed and continuous effects in both models. In both models, FFS
did not significantly affect (P > 0.05) plasma AFP concentrations, and data from both
subsets (i.e. mares having FFS) were combined within groups for further analyses. Post
hoc comparisons for DPI were performed with Tukey’s HSD test.
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6.4. Results

Mares with experimentally induced ascending placentitis aborted on average 9.4 ±
1.3 DPI (range 5 to 25 days). One mare in the control group (subgroup FFS) aborted 8 days
after the last FFS; placental and fetal examination revealed no pathologic lesions and
culture yielded saprophytic non-pathogenic bacteria and negative virus isolation (data not
shown). Therefore, the cause of abortion in this mare was not determined. Three mares
(17.6% of the mares that were inoculated) failed to develop placentitis after a single
inoculation. One of these mares (subgroup without FFS) was not re-inoculated, a normal
foal was delivered, and there was no evidence of placentitis. The two other mares (one with
and another without FFS) that failed to develop placentitis were re-inoculated 14 days after
the first inoculation. One mare (subgroup without FFS) aborted 20 days after reinoculation, whereas the other mare (subgroup with FFS) aborted 9 days after reinoculation. The mare that was not re-inoculated (treatment group) and the control mare
that aborted were excluded from the analyses. Similarly, the first 14 days of samples for
the two re-inoculated mares were excluded from the analyses.
Twelve fetuses and placentas from inoculated mares had S. zooepidemicus as the
sole isolate; E. coli was cultured in association with S. zooepidemicus in 3 fetuses and
placentas from inoculated mares. One fetus and its accompanying placenta had
Actinobacillus equuli isolated in association with S. zooepidemicus. With the exception of
the mare that failed to develop placentitis after experimental induction (above) and the
control mare with FFS that aborted, all mares that aborted developed gross and
histopathologic lesions consistent with ascending placentitis (Hong et al. 1993) (data not
shown). All mares in the control group delivered macroscopically, histologically and
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microbiologically (i.e. non-pathogenic saprophytic bacteria) normal placentas (data not
shown).
Fourteen fetuses from aborting mares in the group with experimentally induced
placentitis were nonviable at delivery. Two foals were delivered alive, one foal was
delivered alive after spontaneous delivery, and one foal was delivered upon induction of
parturition due to sepsis in its dam. Both of these foals had clinical evidence of sepsis and
were euthanized immediately post-delivery.
Except one mare that had positive bacterial culture at 5 DPI, none of the mares in
the control group or the group with experimentally induced ascending placentitis presented
positive bacterial culture of the fetal fluids. As expected, S. zooepidemicus was isolated in
the amniotic fluid of this mare.
Several protein bands of different molecular weights were present in both allantoic
and amniotic fluids (Fig.6.1). A protein band consistent (~68 kDa) with alpha-fetoprotein
(AFP) was present in all samples. Two other protein bands were present in most samples
(i.e. ~250 kDa, 43/44 samples; ~200 kDa, 39/44 samples). To confirm the identity of the
68-kDa protein, immunoblotting for AFP was performed in all samples (Fig. 6.2). A single
band consistent with AFP was present in all samples of both allantoic and amniotic fluid.
As expected, concentrations of AFP were below the limits of detection for the
immunoassay (0.2 units/ml) for geldings and non-pregnant mares, there appear no apparent
crossreactivity with albumin. As predicted, equine fetuses presented high concentrations
of AFP in plasma (ranging from 600 to >1200 units/mL). The manufacturer states that the
assay is not accurate for samples with concentrations above 600 units/mL; despite possible
dilution, samples obtained from equine fetuses can be interpreted as having very high
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concentrations of AFP.

As part of the validation of this assay, we examined the

concentrations of AFP (units/mL) during the last five months of gestation, the results were:
7th (0.8 ±0.1), 8th (0.5 ±0.05), 9th (0.4±0.03), 10th (0.3 ±0.02) and 11th (0.6 ± 0.2) months
of gestation (n = 5 mares). Based upon this biological validation, it appears that the
heterologous human AFP recognized this protein in plasma of pregnant mares, fetal fluids,
and in equine fetal plasma. The AFP immunoassay confirmed the presence of AFP in all
fetal fluid samples from mares with experimentally induced ascending placentitis and
gestationally age-matched control mares (Table 6.1). Analyses of maternal plasma
concentrations of AFP relative to DPI demonstrated no effect of group (p=0.73); however,
there were effects of time (DPI, p<0.0001) and a time-by-group interaction (DPI*Group
p<0.06) (Fig.3). Post hoc comparisons across days and groups showed that AFP
concentrations at 7 DPI were significantly higher in mares with experimentally induced
placentitis when compared to controls (p<0.05) (Fig 6.3). For the analyses of maternal
plasma AFP relative to DFA, there were effects of group (p<0.0001), time (DFA p=0.0002)
and a group by time interaction (Group*DFA p<0.001) (Fig 6.4).
Upon cytological examination of the amniotic fluid, we observed that this fluid is
rich in epithelial cells, and that scant debris is present surrounding these cells, contrarily,
the allantoic fluid is acellular and remarkable amorphous material was observed (Fig 6.5).
There were no apparent differences between mares in the control group and mares with
experimentally induced ascending placentitis, except for one mare that presented numerous
bacterial colonies surrounding the epithelial cells in the amniotic fluid (Fig 6.5).
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Figure.6.1: Representative one-dimensional SDS-PAGE of allantoic and amniotic fluids,
in mares with experimentally induced ascending placentitis and gestationally age-matched
control mares at 0 (D0), 5 (D5) and 12 (D12) days post-inoculation. Day 0 was defined as
the day of inoculation, or commencement of sampling for mares in the control group. L:
represents the molecular weight makers. Mare 1: 0-12 represent allantoic samples; Mare
2: 0-5 amniotic samples; Mare 3 & 4: represent allantoic samples. Several proteins were
present in these samples; however, one protein band (68 kDa) was consistently present in
all samples.
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Figure 6.2: Immunoblotting for alpha-fetoprotein (AFP) in allantoic and amniotic fluids of
mares with experimentally induced ascending placentitis and gestationally age-matched
control mares. Fetal fluid samples were collected at days 0, 5 and 12. Day 0 was defined
as the inoculation day for mares in the placentitis group and commencement of sampling
for mares in the control group. A single immunoreactive protein (~68kDa) was detected
with AFP in all samples of both types of fetal fluids. All the bands in the figure above
represent serial sampling from 3 mares.
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Figure. 6.3. Alpha fetoprotein (AFP) concentrations in plasma of mares carrying normal
pregnancies and mares with experimentally induced ascending placentitis for 0, 5, 6 and 7
days post inoculation (DPI). There were no group differences (p=0.73). There were effects
of time (DPI, p<0.0001) and a time-by-group interaction (DPI*Group; p<0.06). Post hoc
comparisons across days and groups showed that AFP concentrations at 7 DPI were
significantly higher in mares with experimentally induced placentitis compared to controls
(p<0.05). To convert units/mL to ng/mL, multiply units/ml by a correction factor of 1.21.
*Within days different letters denotes significant statistical differences (p<0.05).
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Figure 6.4: Alpha fetoprotein (AFP) concentrations in plasma of mares carrying normal
pregnancies and mares with experimentally induced ascending placentitis for days from
abortion (DFA, -7 to 0). There were effects of group (p<0.0001), time (DFA p=0.0002)
and a group-by-time interaction (Group*DFA p<0.001).
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Figure 6.5. Representative cytological preparations of the fetal fluids in mares with
experimentally induced ascending placentitis and gestationally age-matched control mares.
These slides were prepared by cytospin and stained by Diff-Quick. A & B represents the
allantoic fluid of a control mare at 0 and 5 DPI; C &D represents the amniotic fluid at 0
and 5 DPI; E & F Represents the allantoic fluid at 0 and 5 DPI in mares with experimentally
induced placentitis; G & H represents the amniotic fluid at 0 and 5 DPI. The amniotic fluid
was rich in epithelial type cells and presented relative scant debris among cells; allantoic
fluid was acellular, and remarkable amorphous material was observed. There were no
apparent differences between mares in the control group and mares with experimentally
induced ascending placentitis, except for one mare (represented in G & H above), note
numerous bacterial colonies surrounding the epithelial cells (H), Streptococcus equi
subspecies zooepidemicus was cultured from this mare (contained in the circle). (Scale bars
= 25µm).
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Table 6.1: Concentration of alpha-fetoprotein (AFP) (units/mL) in the allantoic and
amniotic fluids of mares with experimentally induced ascending placentitis and
gestationally age-matched control mares at days 0, 5 and 12 post-inoculation (DPI). Day
0 was defined as the day of inoculation or the commencement of sampling for mares in the
control group. Numbers in parentheses represent number of samples assayed. Data are
expressed as Mean ± SEM.
Day 0
Fluid

Control

Day 5
Placentitis

Control

type

Day 12
Placentiti

Control

s

Placentiti
s

Allanto

120.6±14.3( 107.6±18.6( 100±12(

168±39.2(

110

166±73.8(

ic

5)

6)

5)

±14.5(4)

2)

Amniot

111 ± 5.6(2) 196(1)

65.5(1)

385±148(

260±201(

__

3)

3)

5)

ic

To convert units/mL to ng/mL, multiply units/mL by a correction factor of 1.21.
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6.5. Discussion

To our knowledge, this is the first study to confirm the presence of AFP in the
allantoic and amniotic fluids of mares during the third trimester of pregnancy. However,
this finding was not surprising, as studies in other mammals had long shown that this
protein is present in the fetal fluids throughout pregnancy (Okano et al. 1977, Smith et al.
1979, Luft et al. 1984, Deutsch 1991). Previously, in the horse, indications that AFP was
present in the fetal fluids late in pregnancy came from a study conducted with slaughter
specimens (Zanella 2008), whereby the author sampled mares across pregnancy and based
on fetal measurements, the gestational age was estimated. Upon electrophoresis, using 1DSDS-PAGE, the author observed a protein band consistent with AFP, in all fetal fluids
samples (Zanella 2008).
In the present study, AFP was elevated in plasma of mares with experimentally
induced ascending placentitis. This increase may be due to up regulation and/or an
increased vascular permeability across the placenta. For either mechanism, this finding
provides a new area of investigation, as we confirmed that AFP, a protein produced by the
fetus (and present in the fetal fluids), can be detected in the maternal circulation and that
disease (i.e. placentitis) can increase the concentration of AFP in the maternal circulation.
It is highly suggestive, that similar to AFP, other fetal proteins might cross the placenta
upon normal and pathological conditions.
Despite the extensive use of AFP in human medicine as a marker for placental and
fetal heath for several years, apparently, this is the first study to report AFP in mares with
experimentally induced placentitis. Recent studies in human medicine have shown the
importance of AFP as a prognosticator of neonatal infection (for review, Buhimschi &
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Buhimschi 2012). Although AFP is elevated in plasma of mares with experimentally
induced placentitis, it remains to be determined if similar elevations of AFP concentrations
in plasma occur in mares with spontaneous placentitis. It is worth to note, that AFP was
elevated in the later course of the disease, perhaps this protein may have limited application
as early marker for placentitis, but it may have clinical utility as later marker for placentitis
(i.e. chronic stage of placentitis), thus, probable it may be a useful prognosticator for
placentitis since it changed late stages of disease.
Contrary to our results, a study in pregnant cows experimentally infected with
Aspergillus fumigatus, Sarcocystis cruzi or Campylobacter fetus failed to demonstrate
elevation of AFP in association with placentitis induced by these infectious agents (Baetz
et al. 1981). Biological differences between species and pathogeneses of these diseases in
cattle and horses, may explain the contrasting findings. It is worth-noting, that cows may
take several days to expel a dead fetus; however, in mares this is not usually common.
Differences between the assays with regards to sensitivity may also explain the contrasting
results.
In a clinical trial involving a large group of commercial mares, Sorensen and
collaborators (1990) developed an assay for a molecule termed “equine feto-protein”.
From that report, it is unclear whether this protein is AFP or if it is some other molecule
derived from the fetoplacental unit. If “equine feto-protein” is similar to AFP, their
findings concur with ours that placentitis induces changes in peripheral concentrations of
AFP. Unfortunately, the authors did not report the absolute concentrations derived in the
study, under the allegation that the assay was under revision for patent protection.
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Therefore, we cannot compare absolute concentrations if indeed, they measured the same
molecule.
As previously suggested, but not shown by the authors (Lyle et al. 2006), the
cytological appearance of these fluids are distinct enough that amniotic and allantoic fluid
can be easily differentiated from one another, thus creatinine and electrolytes measures can
be replaced by the cytological examination. An interesting aspect of cytology of the fetal
fluids is the fact that only one mare had detectable bacteria, none of the remaining mares
had evidence of bacterial colonies; aerobic bacterial culture confirmed the presence of the
bacteria. However, it is worth-noting that amniotic fluid represented the minority of
samples in the present study; it is possible that more mares would have presented positive
bacterial cultures of the fetal fluids if more amniotic samples were harvested in the present
study.
Since we performed several bacterial cultures in the allantoic fluid, and none of the
samples yielded positive bacterial cultures, despite severe placentitis, we suggest that
during spontaneous infection (i.e. the bacteria infecting the cervical pole of the placenta),
bacteria likely gain access to the fetus through the umbilical cord. It seems very logical to
us that if bacteria would gain access to the fetus through the allantoic fluid, we would have
seen evidence of this infection (i.e. positive bacterial culture of the allantoic fluid). On the
other hand, positive culture of the amniotic fluid may suggest that the fetus was first
infected, and then respiratory and gastrointestinal secretions of bacteria into the amniotic
fluid may happen as a secondary event to the fetal infection, rather than a primary event.
Therefore, we suggest that infection of allantoic fluid may not play an important role in the
mechanism leading to the fetal infection.
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In conclusion, AFP is present in all fetal fluid samples and is increased in plasma
of mares with experimentally induced ascending placentitis, either due to upregulation
and/or increased vascular permeability across the placenta. Cytological preparations of the
fetal fluids can be used to identify its origin. It appears that infection of the allantoic fluid
may not play an important role in the mechanism leading to the fetal infection. Although,
experimentally induced placentitis was associated with an elevation in plasma
concentrations of AFP.
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7.1. Summary
Little is known about the protein composition of equine fetal fluids. The objectives
of this study were to (i) describe the normal protein composition of the amniotic and
allantoic fluids of mares at 300d of gestation, and (ii) compare the protein composition of
the allantoic fluid before and after experimental induction of ascending placentitis. In study
I, three mares carrying normal pregnancies were euthanized at 300 d of gestation and fetal
fluids were collected and preserved at -80oC until further analyses. In study II, three control
mares and three mares with experimentally induced ascending placentitis had allantoic
fluid collected by transabdominal, ultrasound-guided puncture. Fetal fluids were analyzed
with a high-throughput proteomic technique (LC-MS/MS) to characterize the protein
composition of fetal fluids in late-term mares carrying normal pregnancies and allantoic
fluids from mares with experimentally induced placentitis. Approximately 100 proteins
were present in both allantoic and amniotic fluids. Three proteins (i.e. lactoferrin, serum
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transferrin, alpha-1-proteinase were present in allantoic samples and were elevated at least
two fold in mares with experimentally induced ascending placentitis. It remains to be
determined how these changes in fetal fluid proteins are related to ascending placentitis
and whether they have any diagnostic application for placental disease in the mare.
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7.2. Introduction
Ascending placentitis is an important cause of abortion in mares, its diagnosis is
based on clinical signs (vulvar discharge and premature mammary gland development ±
milk streaming) and transrectal ultrasonography (Troedsson & Macpherson 2011). The
clinical signs and associated ultrasonographic changes (e.g. placental separation) are
variable and may only be present in advanced stages of disease; therefore, early diagnosis
would potentially improve the likelihood of a delivery of a viable foal. Recently, our
laboratory has been focused on developing new diagnostic tests for equine placentitis.
Several markers have been investigated in experimental cases and some appear to be useful
tools to detect experimentally induced placentitis. Among these markers, acute phase
proteins, particularly serum amyloid A, appear to be a sensitive but nonspecific marker for
placentitis (Canisso et al. 2012, Canisso et al. 2014).
In the horse, little is known about the protein composition of fetal fluids (Williams
et al. 1993, Paccamonti et al. 1995, Zanella 2008, Zanella et al. 2013). However, in human
medicine, amniotic fluid has been the focus of numerous reports (Ruetschi et al. 2005,
Buhimschi et al. 2008, Romero et al. 2008 Buhimschi &Buhimschi 2012). Two
dimensional gels and LC/MS have been used to identify proteins in the amniotic fluid of
humans (Romero et al. 2008 Buhimschi &Buhimschi 2012, Tambor et al. 2012, Tambor
et al. 2013) .To date, studies conducted with horses were carried out to examine the
electrolyte composition or to investigate the presence of specific proteins present in other
body systems (Paccamonti et al. 1995, Holdstock et al. 1995, Zanella et al. 2013, Canisso
et al. 2014). The protein composition of the equine fetal fluids has received limited
attention either during normal pregnancy (Zanella 2008) or during pathologic conditions
(Finger et al. 2014). Proteomic analyses applied to study the protein composition of the
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equine fetal fluids in earlier studies (Zanella 2008, Finger et al. 2014) provided only limited
identity of protein composition; therefore a high-throughput proteomic technique would
allow more definitive identification of proteins in equine fetal fluids.
In the recent years, high-throughput proteomics techniques have been used to
identify new diagnostic markers in the amniotic fluid of women experiencing
chorioamnionitis or to identify fetal defects (for review, Klein et al. 2014). The application
of a high-throughput proteomic technique such as liquid chromatographic mass
spectrometry (LC-MS) associated with bioinformatics tools provides an opportunity to
identify proteins that have not yet been described in equine fetal fluids . We hypothesize
that the protein composition of the amniotic fluid differs from that of allantoic fluid and
that ascending placentitis alters the protein composition of the allantoic fluid. The
objectives of this study were to (i) describe and compare the protein composition of
amniotic and allantoic fluids of mares carrying normal pregnancies at 300d gestation (ii),
and to compare the protein composition of allantoic fluid before and after experimental
induction of ascending placentitis in normal and control mares.
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7.3. Material and methods
Clinically healthy adult horse mares were enrolled in these experiments. Mares
were maintained at the Maine Chance Farm, Department of Veterinary Science, University
of Kentucky, Lexington, KY, USA. All the experimental protocols were approved by the
Institutional Animal Use and Care committee at the University of Kentucky (Project
#2010-0769). All the animals were kept in paddocks and supplemented with hay, grain and
water ad libitum along with trace minerals. Immediately pre-abortion or prior to normal
parturition the mares were kept in individual stalls (16 x 16 feet) during the night and turned
out in pasture during the day.
Study I: Protein composition of amniotic and allantoic fluids in mares carrying normal
pregnancies in the third trimester of pregnancy
Allantoic and amniotic fluids from mares (n=3) carrying normal singleton
pregnancies, were collected after euthanasia at 300 days of gestation. Within approximately
20 minutes postmortem, samples were harvested through direct access of both fetal
compartments (i.e. allantoic and amniotic) and frozen immediately. A syringe was used to
collect aliquots of the fetal fluids, aliquots of 2 mL were loaded into cryovials and samples
were immersed in liquid nitrogen. From liquid nitrogen, samples were stored at -80oC until
further analyses.
Immediately before analyses, samples were slowly thawed on ice. A fixed volume
of 10 µl of fetal fluid was submitted to vacuum centrifugation for 3 minutes at 38oC to
concentrate the final volume of protein. Samples (5 µL) were diluted (1:1 v/v) with
Laemmli sample buffer (Bio-Rad Laboratories, Hercules, CA) and incubated at 95°C for 4
min followed by electrophoresis on 10% SDS polyacrylamide gels (Mini-PROTEAN
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TGXTM Precast Polyacrylamide Gel, Bio-Rad Laboratories, Hercules, CA, USA). The gels
were run with Tris-Glycine 0.1% SDS at 200V for 20 min. All gels were briefly stained
with Coomassie blue (0.05%, w/v) and subsequently de-stained with methanol (20%) and
glacial acetic acid (10%). Images were obtained using an automatic reader (Cell &
Biosciences, San Andreas, CA, USA).
After destaining, proteins were analyzed at the laboratory of Protein Analyses
(Department of Molecular and Cellular Biochemistry, University of Kentucky) where
proteins were excised from the gel and digested with trypsin. Peptides resultant from this
digestion were analyzed by tandem LC-MS. Peptides obtained with from the LC-MS
analyses were analyzed by an ion trap mass analyzer (Orbitrap®) (Zubarev & Makarov
2013). Resulting spectra were submitted for a MASCOT search sequence for similarity
against other mammalian proteins present in the SwissProt database (excluding humans,
rats and mice). Proteins present were identified by uniprot entries (www.uniprot).
Study II: Protein composition of the allantoic fluid in mares carrying normal pregnancies
and mares with experimentally inducedascending placentitis
Allantoic fluid samples from six mares carrying normal pregnancies (265-280 days
of gestation) were used in this study. Three mares were non-inoculated controls and three
mares had experimentally induced ascending placentitis. As noted in a parallel publication,
ascending placentitis was induced via intra-cervical inoculation of Streptococcus equi
subspecies zooepidemicus (Canisso et al. 2014a).

Allantoic fluid was obtained by

transabdominal ultrasound guided puncture at 0 and 5 days post inoculation/commence of
the study for control mares (Canisso et al. 2014b).
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To assure that control mares had normal pregnancies and to confirm that
experimentally inoculated mares developed placentitis, all placentas were submitted for
routine histopathologic examination (Hong et al. 1993). All mares with experimentally
induced ascending placentitis had inflammatory necrotic changes consistent with bacterial
placentitis and Streptococcus equi subspecies zooepidemicus was the single isolate in the
placenta and aborted fetuses. All mares in the control group delivered normal foals and
placentas.
Only descriptive analyses were used to characterize proteins present in the amniotic
and allantoic fluids of normal mares. In study II, paired t-tests were used to compare
abundance of proteins present in allantoic fluid samples from mares at Days 0 and 5, and
unpaired t-tests were used to compare abundance of proteins across groups. Protein
abundance was based upon spectral count (Zhu et al. 2010). Significance was set at p<0.05
7.4. Results
Based upon non-redudante sequences, a total of 37 proteins were identified in the
amniotic fluid (Table 7.1) and 59 proteins were identified in the allantoic fluid of mares
carrying normal pregnancies at 300 days of gestation (Table 7.2). Most of the proteins
described are secretory proteins, structural proteins. The list of all proteins including ion
scores are listed in the appendices (D). For study II, a total of eight proteins were present
in all allantoic fluid samples (Table 7.2), and among these eight proteins, lactotransferrin,
serotransferrin and alpha-1-antiproteinase were increased at least two-fold from 0 to 5 days
post inoculation in allantoic fluid from mares with experimentally induced ascending
placentitis (p<0.05) and remained unchanged in control samples. Furthermore,
lactotransferrin, serotransferrin and alpha-1-antiproteinase were significantly increased in
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allantoic fluid at day 5 post inoculation in mares with experimentally induced placentitis
compared to control (p<0.05) (Table 7.3).
Table 7.1: Proteins identified in amniotic fluid samples from normal mares at 300d
gestation based upon LC-MS-MS.
Proteins
Serum albumin

Proteins
Alpha-1B-glycoprotein

Fibronectin

Glycoprotein hormones alpha chain

Apolipoprotein

Actin-related protein 3

Gelsolin

Stress-70 protein, mitochondrial

Alpha-fetoprotein

Angiotensinogen

Keratin, type II cytoskeletal 1

Apolipoprotein D

Keratin, type II cytoskeletal 5

Angiotensin-converting enzyme 2

Keratin, type II cytoskeletal 7

Decorin

Keratin, type I cytoskeletal 10

Apolipoprotein E

Keratin, type II cytoskeletal 75

Surfeit locus protein 6

Alpha-2-macroglobulin

Lactase-phlorizin hydrolase

Lactotransferrin

Proteasome subunit beta type-8

Lumican

Type III iodothyronine deiodinase

Coatomer subunit beta

Alpha-1-antiproteinase 2

Hemoglobin subunit beta

Clusterin

Alpha-1-antiproteinase

Melanotransferrin

Major allergen Equine chromosome 1

Uteroglobin

Serotransferrin

Transmembrane protein 198

Phosphatidylinositol 3-kinase regulatory subunit gamma
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Table 7.2: Proteins identified in allantoic fluid samples from normal mares at 300d
gestation based upon LC-MS-MS.
Proteins
Serum albumin
Fibronectin
Hemoglobin
Alpha-fetoprotein
Serotransferrin
Alpha-1-antiproteinase
Annexin A1
Keratin, type II cytoskeletal 5
Keratin, type II cytoskeletal 75
Keratin, type II cytoskeletal 7
Calsequestrin-2
Keratin, type II cytoskeletal 79
LYR motif-containing protein 7
Amyloid beta A4 protein
CD44 antigen O
Insulin-like growth factor-binding protein
Alpha-1B-glycoprotein
Keratin, type I cytoskeletal 10
Ezrin
Moesin
Radixin
SPARC
G-protein coupled receptor
14-3-3 protein zeta/delta
Coatomer subunit beta'
Actin-related protein
Keratin, type II cytoskeletal 1
Metalloproteinase inhibitor 2
Collagen alpha-2 (IV) chain

Peptidase inhibitor 16
Cationic trypsin
Actin, alpha skeletal muscle
Inter-alpha-trypsin inhibitor
Cadherin-2
Regulator of G-protein signaling
Thrombospondin-1
G-protein coupled receptor
Ubiquitin-40S ribosomal protein S27a
Polyubiquitin-B
Secretogranin-1
Phytanoyl-CoA dioxygenase, peroxisomal
Glycerate kinase
Hemoglobin fetal subunit beta
Tenascin
Peptidase inhibitor
Alpha-1-antitrypsin
Cationic trypsin
Calsequestrin-2
SPARC
Inter-alpha-trypsin inhibitor
LYR motif-containing protein 7
G-protein coupled receptor
Uroplakin-1b
14-3-3 protein zeta/delta
Surfeit locus protein 6
Metalloproteinase inhibitor 2
SCO-spondin
Major allergen Equ chromosome 1
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Table 7.3: List of proteins present in the allantoic fluid of mares carrying normal
pregnancies and mares with experimentally induced placentitis based upon LC-MS-MS.
Proteins
Lactotransferrin
Hemoglobin
Inter-alphatrypsin inhibitor
Serotransferrin
Serum albumin
Alpha-1-antiproteinase
Alpha-fetoprotein
Fibronectin

7.5. Discussion

To the authors’ knowledge, this is the first report using high-throughput protein
sequencing to study the protein composition of fetal fluids in mares with normal
pregnancies and in mares with experimentally induced placentitis. Several proteins were
newly identified both in the allantoic and amniotic fluids. Our findings may guide future
research aiming to investigate the physiology of the fetal fluids and potential role of
proteins in the fetal maturation. Since several proteins were newly known to be present in
equine fetal fluids, investigators can use other techniques to quantify specific proteins
described by us.
Interestingly, most of the proteins detected in equine fetal fluids are similar to the
proteins present in the maternal plasma. It should be noted that the type of placentation in
the horse limits exchange of large molecules, therefore, proteins present in the fetal fluids
are likely originated in the fetus, and for instance some proteins like keratin could originate
from fetal skin. It is worthnoting that some molecules present in the fetal fluids are released
into the maternal circulation (e.g. alpha-fetoprotein) and that placentitis increases its

151

concentration in maternal plasma, probably related to increased permeability (Chapter 6).
In the present study, three secretory proteins (i.e. serum transferrin, lactotransferrin and
alpha-antiproteinase) were increased at least two-fold in the allantoic fluid of mares with
experimentally induced placentitis. It is uncertain whether the increase in these proteins
observed here can be used to assess fetal well-being. The increase in these three plasma
proteins in the fetal fluids suggest that the increased permeability may have occurred.
Interestingly, lactoferrin has anti-bacteriostatic capabilities (Kolm et al. 2006). Since
lactoferrin is produced and secreted by the endometrium and is increased in endometritis
(Kolm et al. 2006), increase secretion of this enzyme in the fetal fluids may reflect the
presence of endometrititis-associated with placentitis. It is unknown whether placentitis is
associated with increased secretion of lactotransferrin in the fetal fluids, although this
hypothesis should be tested. Serum transferrin is responsible for ion transport, in human
medicine genetic defects have been associated with excessive and absent congenital serum
transferrin (Bartnikas 2012), in equine medicine, the role of serum transferrin in equine
placentitis is unknown.
Proteomic studies in humans demonstrated that amniotic fluid presented more than
800 types of proteins (Cho et al. 2007). However, in our study about 100 proteins were
found to be present. Reasons for that discrepancy can be associated with biological
variations, different methodology and the current data base available for proteins of equine
origin. In the present study, we use 1-dimensional electrophoresis to separate the
electrolytes known to be present in the fetal fluids (Paccamonti et al. 1995). It is possible
that some proteins that were overabundant in the samples precluded identification of less
abundant proteins. Alternative methods to isolate proteins, such as protein precipitation
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could have been used to remove electrolytes and then concentrate proteins for LC/MS.
Application of different methods would likely result in different outcomes; however, it was
outside the scope of this study to compare different methods.
Alpha-1-antiproteinase is an acute phase protein. It which acts as an antiinflammatory protein, which is increased several-fold upon inflammation (Kolarich et al.
2006, Ahsan et al. 2014). It is believe that this protein has protective effects against several
lytic proteins secreted by neutrophils.

In human medicine, the levels of alpha-1-

antiproteinase in plasma have been used as a diagnostic and prognostic tool for
keratoconjunctivitis (Ahsan et al. 2014). In horses, this protein has been described but its
role in placentitis is unknown. Because this protein was elevated in fetal fluids in mares
with experimentally induced placentitis, and because it is an acute phase protein, alpha-1antiproteinase inhibitor should be evaluated as a possible biomarker for equine placentitis.
Protein composition of the fetal fluids has been the focus of numerous publications
in human medicine, however, these fetal fluids have received limited attention in equine
reproductive medicine, particularly in mares with placentitis. In the present study, protein
composition of the fetal fluids, determined by high-throughput proteomic techniques (i.e.
LC-MS-MS) identified several proteins in the amniotic and allantoic fluids of mares
carrying normal pregnancies. In addition, we demonstrated several proteins that were
previously undescribed in the allantoic fluids of mares with placentitis. Further ongoing
evaluations may determine whether the any of the three proteins found to be elevated in
the allantoic fluid are also elevated in plasma. It remains to be determined whether the
increase is related to protein extravasation or to increased production of these proteins or
whether these proteins are of fetal or maternal origin. For either mechanism, our results in
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both studies open a new field of investigation regarding diagnostic markers present in the
fetal fluids that may be increased or reduced in maternal plasma.
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Chapter 8
General Conclusion and Future Directions

Bacterial placentitis is an important cause of pregnancy loss in mares. Two types
of placentitis were examined in this dissertation: ascending and nocardioform placentitis.
Both types of placentitis occur late in pregnancy, and acute-chronic inflammatory lesions
are present upon delivery/abortion. Acute infections of the gravid equine uterus during
mid-gestation are commonly associated with fulminant bacterial infection of the fetus with
minimal or no lesions present in the placenta, this type of infection is unnoticed and
invariably result in abortion. On the other hand chronic infections of the placenta occurring
from the mid to late term are associated with acute-chronic lesions present in the placenta.
Ascending placentitis and nocardioform placentitis manifest as chronic insidious
infections.
Despite the fact that the first diagnosis of nocardioform was made three decades
ago, little is known about the pathogenesis of nocardioform placentitis. Until now, all our
knowledge about nocardioform placentitis in mares results from epidemiological
observations carried out by the University of Kentucky Veterinary Diagnostic Laboratory.
Lack of a research model to experimentally induce nocardioform placentitis has limited
our understanding of the disease. Since nocardioform lesions are located at the base of the
uterine horn and body, it has been speculated that the bacteria gain access to uterus during
breeding or other gynecological interventions; however, inoculation of mares with C. equi
after artificial insemination did not result in nocardioform placentitis. In addition,
endometrial swabs collected from commercial Thoroughbred mares immediately before or
after mating did not provide evidence or suggest that nocardioform placentitis is
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transmitted during mating. Furthermore, oral, respiratory, and intravenous inoculation of
C. equi did not result in clinical nocardioform placentitis. These findings demonstrated that
the simple presence of C. equi was not sufficient to induce disease. This may indicate that
other unidentified factors may play a role in disease pathogenesis. Alternative routes of
inoculation (e.g. ocular), using different bacterial isolates and species of microorganisms,
different doses and intervals of inoculation should be tested.
The second and major component of this dissertation involved the identification of
diagnostic markers for placentitis. Because ascending bacterial placentitis is readily and
predictably induced using existing experimental models, this type of placentitis was used
to identify diagnostic markers for placentitis in maternal plasma and fetal fluids. Currently,
the diagnosis of ascending placentitis is based on transrectal ultrasonography and clinical
signs. Often clinical signs and associated ultrasonographic changes are only present in
well-advanced stages of placentitis, thus there is a real need to investigate new markers for
placentitis. In the present dissertation, three main fields were explored to identify new
markers for bacterial placentitis as follows: acute phase inflammatory proteins, steroid
hormones produced by the fetal placental unit, and protein composition of the fetal fluids.
Of the three acute phase proteins investigated, serum amyloid A and haptoglobin
but not fibrinogen increased remarkably in association with experimentally induced
ascending placentitis. Until very recently, placentitis was thought to be a disease of the
equine pregnant uterus without detectable inflammatory changes in maternal plasma. The
anecdotal suggested lack of changes in WBC cells and fibrinogen in maternal plasma, as
these two are the most widely used means to evaluate inflammation in the horse. Indeed,
our experimental findings here confirmed that placentitis was not associated with changes
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in WBC and fibrinogen. The findings that serum amyloid A and haptoglobin are elevated
in maternal plasma raise the question of the origin of this elevation. It is likely that this
detectable increase in maternal plasma has some involvement of the endometrium, since
experimentally induced endometritis using a high inoculating dose was associated with
systemic elevation in serum amyloid A. It is likely that other inflammatory markers change
in mares with placentitis, thus further investigation in this particular field may enhance our
knowledge about placentitis and may allow us to identify new markers for placentitis.
Steroids produced by the fetoplacental unit including androgens, estrogens and
progestins were investigated in the present dissertation. The use of fetoplacental unit
steroids as markers for placental health are not necessary a novel idea, however, we
investigated steroids (i.e. testosterone, estrone sulfate, DHEA-S, and estradiol 17β) that
have not been investigated yet in mares with placentitis. Androgens appear to be poor
marker for experimentally induced ascending placentitis. On the other hand, concentration
of estradiol 17β and estrone sulfate were reduced in mares with experimentally induced
placentitis. Estrone sulfate has been suggested for years to be a good marker to assess fetalwellbeing; however, until now it has not been evaluated in mares with placentitis. Mares
with experimentally induced placentitis presented reduced concentrations of estrone sulfate
close to abortion, and this probably limits the use of this molecule as a biomarker for
placentitis in mares. On the other hand, estradiol 17β was reduced in mares with
experimentally induced placentitis, and this molecule appears to be a good potential marker
for placentitis in mares.
Protein composition of the fetal fluids has been the focus of numerous publications
in human medicine; however, analysis of fetal fluids has received limited attention in
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equine reproductive medicine. In the present dissertation, different methods were used to
study the protein composition of the fetal fluids. In the first study, alpha-fetoprotein was
characterized as a major protein present in the equine fetal fluids, and this protein was
elevated in plasma of mares with placentitis. In a second study, conducted to evaluate the
protein composition of the fetal fluids, using a high-throughput proteomic technique (i.e.
LC-MS-MS) several new proteins were discovered in the amniotic and allantoic fluids of
mares carrying normal pregnancies. In addition, for the first time using a LC-MS-MS, we
demonstrated several proteins that were unknown to be present in the allantoic fluids of
mares with placentitis. Further ongoing evaluations, may determine whether some of these
newly discovered proteins are elevated in allantoic fluid. In the first study involving protein
composition of the fetal fluids, we demonstrated that alpha-fetoprotein, a protein originated
in the fetoplacental unit is released in the maternal circulation, and that placentitis increases
its concentrations. It remains to be determined whether the increase is related to protein
extravasation or to increased production of this molecule. For either mechanism, our
results in both studies open a new field of investigation regarding diagnostic markers
present in the fetal fluids that may be increased or reduced in maternal plasma.
In the present dissertation, an experimental model to induce ascending bacterial
placentitis was used to identify new diagnostic markers for this disease; however, further
studies should be carried to investigate whether the diagnostic markers for experimentally
induced placentitis are useful markers for spontaneous placentitis.

Copyright © Igor Frederico Canisso 2014
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Appendices
Appendice A:
The information listed in the present manuscript has been included as
supplementary material in the manuscripts generated out of this dissertation.
Study I: Breeding Management

The mares were examined 3 to 4 times per week by transrectal palpation and
ultrasonography (coupled with a linear transducer 5 MHz Titan® Sonosite Bothell, WA,
USA) until a preovulatory follicle (i.e. ≥35 mm, presence of endometrial edema) was
detected. If needed, mares were given prostaglandin F2α (7.5 mg, IM, Pfizer Animal
Health, USA) to induce estrus. The mares were bred with fresh extended semen using a
commercial extender (Equi-Pro®, Minitube of America, Verona, WI, USA) without
antibiotics.’
Once mares had a preovulatory follicle, they were bred with ≥ 500 million
progressive motile sperm with pooled semen from three fertile stallions. A single dose of
human chorionic gonadotropin (i.e. 2,500 units, Intervet/Schering-Plough Animal Health
New York, NY USA) was given intravenously to induce ovulation. If the mare did not
ovulate by 48 h after the first breeding, she was re-bred every 48 h until an ovulation was
detected.
At 24 h post breeding, each mare received an intrauterine inoculation of C. equi (1
x 104 cfu in 1mL of skimmed milk). The inoculum was deposited into the uterine body
through the use of a commercial (Minitube of America, Verona, WI, USA) semi-flexible
AI pipette containing a stylet for deposition. Each inoculum was cultured to confirm
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viability of the bacterial agent. At 24h post inoculation, each mare had an endometrial swab
collected for PCR testing for C. equi [Reference 7]. The mares were re-checked by
transrectal palpation and ultrasonography every 48 h until ovulation was detected. The
mares accumulating intrauterine fluid received oxytocin injections twice daily (20 iu; IM,
Bimeda Animal Health, Oakbrook Terrace, IL, USA) until fluid accumulation was not
detectable with ultrasound.

Study II
Bacterial culture

The culture was prepared on blood agar plates, and incubated at 37oC for at least 3
days in aerobic culture. Pure culture of C. equi was confirmed using the characteristic
pungent/soil odor, hard colonies, dark field examinations, gram staining and PCR analysis
[References:7,14]. Briefly, 20-30 colonies were picked, suspended in 2 ml of Mueller
Hinton Broth (with cation adjusted) in Magna lyser Green Beads Tubes (Roche
Diagnostics, Indianapolis). To break hard C. equi colonies, suspension was homogenized
using a commercial bead-beating system (Roche Diagnostic, Indianapolis) at the speed of
7,000 rpm for 30 sec. The homogenate was centrifuged at 12000 rpm for 3 min, and then
the cell pellet was washed 3 times with PBS. The final pellet was resuspended in PBS and
kept on refrigerated. This final suspension was then 10 fold-serial diluted and plated on
agar plates. Cell numbers were counted, cfu was calculated and inoculation was performed
next day. Since approximately 30% of the bacterial cells become dead by next day by this
procedure (unpublished data, Erol), inoculum (cfu) was adjusted accordingly to make 109
viable Crossiella. equi.
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Appendice B

Figure 3.1 (A & B): Serum amyloid A (SAA) and haptoglobin (Hp) concentrations in a
control mare excluded from the statistical analyses. During the entire sampling period the
concentrations of SAA (<20mg/L) and Hp (<2.7 mg/mL) remained within normal ranges.
Transabdominal guided fetal fluid sampling was performed at days 0, 5 and 12. She aborted
8 days after the last fetal fluid sampling. Pathological and microbiological examination of
the placenta and fetus revealed no lesions and culture yielded saprophytic non-pathogenic
bacteria and negative virus isolation; thus the cause of abortion was not determined.
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Figure 3.2 (A &B): Serum amyloid A (SAA) and haptoglobin (Hp) concentrations in a
mare that failed to develop placentitis after experimental induction of placentitis. This mare
was excluded from the statistical analyses. During the entire sampling period the
concentrations of SAA (<20mg/L) and Hp (<2.7 mg/mL) remained within normal ranges.
This mare was not re-inoculated. At parturition, there was no evidence of placentitis. This
mare belonged to the subgroup without fetal fluid sampling. The mare delivered a normal
foal and placenta with no pathological or microbiological evidence of placentitis.
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Figure 3 (A & B): Serum amyloid A (SAA) and haptoglobin (Hp) concentrations in a mare
that failed to develop placentitis after experimental induction of ascending placentitis.
During the first two weeks follow to inoculation concentrations of of SAA (<20mg/L) and
Hp (<2.7 mg/mL) remained close to normal ranges. Transabdominal guided fetal fluid
sampling was not performed at any time on this mare. There were no signs of placentitis
upon ultrasonographic examination. This mare was re-inoculated two weeks after the first
attempt. Data for SAA and Hp concentrations in the first two weeks were excluded from
statistical analyses. After re-inoculation this mare developed signs of placentitis and
aborted 20 days after re-inoculation.
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Figure 4 (A & B): Serum amyloid A (SAA) and haptoglobin (Hp) concentrations in a mare
after experimental induction of ascending placentitis. Transabdominal guided fetal fluid
sampling was performed at days 0, 5 and 12. SAA concentrations remained slightly
elevated normal ranges upt across all days (i.e. <20mg/L). Concentrations of Hp remained
within normal ranges across all days (i.e. < 2.7 mg/mL). This mare failed to develop
placentitis; there were no signs of placentitis upon ultrasonographic examination. Data for
SAA and Hp concentrations in the first two weeks post the inoculation were excluded from
statistical analyses. The mare was re-inoculated 14 days post inoculation, developed signs
of placentitis and aborted 9 days post-re-inoculation.
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Figure 3.5: Serum amyloid (SAA), haptoglobin (Hp), fibrinogen (Fb) concentrations and
white blood cell counts (WBC) in a control mare subgroup with fetal fluid sampling. This
mare developed extensive cellulitis at the Viborg’s triangle secondary to venipuncture, thus
she was excluded from the analysis. Concentrations of SAA, Hp, Fb and WBC were
elevated once the mare developed the condition. The mare delivered a health foal and
normal placenta at 330 days of gestation.
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Table 3.1: Separation of the chorioallantois from the endometrium near the cervical star in
mares (n = 14) with experimentally induced ascending placentitis. The placenta was
examined by transrectal ultrasonography performed every other day from inoculation until
abortion.

As noted in the manuscript, three mares did not develop placentitis (data not included in
the table above). During the first 14 days post inoculation none of these three mares
developed areas of placental separation. Two of the mares were re-inoculated 14 days
following the first inoculation; both mares were detected to have areas placental of
separation by 5-6 days post inoculation, one mare aborted 3 days later, another mare
aborted 14 days.
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Appendice C
Table 1: Proteins present in the amniotic fluid in 1 or 2 samples. The entries on the left
column represent the accession number on uniprot.
Protein
identification
P49822
P02062
P38029
Q95182
P24627
P09571
P34955
P12725
P23035
O46404
Q2KJF1
P35605
P01219
P61157
Q6EIY9
P85295
Q3ZCH0
Q95182
P20757
Q29477
Q32KY0
P37153
Q56H28
Q58DD0
Q56NL1
Q29443
Q28888
Q7M2U7
P18649
Q03247
P18287
Q0VCY3
P09849
Q3T112

Comon name (Species)
Serum albumin (Canis familiaris)
Hemoglobin subunit beta (Equus caballus)
Alpha-1-antiproteinase (Equus caballus)
Major allergen Equ c 1 (Equus caballus)
Lactotransferrin (Bos taurus)
Serotransferrin (Sus scrofa)
Alpha-1-antiproteinase (Bos taurus)
Alpha-1-antiproteinase (Ovis aries)
Alpha-1-antiproteinase (Oryctolagus cuniculus)
Phosphatidylinositol 3-kinase regulatory subunit gamma (Bos taurus)
Alpha-1B-glycoprotein (Bos taurus)
Coatomer subunit beta' (Bos taurus)
Glycoprotein hormones alpha chain (Sus scrofa)
Actin-related protein 3 (Bos taurus)
Keratin, type II cytoskeletal 1 (Canis familiaris)
Serum albumin (Fragments) (Capra hircus)
Stress-70 protein, mitochondrial (Bos taurus)
Major allergen Equ c 1 (Equus caballus)
Angiotensinogen (Ovis aries)
Lactotransferrin (Capra hircus)
Apolipoprotein D (Bos taurus)
Apolipoprotein D (Oryctolagus cuniculus)
Angiotensin-converting enzyme 2 (Felis catus)
Angiotensin-converting enzyme 2 (Bos taurus)
Angiotensin-converting enzyme 2 (Paguma larvata)
Serotransferrin (Bos taurus)
Decorin (Oryctolagus cuniculus)
Apolipoprotein E (Zalophus californianus)
Apolipoprotein E (Canis familiaris)
Apolipoprotein E (Bos taurus)
Apolipoprotein E (Oryctolagus cuniculus)
Surfeit locus protein 6 (Bos taurus)
Lactase-phlorizin hydrolase (Oryctolagus cuniculus)
Proteasome subunit beta type-8 (Bos taurus)
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Q5W416
Q29576
Q5I3B1
Q6QN11
Q6DN07
P38029
P14632
Q29482
P14632
O97490
Q6EIZ0
Q8MKG2

Q08E36
P18649
Q03247
Q3SZ57

Proteasome subunit beta type-8 (Canis familiaris)
Proteasome subunit beta type-8 (Fragment) (Sus scrofa)
Type III iodothyronine deiodinase (Bos taurus)
Type III iodothyronine deiodinase (Sus scrofa)
Type III iodothyronine deiodinase (Ovis aries)
Alpha-1-antiproteinase 2 (Equus caballus)
Fibronectin (Bos taurus)
Lactotransferrin (Bos taurus)
Clusterin (Equus caballus)
Lactotransferrin (Sus scrofa)
Melanotransferrin (Oryctolagus cuniculus)
Keratin, type I cytoskeletal 10 (Canis familiaris)
Uteroglobin (Equus caballus)
Serotransferrin (Sus scrofa)
Keratin, type II cytoskeletal 1 (Canis familiaris)
Alpha-1B-glycoprotein (Bos taurus)
Transmembrane protein 198 (Bos taurus)
Apolipoprotein E (Canis familiaris)
Apolipoprotein E (Bos taurus)
Alpha-fetoprotein (Bos taurus)
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